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The regulation of human DNA replication operates via the time-programmed activation 
and deactivation of approximately 30,000 replication origins distributed along the 
genome. A multi-protein replicative complex recognizes and assembles onto each 
origin; this determines the local unwinding of the origin DNA and the start of two 
oppositely moving replicative forks. The mechanism that governs the selection of a 
specific DNA sequence as human (and, more generally, metazoan) origin, in the course 
of G1 phase of the cell-cycle, is still poorly understood. The lack of DNA-sequence 
consensus among well-characterized replication origins, together with the little binding-
specificity displayed by the Origin Recognition Complex, suggest that origin selection 
might rather be determined by local chromatin structures and/or accessory targeting 
proteins. With regard to the latter possibility, it was interesting to find out that three 
homeotic proteins, namely HOXC13, HOXC10, and HOXA13 display a specific 
affinity for a DNA fragment corresponding to the sequence covered by the Replicative 
Complex of the human Lamin B2 replication origin.  
 In the study conducted during this Ph.D. program, the possible role of homeotic 
proteins in origin function was explored by investigating the involvement of a selected 
homeotic protein, namely HOXC13, within the replicative complexes in living human 
cells. To this purpose, recent advances in biophysical microscopy technologies were 
exploited to study in vivo the localization, dynamics, and interactions of HOXC13 
protein in the context of DNA replication regulation. The data reported in this thesis 
demonstrate that HOXC13 indeed participates in origin function. The protein is a stable 
component of early replicating chromatin, as it displays stable chromatin binding in 
correspondence to the nuclear areas where replication foci of early S phase are 
collected. This peculiar behavior is driven by the homeodomain and relies mainly on the 
conserved homeodomain arginine-5 anchoring to the DNA minor groove. Furthermore, 
HOXC13 displays unambiguous affinity for origin sequences and for selected 
replicative-complex proteins. The close proximity of HOXC13 to both Cdc6 and ORC2 
proteins measured in living cells proves that the homeotic protein is involved in direct 
protein-protein interactions within the replicative-complex; not unexpectedly, such 
interactions are modulated in a cell-cycle dependent fashion that is consistent with 
origin function. 
Abstract 2 
 These observations are not restricted to a single origin, but rather appear to have a 
general significance in the nuclear architecture of DNA replication; nor are they 
restricted to a single homeotic protein, as the HOXC13 exerts its function via highly 
conserved homeodomain residues. Hence, this dissertation argues that the 
homeoproteins functionally contribute in a general manner, dependent on their 
chromatin-binding properties, to the specification of origins, likely the early replicating 
ones. In this view, HOX proteins, probably in the context of a multi-protein homeotic 
effector, contribute to recruit and stabilize the replicative complexes onto early 
replicating origins, in presence of specific chromatin and topological configurations. 
Considering that HOXC13, involved in development and differentiation, is also an 
oncoprotein, the data presented in this thesis, besides offering an indication for the basis 
of origin selection, hint at the homeotic proteins as actors in the cross-talk between 




The work reported in this dissertation explores the possible connection between two 
traditionally separated fields of biology, namely the regulation of DNA replication and 
the function of homeotic proteins. Therefore, in order to provide the conceptual frame 
of my experimental work, the two following paragraphs will be focused respectively on 
a description of the mechanisms of DNA replication (paragraph 1.1) and of the 
structure and function of homeotic proteins (paragraph 1.2). In particular, I shall 
underline what is still missing for a satisfactory understanding of DNA replication 
regulation in metazoan organisms, and to what extent could the homeotic proteins be 
involved in principle in the process. Moreover, in this thesis I describe novel 
technological approaches for the investigation of the dynamics of DNA replication 
regulation in living cells. They result from recent advances in biophysical and 
microscopy technologies, providing improved strategies and tools for approaching 
problems in modern proteomics, namely high-resolution imaging of biological 
processes and in vivo analysis of protein dynamics and protein-protein interactions. 
Accordingly, in paragraph 1.3 I shall review the main advantages offered by 
biophysical approaches and the results achieved through them so far in the study of 
nuclear dynamics and of the subnuclear details of DNA replication mechanisms. 
Finally, paragraph 1.4 will clearly indicate the scope of this thesis and how it has 
oriented the choice of the experimental approach.  
1.1 Regulatory mechanisms of eukaryotic DNA replication  
1.1.1 Eukaryotic DNA replication: an overview  
DNA replication is a tightly regulated and complex process whereby the exact 
duplication of a genome is achieved, only once per cell division, in every proliferating 
cell. The regulation of DNA replication in eukaryotic genomes appears to be far more 
complex than in bacteria, where replication occurs starting from a single origin (Figure 
1.1a). The latter case is suitably described by the original replicon model proposed in 
1963 by Jacob and Brenner, who postulated the existence of two important elements 
required for replication initiation: the replicator and the initiator [1]. The replicator is 
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the cis-acting sequence within the genome from which replication starts; the initiator is 
a positive trans-acting factor able to recognize specifically the sequence of the replicator 
within the genome. In response to the appropriate cellular signals, the initiator directs 
the local unwinding of the replicator sequence and recruits additional factors to initiate 
the process of DNA replication. Eukaryotic genomes are very large and their replication 
rate is slow, when compared to the prokaryotic replicon model [2]. Nevertheless, the 
process of DNA replication is restricted to a relatively narrow window of the eukaryotic 
cell-cycle, namely the S phase. This is made possible by the start of DNA replication at 
thousands of different chromosomal locations that are specifically selected (Figure 
1.1b). These sites are referred to as origins of DNA replication, and the process of DNA 
synthesis relies on a spatio-temporal coordinated cycle of activation and deactivation of 
the origins. The advantage of this mechanism, besides reducing the overall time 
required to duplicate the entire genome, is that the generation of single-stranded DNA 
(ssDNA) is much more localized and transient, helping preserving the genome integrity 
[3, 4]. Actually, the activation of all origins dislocated in eukaryotic genomes leads to 
the formation of tandemly arranged replication units, and each one can be putatively 
considered as an analog of the bacterial replicon [5].  
 
 
Figure 1.1 Regulation of DNA replication by origin usage. a) Prokaryotes have a single origin on a 
circular chromosome. b) In eukaryotes, multiple origins are found on a single, linear chromosome. This is 
useful to achieve a “fast” replication, whereas if only one origin were used in this region replication 
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would be “slow”. Replication proceeds bi-directionally from an origin to form a replicon (bottom). Taken 
from Sclafani et al. [6]. 
 As a process, DNA replication can be divided into three steps: initiation, elongation 
and termination. During initiation [7], a DNA sequence is selected to be an origin (i.e. 
the start site) of DNA replication, usually in correspondence to AT-rich sequences, and 
initiator proteins assemble thereon. This results in the formation of a multi-protein 
complex which is responsible of the local melting of the duplex, that is necessary for the 
proteins to have access to the template strands; subsequently, the complex stabilizes the 
ssDNA that is formed, and two replication forks comprising DNA helicases and 
polymerases start to replicate the two parental DNA strands in opposite directions. The 
elongation [8, 9] is actually the continuation of the unwinding activity by the two fork 
complexes that ensures simultaneous replication of both parental DNA strands also 
outside of the origin sequence. When two replication forks converge, they merge and 
termination of replicon duplication can occur [10, 11]. 
 Significant differences exist between DNA replication mechanisms in lower and 
higher eukaryotes. In the former ones, replication occurs at site-specifically defined 
replication origins (e.g. 250 - 400 in S. cerevisiae) that share conserved features in their 
sequence [3]. Conversely, higher eukaryotic organisms display a number of origins that 
is at least 100-fold higher and, at present, no sequence specific replicators have been 
found [12-15]. For example, it is estimated that in human cells replication initiates from 
30,000 replication origins, a complexity that is difficult to harmonize with the simple 
replicon model. In spite of theses disparities between lower and higher eukaryotes, the 
proteins that regulate replication are highly conserved in function from yeast to 
Drosophila, from Xenopus to human, suggesting a common mechanism in the 
replication function that does not depend on the origin sequence itself [16-19]. In 
addition, structural and functional homologues of many proteins involved in DNA 
replication also exist in Archea. Even in these organisms, the starting mechanism of 
DNA replication is similar to eukaryotes and involves the binding of a multi-protein 
complex to the replication origin [20].  
1.1.2 Multiple levels of DNA replication regulation within cell-cycle 
progression 
The complexity of DNA replication in higher eukaryotes implies many levels of 
regulation including origin decision, timing of origin firing and inhibition of origin re-
firing. Although DNA is replicated only during the S phase of the cell-cycle, these 
mechanisms take place at different times during cell-cycle progression, to ensure a 
stepwise regulation of the process and its coordination with the other events of the life 
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cycle of the cell. The first regulatory step of DNA replication concerns the initiation, i.e. 
the activation of the replication origins. This occurs starting from the end of M phase 
and onset of G1 phase [21], when several proteins taking part to the pre-replicative 
complex (pre-RC) select the DNA sequences to be replication origins and, by binding to 
these regions, commit the recruitment of other proteins involved in origin firing. By the 
beginning of S phase, after origin firing, the pre-RC gets reorganized at the origin due to 
the modification or degradation of several of its members, as regulatory mechanisms to 
avoid re-replication [22-24]. It is actually the temporal separation of pre-RC assembly 
from origin activation that ensures that new pre-RC cannot assemble on origins which 
have already fired [22, 25]. These mechanisms rely on the activity of cell-cycle 
regulated kinases, among which CDK (cyclin-dependent kinase) that act on several 
target proteins [7], and will be listed in detail in the next paragraph 1.1.3. Because this 
kinase activity remains high from S phase onset to the end of the following mitosis, re-
licensing cannot occur until the beginning of the next cell cycle [22, 26, 27]. 
 Meanwhile in G1 phase, for all the sequences selected as origins, a timing of 
replication initiation is assigned and only a subset of these will fire immediately after 
entry into S phase (early origins). The rest (middle and late origins) are programmed to 
fire in ordered manner later on after early origins. This results in an organized spatio-
temporal activation of replication clusters of different subchromosomal domains at 
different times during S phase [28, 29]. CDKs have also been implicated in controlling 
the time of replication initiation at specific origins [29, 30]. However, the mechanism 
that regulates the timing of replication is not completely understood and currently under 
intense investigation. Originally, because transcriptionally active euchromatic regions 
replicate early and inactive heterochromatic regions late, it was thought that early 
replication is a prelude to transcription. Under this hypothesis, transcription requires an 
opening of chromatin which allows also easy access to replication factors. Up to date, 
the relationship between transcription and replication in regulating the temporal 
program is unclear in that it has never been established whether transcription of these 
regions causes replication or vice versa [6, 31]. Furthermore, the timing of origin 
activation has been reported to correlate with a developmental program rather than with 
transcription per se [32, 33]. Recent advances in DNA microarray technology have 
enabled eukaryotic replication to be studied at whole-chromosome and genome-wide 
levels. These studies, in both S. cerevisiae and higher eukaryotes, have provided new 
insights into the temporally coordinated activation of replication initiation [34]. In 
detail, they have revealed clear connections between chromosome organization and 
replication timing. For example, in yeast, the centromeric proximal sequences are 
consistently early replicating and telomeric regions are consistently late replicating. 
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Studies in metazoa have so far confirmed the recurring correspondence between 
replication and transcriptionally active regions [14, 15, 34]. 
 During the course of S phase, several other proteins ensure the fork progression 
during DNA replication elongation. Given the complexity and the importance of this 
phase for the maintenance of genome integrity, many different checkpoint pathways are 
active within this time window, as demonstrated by studies in the yeast model [35]. 
These checkpoints encompass the whole phase of DNA synthesis, as well as the switch 
to G2 phase, and comprise a variety of mechanisms to prevent replication defects, repair 
damaged replication forks, and enable fork reactivation. For their role in the overall 
control of the cell-cycle progression, as well as the control of genomic stability, they are 
often referred to as cell-cycle checkpoints [36, 37]. Very interestingly, often the 
induction of a cell-cycle checkpoint results in the retroactive regulation of the 
recruitment of key members of the pre-RC to the origin site. For example, in budding 
yeast, hydroxyurea treatment not only blocks fork progression from early-origins but 
also prevents the firing of late-origins, and this mechanism was shown to depend on 
Rad53 and Mec1 [38]. The same conclusion was obtained also following induction of 
double-strand breaks, and the protein involved in this regulation was shown to be yeast 
ORC2 [39]. Moreover, a post-S phase role was recently proposed for the control of re-
replication also for the initiator protein Cdc6 [40, 41]. 
 Altogether, these data point to the same factors involved in DNA replication 
initiation as important actors also in the regulation of the replication process at different 
stages during the cell-cycle, being the targets of many checkpoint controls. It is 
therefore worth to go into more depth with regard to pre-RC proteins and the switch 
from initiation to elongation, as will be discussed in the next paragraph.  
1.1.3 From initiation to elongation in eukaryotic DNA replication 
DNA replication starts from the stepwise recruitment of the replication machinery to the 
various origins on the chromosome. The recruitment process is called initiation, to 
distinguish it from the subsequent replication of the DNA by the replisome that is called 
elongation. As explained in the previous paragraph, initiation is a major point at which 
DNA replication is regulated: the ordered recruitment of these proteins onto the origin is 
indeed responsible for controlling the process of initiation of DNA replication in terms 
of both space and time; furthermore, their subsequent inactivation or removal is 
believed to be necessary to prevent re-replication during S phase. For these reasons, 
initiator proteins are crucial in regulating origin activity. 
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 The basic mechanism of initiation occurs in several steps that finally lead to 
bidirectional replication from the origin (Figure 1.2), namely: 
1.  Recognition: labeling of the origin by ORC (Origin Recognition Complex), 
Cdc6 and Cdt1; 
2.  Initiative assembly (or Licensing): loading of the MCM DNA-helicase to form 
the pre-RC; 
3.  Unwinding: activation of the MCM DNA helicase; 
4.  Elongative assembly: loading of the complete replisome, including DNA 
polymerase enyzmes and SSB (single-stranded DNA binding protein). 
The ordered sequence of these four steps allows the switch from initiation of elongation; 
each of them will be briefly summarized below. 
 
 
Figure 1.2 Model of the regulation of DNA replication. In eukaryotic DNA replication, a replication 
origin is recognized by ORC, and then Cdc6 and Cdt1 proteins load the MCM helicase to form the 
“licensed” (L) pre-RC in G1 phase (L = 1, A = 0). Geminin inhibits Cdt1 and pre-RC formation. CDK 
and DDK become active in late G1, activate (A) the MCM helicase and load on the replisome that 
contains the DNA polymerases. In addition, CDK inhibits any further licensing (L = 0, A = 1). To this 
end, CDK phosphorylates Sld2 and Sld3 proteins and DDK phosphorylates MCM proteins, which 
“pushes out” the “A” domain of Mcm5. Adapted from Sclafani et al. [6]. 
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1. Recognition: in this step, ORC recognizes and marks the origins, which is proposed 
to occur between late M and G1 phase [21], and provides a “landing-pad” for other two 
proteins coming during the course of G1 phase, namely Cdc6 and Cdt1. The ORC is a 
six-protein complex containing ORC1–6 proteins (Figure 1.3) in equal stoichiometry 
and was first isolated in yeast cells for the specific recognition of origin sequences [42]. 
Although the ORC1–6 proteins are conserved in evolution (Figure 1.3B), the 
recognition of specific sequences is a property lost in ORC of most higher eukaryotes, 
and only a preference for AT-rich sequences can be observed. This is expected because 
origins have no consensus DNA sequence in metazoa (see paragraphs 1.1.1 and 1.1.5). 
The most striking example of this phenomenon is when recombinant ORC1–6 proteins 
from human replaced the frog ORC1–6 proteins in vitro to initiate DNA replication in a 
sequence-independent manner [43].  
 
 
Figure 1.3 Schematic pictures of ORC1-6 and Cdc6 proteins from S. cerevisiae. A) ORC1-5 and 
Cdc6 each contain an AAA+ domain as part of a larger ORC/Cdc6 homology domain (orange). Motifs 
within the AAA+ domain include Walker A (WA), Walker B (WB), Sensor-1 (S1) and Sensor-2 (S2). 
The winged-helix domain (WH) is involved in DNA binding. ORC1 contains an additional BAH (bromo-
adjacent homology) domain (pink). ORC1 and ORC2 have disordered regions (yellow); a DNA-binding 
AT- hook motif (here PRKRGRPRK) is identified in S. cerevisiae ORC2, and several of these have also 
been identified in disordered regions of S. pombe ORC4. B) Homology between ORC6 in D. 
melanogaster (Dm), H. sapiens (Hs), A. thaliana (At), S. pombe (Sp), and S. cerevisiae (Sc). The 
conserved domain is depicted in orange. ORC6 has no recognizable homology to ORC1-5 or AAA+ 
domains. The C-terminal region of ORC6 in D. melanogaster has been proposed to be a coiled-coil motif. 
The number of amino acids for each protein is indicated at the right side. Adapted from: Duncker et al. 
[44]. 
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 To date, it is not clear which DNA or chromatin structure the ORC from most 
organisms recognizes. ORC may recognize a unique chromatin structure dictated by 
epigenetic determinants and not primary DNA sequence. This recent theory is supported 
by several observations. Histones at the origins in Drosophila follicle cells are 
hyperacetylated and changes in the acetylation level affect ORC binding [45]. In frog, 
acetylated histones are preferentially found at active origins [46]. Recently, ORC was 
found to map at a precise nucleosome positioning [34]. Overall, these observations fall 
within the more general riddle of how replication origins are actually determined in 
metazoa, which will be addressed in detail in paragraph 1.1.5. 
 Most ORC subunits belong to the superfamily of AAA+ ATPases (ATPases 
Associated with various cellular Activities) and share conserved motifs, except for 
ORC6 [44] (Figure 1.3). The ATP-binding activity is required in the process of origin 
DNA recognition. Indeed, in S cerevisiae the ORC1 ATPase activity is inhibited until 
Cdc6 protein, which is also an AAA+ ATPase (Figure 1.3A), is recruited and activates 
ORC1 ATPase, thus resulting in the specific recognition of the origin (see also Figure 
1.7A and next paragraph) [47]. The role of the ORC6 protein is controversial. ORC6 is 
required for viability in yeast but is not required for DNA binding in vitro. In metazoan 
cells, complexes with lower amounts of ORC6 than the other ORC1–5 proteins still are 
active and in Drosophila all six subunits are needed [44]. 
 In yeast, the ORC is bound to origins throughout the cell cycle and re-replication is 
avoided by phosphorylation of ORC2 and ORC6 by CDK1. However, in other 
eukaryotes, ORC binding is regulated, based on a mechanism known as the “ORC 
cycle” [48]. This is used to avoid re-replication and consists in the dissociation of ORC1 
from the chromatin-bound ORC2–5 complex and its subsequent degradation in cells at 
the end of G1 phase and beginning of S phase [23, 49]. The process is regulated by 
CDK1-cyclin A phosphorylation [50]. 
 Recent research avenues have identified roles for ORC proteins other than direct 
controlling DNA replication initiation. ORC1 has been reported to participate in gene 
silencing via its BAH domain (Figure 1.3) providing a direct interaction with 
heterochromatin protein Sir1 in S. cerevisiae [51], as well as with heterochromatin 
protein 1 (HP1) in Xenopus and Drosophila [52]. In both cases ORC1 helps Sir1 and 
HP1 to propagate silenced chromatin. Also ORC2 has been reported to be important for 
heterochromatin maintenance [53]. In metazoan cells, ORC localization clearly extends 
beyond origin sequences (reviewed by Chesnokov et al. [54]). Studies in human cells 
have revealed that ORC6 also localizes to the cleavage furrow in dividing cells, and a 
role for this protein in cytokinesis has been confirmed by RNA interference depletion of 
the protein [55]. In addition, human ORC6 was shown to localize to kinetochores and 
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reticular-like structures around the cell periphery during mitosis, and to be required for 
the proper progression of this cell-cycle stage [56]. Human ORC2 also localizes to the 
centrosome throughout the cell-cycle and its depletion results in mitotic defects and 
multiple centrosomes [53]. Recently, a similar role in controlling centrosome copy 
number was reported for human ORC1 [57]. 
2. Initiative assembly: The next step is to load the DNA helicase onto the origin 
(Figure 1.2). This is accomplished by at least two proteins, Cdc6 and Cdt1, that recruit 
the MCM helicase to finally achieve the pre-RC assembly onto the origin. “Replication 
licensing” is a useful term that is used to describe the process in which origins are 
“licensed” when the MCM helicase is loaded onto them in G1 of the cell-cycle [58]. 
Thus, pre-RC formation equates with “licensing.”  
 Cdc6 is also an AAA+ ATPase (see Figure 1.3A), which is required to load on the 
MCM helicase in G1 phase, as shown in experiments performed in budding yeast which 
also revealed the importance of its ATPase activity to exert this function [59]. In detail, 
the Cdc6 and ORC ATPases act sequentially, with Cdc6 required initially. In a recently 
proposed model, Cdc6 and origin chromatin set off a molecular switch in ORC for pre-
RC assembly [47]. Indeed, in S. cerevisiae the ORC1 ATPase activity is inhibited until 
Cdc6 protein is recruited and activates ORC1 ATPase. This then produces a 
conformational change in the ORC-Cdc6-DNA complex to achieve a ring-like structure 
(see below, Figure 1.7A) with increased specificity for the origin sequence. Origin DNA 
inhibits ATP hydrolysis by Cdc6 and stabilizes the complex, whereas mutations in the 
origin sequence can increase Cdc6 ATPase activity, resulting in a less stable Cdc6-DNA 
complex. This means that ORC binding to the origin is not specific unless Cdc6 is also 
bound, i.e. Cdc6 rather than ORC is responsible of origin selection [47]. The proposed 
structure of Cdc6, which was deduced by comparison with the ORC structure, is similar 
to the atomic structure of the archaeal homologue, ORC1/Cdc6. ORC1 and Cdc6 
proteins are homologues (Figure 1.3), and indeed archaeal species have one protein 
Orc1/Cdc6 that does both functions, i.e., origin recognition and the loading of the MCM 
helicase. Some archaeal species, such as Sulfolobus solfataricus, have multiple 
Orc1/Cdc6 proteins that bind to two different origins [60]. 
 Cdt1 protein, like Cdc6 protein, is also required to load the MCM helicase during 
G1 of the cell cycle of eukaryotes [7]. This protein, which was initially found in fission 
yeast, is clearly conserved in eukaryotic evolution. As Cdc6 ATPase is needed for Cdt1 
binding on the origin in vitro, it has been proposed that a Cdt1-MCM complex is loaded 
onto the ORC-Cdc6-origin complex during initiation [59, 61]. Cdt1 and Cdc6 then 
dissociate and finally ATP hydrolysis by ORC completes the MCM helicase loading 
reaction [47, 59]. 
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 As stated in paragraph 1.1.2, licensing is blocked during S, G2, and M phases of 
the cell-cycle to prevent re-replication. Re-replication is actually avoided by the 
concurrence of several, redundant mechanisms that block MCM loading during S, G2 
and M phases. In other words, pre-RCs can be assembled only in G1 phase, but are 
activated for origin firing only during S phase. There never exists a cell-cycle phase in 
which pre-RC formation (licensing) and activation can occur. In binary terms, if off = 0 
and on = 1, then there is no phase in which replication licensing (L) and activation (A) 
are both 1. In G1 phase, L = 1 and A = 0, while L = 0 and A = 1 in S phase [6] (Figure 
1.2). A major level of regulation is catalyzed by CDK, which acts at many redundant 
levels to block licensing in most eukaryotes [62]. These levels include the degradation 
and localization of several pre-RC components. Besides the already mentioned ORC1 
protein in higher eukaryotes, another modified protein is Cdc6: in yeast it is degraded 
after CDK phosphorylation [63], while in mammals Cdc6 is exported from the nucleus 
after CDK phosphorylation [64]. Another level of regulation to block re-replication 
occurs through a protein known as Geminin (Figure 1.2), which was discovered in frog 
egg extracts [65] and is only found in metazoans. Geminin binds to and inhibits Cdt1 
and thus prevents replication licensing by blocking the loading of the MCM helicase 
[65]. The same role for Geminin is reported to occur also in human [24]. The finding 
that Geminin specifically recognizes and binds HOX proteins [66] has also shed light on 
a possible concomitant role for this protein in development, as will be reviewed in 
paragraph 1.2.5.  
 The redundancy of these mechanisms avoiding re-replication has been proposed to 
provide a key driving force in the evolution of licensing control [22, 67] (Figure 1.4). 
Because no single mechanism for inhibiting pre-RC components can be completely 








Figure 1.4 Proposed model for the evolution 
of multiple pre-RC regulatory pathways. 
Details are in the main text. Taken from: Drury 
et al. [63]. 
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However, as the number of inhibitory mechanisms increases, the relative importance of 
any single mechanism decreases. During evolution, these regulatory mechanisms may 
be gained or lost, and an organism may ‘‘sit’’ at different positions along the curve in 
Figure 1.4. This could explain the different regulatory mechanism of Cdc6 in yeast and 
human as well as the appearance of Geminin in metazoa to provide an additional 
mechanism for preventing re-replication, which may have been important in supporting 
an increase in genome size with respect to lower eukaryotes. 
 3. Unwinding and 4. Elongative assembly: these two steps refer to the activation 
of the helicase activity at the origin and to the replisome assembly, respectively; they 
are closely interconnected, and will therefore be reviewed together. The MCM complex 
is believed to be the engine of the replicative helicase. This complex is a hexamer 
comprising six related polypeptides (Mcm2–7) coded by a family of six paralogous 
genes, which are conserved from yeast to human. All six members of the gene family 
are essential genes in both budding and fission yeast. All are AAA+ ATPases with 
similarity to DNA helicases. A pioneering work in fission yeast first identified a 
complex that contained all six subunits in 1:1:1:1:1:1 stoichiometry and had a ring-like 
structure [68]. Thereafter, a large body of work has been done in order to elucidate the 
structure of the MCM ensuring the helicase activity to the replisome, as will be 
discussed in detail in the next paragraph. Here it is just worth to recall that most of these 
studies have been performed with MCM from yeast and Archea.  
 In G1 phase, pre-RCs with the Mcm2–7 helicase bound are present on almost all 
origins. Indeed, nearly 90% of all origins that are bound by ORC also have MCM 
complex bound [69]. Nevertheless, MCM is loaded inactive in the pre-RC, when CDK 
activity is low. The next step is to activate the MCM helicase. This is achieved by the 
binding of several other proteins to the origin, up to the loading of the replisome 
(Figures 1.2 and 1.5). The multi-protein complex assembled on the origin at this stage is 
referred to as pre-initiation complex (pre-IC), and is required for the activation of the 
Mcm2–7 helicase. In this manner, the cooperation between helicase activation and 
replisome loading assures coordinated replication. 
 Both helicase activation and replisome loading require phosphorylation by CDK 
(cyclin-dependent kinase) and DDK (Dbf4-dependent kinase, comprising a heterodimer 
of Dbf4 and Cdc7) enzymes. In budding yeast, there is only Cdk1 or Cdc28 enzyme, but 
there are six B-type cyclins (Clb1–6) needed for S and M phases [70]. Most likely, 
Cdk1-Clb5 complexes are the most active in regulating DNA replication and Cdk1-Clb2 
for regulating mitosis. In mammals, while there is only one DDK, there are many 
different CDKs and cyclins with at least four CDKs (Cdk1–4) and four classes of 
cyclins (A, B, D, and E) required for cell-cycle progression [70]. The Cdk2 homologue 
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is probably used in DNA replication. By analogy, Cdk2-cyclin E and Cdk2-cyclin A act 
as yeast Cdk1-Clb5 for DNA replication, whereas Cdk1-cyclin B act as yeast Cdk1-
Clb2 for mitosis. Thus, it is substrate specificity by different Cdk-cyclin complexes that 
drives the cell-cycle. CDK and DDK enzymes are regulated independently of each 
other, but by similar mechanisms [70]. Both kinase subunits are inactive in monomeric 
form and are activated by the binding of an unstable activating subunit, Cyclin and 
Dbf4/Drf1 protein for CDK and DDK, respectively. Thus, CDK is Cyclin-dependent 
kinase and DDK is Dbf4-dependent kinase (in vertebrates, Drf1 is the Dbf4 paralogue). 
Cell-cycle regulation of the unstable subunit assures cell-cycle regulation of the kinase 
activity. With CDKs, other levels of regulation occur including protein inhibitor 
binding, phosphorylation by other kinases, and cyclin subcellular localization [70]. With 
DDK, it is simpler in that Dbf4 protein is absent in G1 phase because it is targeted for 
proteosomal degradation by the APC (anaphase promotion complex). As cells enter S 
phase, the APC is inactivated by CDK phosphorylation and Dbf4 is stabilized. Thus, 
CDK might have evolved later to coordinate the cell-cycle with DNA replication, while 
DDK is simpler as it has only a very specific role in DNA replication. 
 How do the two protein kinases activate the MCM helicase and load on the 
replisome (Figure 1.2)? A large body of evidence indicates that the Mcm2–7 complex is 
a target of phosphorylation by DDK, and this occurs in several eukaryotes [7, 71]. 
Studies performed in yeast have identified phosphorylation sites in the N-terminus of 
Mcm4, Mcm2 or Mcm6 to be important for formation of the pre-IC and for DNA 
replication [72]. The hypothesis is that there is considerable redundancy in the system 
with any of 3 different subunits of the MCM complex acting as targets for DDK. 
Phosphorylation of the MCM complex by DDK leads to the loading of Cdc45 protein 
onto origin chromatin with a mechanism conserved from yeast [73] to human [74]. 
Cdc45 protein is needed for loading of the replisome, including DNA polymerases and 
RPA, the eukaryotic SSB (Figure 1.5), and moves with the replication fork [75]. There 
is a conserved genetic interaction between Cdcc45 and the Mcms; specific mutations in 
these genes can either suppress or show synthetic lethality with the other [30]. How 
would phosphorylation of Mcm2, Mcm4, or Mcm6 by DDK activate the helicase and 
load the replisome? One hypothesis is that DDK phosphoryation results in a 
conformational change in the Mcm5 protein that activates the helicase and is a signal 
for the binding of Cdc45 protein (Figures 1.2 and 1.5) [6]. In some cases, Cdc45 has 
been reported to bind the origin earlier in G1 phase, before the MCM activation by 
DDK. In this case, it is possible that Cdc45 protein may be weakly bound to origin 
chromatin in G1 phase, and that it is later stabilized by CDK rather than DDK 
regulation. 
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 The role of CDK in promoting origin activation has also been thoroughly 
investigated. In yeast, CDK phosphorylates Sld2 and Sld3 [76], causing them to bind 
Dpb11 (DNA Polymerase B possible subunit, a subunit of DNA polymerase $ 
holoenzyme, also called Pol2 or PolB), which in turn serves as an anchor for DNA 
polymerase, RPA and the GINS complex to reach the replisome. The GINS complex, 
which name is based on the numbers 5, 1, 2, and 3 in Japanese (Go, Ichi, Nii, San), is 
composed of the Sld5, Psf1, Psf2, and Psf3 proteins, and is required for replication by 
functioning interdependently with Cdc45 protein in the loading of the replisome. Most 
of these proteins are conserved in eukaryotic organisms [74]: only yeast Sld3 does not 
have any homolog in metazoa, while Sld2 and Dbp11 are related to mammalian 
RecQ4L and TopBP1, respectively; the GINS complex is highly conserved in yeast 
[73], Xenopus [77] and human [78]. Recently, another mcm member was identified to 
take part to the pre-IC assembly, namely Mcm10, which is not a Mcm2–7 homologue 
[79]. Mcm10 is needed for the loading of the Cdc45 protein after pre-RC formation and 
for stabilizing the replisome, a mechanism conserved up to human [80]. Mcm10 protein 
may act by stimulating DDK and DNA polymerase activity at the fork.  
 To summarize, a large number of proteins is needed to load the replisome onto the 
origin (all of them appear in Figure 1.5). These proteins help to activate the MCM 
helicase. Indeed, the association of Mcm2–7, Cdc45, and GINS constitutes a complex 
named CMG complex which, when purified from Drosophila embryos, has helicase 
activity in vitro [81]. Moreover, these proteins bring the DNA polymerases onto the 
origin, thereby coupling helicase activation and replisome loading. It is also evident that 
CDK and DDK regulate similar events independently. This explains why both kinases 
are needed for replication in all eukaryotes examined [6]. In this proposed model, DDK 
phosphorylates any one of Mcm2/4/6 proteins, resulting in the Mcm5 protein structural 
change, which together with CDK phosphorylation of Sld2 and Sld3, recruit Cdc45, 
Dpb11, Mcm10 and GINS proteins; this results in the activation of the Mcm2–7 
helicase. The DNA is unwound by the helicase and the DNA is replicated by the 
replisome. It is not clear what the exact role of Mcm10 is in this model but it is known 
to be required for Cdc45 loading and replisome stability. In order to avoid confusion in 
the nomenclature, in all subsequent paragraphs and chapters the proteins listed so far to 
be part either of the pre-RC or of the pre-IC, will be generally referred to as replicative-




Figure 1.5 Helicase activation and replisome loading at the onset of S phase. Pre-RCs are assembled 
in a window of opportunity during the G1 phase of the cell-cycle when the CDK and DDK activities are 
low. In a DDK- and CDK-dependent process, additional complexes bind to origins to form the pre-
initiation complex (pre-IC). This includes the Cdc45, Mcm10, the GINS complex (Sld5, Psf1, Psf2, Psf3), 
Sld2, Sld3, Sld7 and Dpb11, which finally lead to the loading of the polymerase !%primase complex and 
polymerase $. RPA (light circles) stabilizes locally unwound ssDNA. Adapted from: Schepers et al. [31]. 
1.1.4 Recurrence of the ring-shape geometry in RC protein structures  
In the last years, a large body of work has been done to elucidate the exact mechanisms 
by which MCM is recruited to the origin, as well as it subsequently exerts DNA 
unwinding during chromosomal replication. In the latter case, several mechanisms have 
been proposed to explain how the helicase activity works, namely: i) the SV40 T-
antigen model, in which MCM resembles the SV40 T-antigen in that two hexamers are 
put together forming a loop. In this model, the DNA is pumped into the channel of the 
double hexamer and then extruded out the holes in the outside C-terminal domains of 
MCM; ii) the pump-in-ring model, in which each single hexamer translocates on a 
different strand of DNA; iii) the ploughshare model, in which a double MCM hexamer 
is loaded onto the origin, then single hexamers translocate in opposite directions along 
the dsDNA with a ploughshare protein acting as a wedge and helping to keep the 
ssDNA unwound as it emerges from behind the helicase; iv) the rotary pump model, in 
which different single hexamers twist the DNA at a distance resulting in topological 
strain and unwinding in the center. These models are reviewed in detail by Sclafani et 
al. [6] and are here summarized in Figure 1.6. 
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Figure 1.6 Models for MCM helicase activity. Top: single hexameric MCM is depicted as a blue ring at 
the ends of a conventionally drawn replication fork. Lagging strand Okazaki fragments are shown with 
red RNA primers at their 5’ ends. i-iv) four models proposed for MCM unwinding activity, as discussed 
in the main text. Adapted from: Sclafani et al. [6]. 
 Clearly, what mechanism is exactly used by MCM for DNA unwinding depends on 
the real geometry displayed by the MCM complex when loaded on the origin. For 
example, both models reported in panel i) and iii) of Figure 1.6 (the SV40 T-antigen and 
the ploughshare models, respectively) assume that MCM is loaded as a double hexamer 
onto the origin. Therefore, a lot of effort has been put in trying to understand the 
geometry adopted by MCM, as well as by the other RC proteins recruiting MCM, when 
bound to replication origins. In this perspective, transmission electron microscopy 
applied to image purified RC components (usually from yeast, but often from Archea 
and sometimes also from human) turned out to be an extremely useful method. It was 
first used in a pioneering work in fission yeast where the six MCM subunits were found 
to display a ring-like structure [68]. Strikingly, this approach has revealed that many RC 
proteins share a ring-shape structural geometry, so that this can be considered as the 
leitmotif of the RC assembly.  
 The first to be recruited onto the origin is the Cdc6-ORC1 ATPase complex (Figure 
1.7A). The overall shape and dimensions of the ORC–CDC6 complex match the 
structure of a ring, with dimension similar to a single Mcm2-7 hexamer [47]. This has 
suggested that CDC6, when bound to ORC (indeed, ORC1) acts as a “clamp loader” for 
the recruitment of MCM, i.e. it uses the energy derived from ATP hydrolysis to engage 
ring-shaped molecules with similar dimensions. The loading of MCM by CDC6 and 
ORC could be achieved by a series of conformational changes, coupled to ATP binding 
and hydrolysis, which open and close the MCM ring around the DNA. However, 
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additional structures of ORC, CDC6 and MCM, ideally in complex with each other, will 
be required to construct a structural model for the DNA helicase loading reaction. 
 The electron microscopy approach has been instead recently decisive in elucidating 
that MCM is loaded onto origin chromatin as a head-to-head double hexamer (Figure 
1.7B and [61]), capable of passive sliding along dsDNA. This actually leads to only two 
possible mechanisms for its helicase activity once the replisome is assembled: the SV40 
T-antigen or the ploughshare model (Figure 1.6 i and iii, respectively). However, the 
observation that also the GINS complex has a ring-shape structure conserved up to 
human (Figure 1.7C and [78]) makes the latter more likely. The proposed model in this 
case is depicted in Figure 1.7D: MCM double hexamer exploits its passive sliding along 
dsDNA and acts as a dsDNA translocase, and GINS and/or Cdc45 play a direct, 
structural role in strand separation acting as a plough. 
 
 
Figure 1.7 3D reconstructions of the RC proteins structure imaged by electron microscopy. A) 
Cdc6-ORC1 complex in yeast, taken from Speck et al. [47]. B) Yeast Mcm2-7 complex is loaded onto the 
origin as a double hexamer, taken from Remus et al. [61]. C) Human GINS complex, taken from 
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Boskovic et al. [78]. D) Picture of the proposed ploughshare model (same as Figure 1.6, iii), with the 
GINS acting as the wedge. Adapted from: Boskovic et al. [78]. 
1.1.5 The riddle of origin specification in metazoa 
As already mentioned in paragraph 1.1.1, the selection of defined and adequately 
distributed replication origins seems to represent the safest way to achieve complete 
genome duplication in eukaryotes. Specific sites (named ARS: Autonomously 
Replicating Sequence), determined by precise sequence motifs were found in S. 
cerevisiae [82]. However, this revealed not to be the case for other eukaryotes, in which 
the sequences directing replication initiation appear to be far less defined. Extreme 
situations have been reported in Drosophila and Xenopus early embryos, in which 
replication initiation occurs at random sites along the chromosomes. Strikingly, during 
embryonic development, in correspondence to remodeling of nuclear structure and 
chromatin organization, initiation events become restricted to preferred regions [83]. 
The factors determining the confinement of initiation events to specific regions during 
embryogenesis have been in the last years intensively studied, but are still unclear [13, 
17]. In agreement with the fact that preferred sites of initiation are selected during 
development, DNA synthesis does not start at random locations in somatic mammalian 
cells. Also in this context, the mechanism that governs the selection of replication 
origins in metazoan genomes taking place in the G1 phase of the cell-cycle, is still not 
clear. What makes the understanding of origin specification difficult is mainly the high 
degree of degeneracy of metazoan origin sequences. In human cells, only few origins 
are well characterized and they share no evident sequence similarity [84-86]. More 
recently, genome-wide approaches have led to the identification of several origins, but 
still no consensus has been clearly identified, besides a relative frequency of CpG 
islands [14] and asymmetric A/T stretches [15] in correspondence to highly active 
origin sequences (Figure 1.8).  
 On the other hand, also ORC, the protein structure that marks all replication origins 
and which is needed for the sequential assembly of the full RC, exhibits little sequence 
specificity in higher eukaryotes spanning from Drosophila to mammals [13, 17, 43, 87, 
88], as already mentioned in paragraph 1.1.3.  
 All these observations suggest that the binding of ORC at origins might be 
determined not only by the recognition of specified DNA elements (e.g. AT-rich 
sequences and CpG-islands reported in Figure 1.8, as well as promoter regions, 
dinucleotide repeats, matrix attachment regions), but also by a series of other factors 
which could facilitate the ability of a DNA region to function as an origin, namely: i) 
the overall chromatin structure, comprising also the local DNA topology and possible 
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epigenetic marks; ii) ORC-chaperon proteins that function as auxiliary ORC-targeting 
factors [31].  
 
 
Figure 1.8 AT-rich and CpG-rich islands at DNA replication origins. A) AT content (%) across the 
50 kb regions including the 1041 and 1098 AT-rich islands in S. pombe. Red and blue rectangles 
represent genes transcribed towards the left and the right, respectively. Broken lines indicate the average 
intergenic AT content (70%). B) CpG content (%) across the 50 kb regions spanning the first two exons 
of the human TOP1 gene and the bidirectionally transcribed PRKDC and MCM4 genes. Arrows indicate 
the direction of transcription. Red and blue bars represent exons. Broken lines indicate the human average 
genomic CpG content (41%). In both panels, the black bars underline the presence of an active origin in 
correspondence to peaks of AT% or CpG% over the average values. Scale bar: 10 kb. Adapted from: 
Antequera et al. [89]. 
 One of the most probable candidates, which could likely contribute to origin 
specification, is a local chromatin environment ideally suited for the pre-RC assembly. 
This could result from the combination of several elements, such as an open, 
transcriptionally active chromatin structure, bent DNA structures, gene promoters close-
by, binding sites for sequence specific proteins or asymmetric AT-rich stretches. 
According to this scenario, origins could take advantage of—or parasitize—regions that 
are maintained in an accessible conformation for structural reasons or to facilitate 
transcription, as suggested by the preference of origins to map near promoters in many 
cases [89]. This “opportunistic” origin specification would remove the selective 
pressure to maintain each single origin sequence in the genome for its individual 
contribution to replication. This model is supported by at least two considerations: i) 
eukaryotic origins are present in excess through the genome; not all of them fire in 
every S phase and many remain silent and are inactivated by replication forks passing 
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by during S phase [90]; ii) open chromatin appears to be the underlying feature that is 
deterministic for ORC binding as revealed by genome-wide approaches [34]. Thus, 
origin specification could be achieved by a progressive restriction of the potential to 
initiate replication from too many or undesired sites; the driving force of this selection 
could be the chromatin re-organization associated with development and/or with the 
cell-cycle progression, particularly with the G1/S transition. These assumptions 
characterize a model [13, 17, 91] in which two stages need to be passed in G1 to 
achieve origin specification: the former is the timing decision point (TDP), where early 
and late replication domains are established, and the latter is the origin decision point 
(ODP), which selects only a fraction of the sites previously licensed to be used in the 
next S phase (Figure 1.9).  
 
 
Figure 1.9 Model describing the “opportunistic” origin specification during G1 phase. In early G1 
phase, many sites distributed throughout the genome have an equal potential to be used as early 
replication origins. At the TDP, late replicating chromosomal domains become excluded from the pool of 
potential early replicating origins. At this time, origins within these early replicating domains still have an 
equal potential for initiation regardless of their position within the domain. At the ODP, a subset of these 
potential origins is chosen for initiation in the upcoming S phase. Taken from: Li et al. [91]. 
It must be underlined that this view hints at a role also for DNA topology in establishing 
an origin of DNA replication. A particular chromatin structure is indeed maintained by 
a peculiar DNA conformation and topology. If this model holds true, topoisomerases, 
which are enzymes able to alter the topology of a DNA region, should play a 
determining role in origin function; in detail, topology-modifying events may be 
required for the formation of the pre-RC. And indeed, both topoisomerases I and II were 
found to interact with the lamin B2 origin, and to be essential for origin firing in close 
interaction with ORC [88, 92].  
 Chromatin accessibility, however, is unlikely to be the only requirement for origin 
specification, as several specific sequences ranging in size from 1 to 6 Kb have been 
described that are capable of maintaining their activity at ectopic positions in the 
genome [93]. Thus, likely origin specification relies on other factors; these could 
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include proteins, which display a preference for certain origin features (like sequence or 
other structural properties) and target the RC proteins onto the origin by direct or 
indirect protein-protein interaction. So far, several proteins have been identified, that 
can either specify sites of ORC binding, or in any case have a role in DNA replication 
initiation. Among these it is worth to mention AIF-C [94], Trf2 [95], Ku80 [96, 97], 
EBNA1 [98], and HMG1a protein [99]. In many of these cases, the proposed proteins 
were shown to function as “ORC-chaperons” in targeting ORC to chromatin regions 
thus contributing to origin formation and to a more specified binding of ORC. 
Interestingly, also an important transcription factor (and proto-oncogene) like Myc was 
recently found to bind the well-characterized human replication origin sequences and 
participate in origin activation [100], again hinting at transcription events as actors in 
origin specification.  
 In this context, it was very interesting to find out that another family of transcription 
factors, namely the homeotic proteins, displays an affinity for the origin sequences 
[101], which seems to correlate with cell-cycle as well as DNA replication regulation 
[102, 103]. A possible role for homeotic proteins in origin decision would be 
particularly intriguing, because it could represent a basis of the interplay between DNA 
replication and development, as well as explain the proto-oncogenic properties often 
displayed by these proteins [104]. In order to better understand to what extent could 
homeotic proteins be involved in origin function, some knowledge about their structure 
and function is required; accordingly, the next paragraph will be focused on this family 
of transcription factors involved in the regulation of development and often in cancer. 
1.2 The family of HOX proteins 
Homeotic proteins are the product of the regulatory family of homeobox genes. First 
identified in the fruit fly Drosophila melanogaster [105], they are highly conserved 
across different species, and share a functional activity as transcription factors during 
normal development [106-108]. They are characterized by the presence of a highly 
conserved motif about 61 aminoacids long, called the homeodomain. This enables 
homeodomain proteins to bind DNA at specifically recognized binding sites and 
transcriptionally activate (or repress) their target genes, as extensively reviewed [109-
111]. Some variations besides the common homeodomain sequence allow grouping 
them into different families. Most strikingly, however, is their seemingly universal 
involvement in cellular specification and identity. They all seem to be key regulators of 
cellular identity, from the specification of regional identity of several skeletal and 
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neurological areas to the cooperative role in the regulation of epithelial-mesenchymal 
cell interactions in extra-embryonic tissues. 
 At present, a large number of homeobox genes have been characterized and novel 
isolates are still being identified [107]; up to date, the list comprises more than 350 
known homeodomain sequences, making up an extensive super-family of regulatory 
genes, that can be grouped in at least 10 different classes, with members found in all 
animal species, and even in many plants. In other words, there is a large catalogue of 
divergent homeobox sub-families (estimated to be around 0.1-0.2% of the whole 
vertebrate genome [112]), of which the best characterized and most extensively studied 
is the Hox family.  
 As the homeotic proteins were identified quite early as regulatory transcription 
factors with DNA-specific recognition via the conserved homeodomain, much effort has 
gone into trying to elucidate the exact mechanisms by which the HOX proteins gain 
their functional specificity and where in the regulatory hierarchy they exert their effect. 
In parallel, obtained results have also strongly suggested that these proteins are key 
regulators of many biological processes in adult eukaryotic cells. Among these 
processes are cell-cell and cell-extracellular matrix interactions [113], capillary 
morphogenesis and angiogenesis [114], cell cycle control [115], DNA replication and 
cell-cycle regulation [66, 101] and cell growth and differentiation [116]. 
 For the many attractive, interdisciplinary implications raised by the study of HOX 
proteins, these will be actually the focus of this section (although the most general 
features can be extended also to other homeobox sub-families). First, we shall present 
the classification of HOX proteins in vertebrates and, indeed, in mammalian species; 
furthermore, we will present the structural basis of DNA-HOX recognition and then 
switch to the structure-function related aspects of HOX activity; finally, we will present 
the most recent evidence that HOX proteins are involved as proto-oncogenes in cancer 
and that this could depend on an involvement of these proteins in the regulation of DNA 
replication and cell-cycle progression. 
1.2.1 Hox genes encode HOX proteins regulating development 
Due to the high number present in the vertebrate genome, homeobox genes have been 
organized into classes characterized by their conserved aminoacid variants in the 
homeodomain and other parts of the protein. Those homeobox genes which are 
structurally and functionally homologous to the Antennapedia complex (Ant-C) and the 
Bithorax complex (Bx-C) of Drosophila are referred to as class 1 of homeobox genes, or 
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Hox genes [117]. The numerous other genes encoding homeoproteins, which are found 
outside the Hox gene cluster, are referred to as divergent homeobox genes.  
 All vertebrate species display several Hox members; although the number of Hox 
genes is variable, they are always localized together in four clusters on different 
chromosomes in an evolutionary conserved manner, where their positioning on the 
chromosomal coordinate can be directly linked to their spatio-temporal expression 
pattern. Hox genes encode transcription factors that operate as transcriptional trans-
regulators, exerting their regulatory potential from high up in the genetic hierarchy. 
Their target can be genes either directly involved in development (“realizators”), or 
rather transcription factors [118] or other signal molecules [119], which in turn may 
control the actual “realizators”. The clustered arrangement of Hox genes hints towards a 
complex genetic unit that exerts its function as a single entity. Indeed, no one HOX 
protein can alone control the fate of a given downstream target gene and subsequently a 
particular morphogenetic pathway. HOX members rather seem to share functional 
complementation with other members of the Hox cluster [120].  
 In mammalian species, there are 39 Hox genes organized in four clusters located on 
four different chromosomes in the genome [121]. They are thought to have arisen 
through the combination of cis-amplification and trans-duplication of the Drosophila 
antennapedia and bithorax complexes during separate evolutionary events. In detail, it 
is believed that the evolutionary amplification of the Hox genes started with a cis-
amplification of a primordial Hox gene, producing 13 members, which was followed by 
a trans-duplication of most of the Hox complex. The trans-duplication is further 
believed to have occurred twice, leading to the four Hox clusters evident in the 
mammalian genome [122-124]. 
 As depicted in detail in Figure 1.10, the four different chromosomal groups are each 
identified by a single letter (A, B, C or D), which is followed by a number from 1 to 13, 
depending on their position in the 5' to 3' chromosomal coordinate. The numbering 
correlates with a differential morphological expression of these genes during 
development: those with the lowest numbers are expressed most anteriorly, with a more 
posterior expression corresponding to increasing numerical value. Thus, the Hox genes 
are expressed in a spatio-temporal fashion during development, where they confer 
segmental identity along the primary body axis, from posterior to anterior. 
 The figure also shows that duplication events from the homeotic complex (Hom-C) 
of Drosophila have had a direct consequence on the striking homology seen between 
the 39 Hox genes. The trans-paralogous genes (genes occupying the same relative 
position along the 5' to 3' chromosomal coordinate) share a higher degree of sequence 
similarities than the cis-paralogous genes (genes occupying adjacent positions on the 
The family of HOX proteins 25 
same chromosome). It should be noted that columnar correspondence (i.e. trans-
paralogous relationship) of genes in the four clusters are based solely on the 
homeodomain sequences. For example, by comparing the homeodomain peptide-
sequences of HOXA1 with the trans-paralog HOXB1 and both its adjacent and distant 
cis-paralogs HOXA2 and HOXA13, it becomes evident that HOXA1 shares as much as 
53 of the 60 amino acid residues with HOXB1 (~88% homology), but only 40 residues 
with HOXA2 (~67% homology), and 29 residues with HOXA13 (~48% homology). 
This strongly indicates a more similar expression pattern and functional 
complementation between the trans-paralogs than between the cis-paralogs, as it has 
been demonstrated for mouse HoxA3, HoxB3 and HoxD3 by Greer and colleagues 
[124]. They showed that the three trans-paralogs are capable of carrying out identical 
biological functions even though they do not show functional equivalence in their 
normal, wild type chromosomal environment. They found that in knockout mice lacking 
either one of the three Hox genes there was no obvious overlap in phenotype, but rather 
a unique mutated phenotype. However, by replacing any of the deleted Hox genes with 
one of its trans-paralogs, the normal phenotype was restored. Based on their findings, 
they postulated that the observed non-equivalence of the trans-paralogs in wild-type 
tissues might be attributed to quantitative differences in expression levels rather than 
qualitative differences.  
 Thus, not only do the HOX proteins show specific spatio-temporal expression 
patterns in the developing organisms, but also individual Hox genes, at least in higher 
animals, show a degree of functional redundancy, potentially caused by the duplication 
events of the Hox cluster. It is therefore possible that morphologic specification by 
HOX proteins is partially determined by the concentration of individual HOX members 
in a dynamic interactive play with other HOX proteins, collectively working together as 
a specific “blueprint”.  
 Hox genes are transcribed long after the cells have differentiated and gained their 
morphological and phenotypical traits; the expression pattern of the Hox cluster differs 
greatly between organs and tissues [125]. The actual function exerted by HOX 
transcription factors in the fully differentiated cells is yet largely unknown, but indicates 
a role for these proteins in the maintenance of cell identity. Studies on malignant 
transformation in mammalian systems however, elicit intriguing hypotheses with 
respect to HOX function and expression patterns and will be reviewed in the following 
paragraphs 1.2.4 and 1.2.5. 
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Figure 1.10 Hox Genes: evolutionary conservation of genomic organization and expression patterns 
from Drosophila to mammals. The top of the figure (blue) depicts a 10hr Drosophila embryo: the 
horizontal bars indicate the approximate extents of the epidermal expression domains of the eight 
homeotic genes, whereas a dotted extension indicates posteriorly overlapping expression domains. T1, T2 
and T3 depict the thoracic segments and A1-A8 the abdominal segments. The HOM-C cluster is divided 
in the middle, with two clusters (Ant-C and Bx-C) organized on the same chromosome. The lower part 
(black) depicts the mammalian Hox gene complex and its genomic organization (chromosomes are 
indicated on the right side). The official names for the Hox genes are those present on top of each square, 
whereas the most commonly used old names of the human and mice Hox genes are present below each 
corresponding square. The red arrows align the Drosophila and mammalian gene orthologs, also 
indicating corresponding expression patterns. Note also the conserved direction of transcription of the 
Hox genes, which is conserved from Drosophila, with the exception of Dfd, of which transcription occurs 
in opposite direction. Modified from: [110, 120, 121]. 
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1.2.2 The homeodomain and other homeobox signatures 
Although the early work of Lewis et al. [105] allowed for the characterization of key 
genetic loci controlling Drosophila development, including homeotic genes, the actual 
homeobox was discovered some years later as a highly conserved 183-bp DNA 
sequence, contained in all the above-mentioned loci, and encoding for a 61-aminoacids 
domain, termed the homeodomain [111, 126]. 
 After the first pioneering structural studies by NMR spectroscopy [127, 128], 
several crystal structure studies of both free and DNA-complexed homeodomains have 
followed [129-135], so that by now the tertiary structure of the homeodomain is 
exhaustively described. It consists of a flexible N-terminal arm preceding three helical 
regions, where helices 2 and 3 form a helix-turn-helix motif (Figure 1.11). The relative 
arrangement of helices displayed by the helix-turn-helix motif seems not to be a direct 
requirement for DNA-binding, but actually helps to stabilize a global fold with helix 3 
exposed so that it can penetrate the DNA major groove (Figure 1.12A). This is indeed 
known as “recognition helix”: it spans over the entire major groove, so that residues 
from the helical turns can reach the DNA bases; in the conventional homeodomain 
numbering (see e.g. Billeter et al. [136]), these are residues 47, 50, 51, and 54, reported 
also in panel B of the same figure. On the other side, conserved arginine residues 3 and 
5 of the N-terminal flexible arm preceding the three helices of the homeodomain form 
additional contacts with the DNA bases, in this case by inserting into the minor groove. 
Several studies elucidating DNA motifs recognized by the HOX proteins have by now 
identified a canonical (T1A2A3T4X5X6) consensus sequence as the core of HOX-DNA 
binding. In detail, residues 3 and 5 of the homeodomain N-terminal arm contact the 
bases in positions 1 and 2 at the minor groove, and amino acid residues 47 and 51 of the 
homeodomain helix 3 contact the bases in positions 3 and 4 at the major groove (Figure 
1.12B). Interestingly, 47 and 51 are conserved isoleucine (or other hydrophobic residue) 
and asparagine, respectively; similarly, residues 3 and 5 are conserved arginine 
residues; conversely, residues 50 and 54 are less conserved and this is supposed to serve 
to differentiate the binding properties of different homeodomains, by recognition of the 
less conserved DNA bases at position 5 and 6 [137]. 
 Overall, these protein-DNA contacts are referred to “specific” contacts, i.e. 
interactions of the protein with DNA bases, which are responsible for the selection of a 
certain DNA sequence to be bound. Other “unspecific” contacts are displayed by the 
homeodomain with DNA backbone, and mostly serve to increase the stability of the 
complex. Many of these interactions involve basic residues that contact DNA phosphate 
groups, like conserved arginines at positions 31, 52, 53, or lysine 55. 
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Figure 1.11 The homeodomain tertiary structure. Schematic representation of a prototypic 
homeodomain protein. The homeodomain is further highlighted with the three alpha helices. Taken from: 
Castronovo et al. [138]. In the inset, the structure of the homeodomain from the Drosophila Antennapedia 
protein is taken as a reference [127, 128] for the visualization of the helix-turn-helix structural motif. The 
Antennapedia homeodomain is 68 amino acid residues long. It contains three alpha helices: Helix 1 
(res.10-21) = Red, helix 2 (res.28-38) = Yellow, helix 3 (res.42-52) = Green. The C-terminal part of helix 
3 (res.53-59) is depicted in blue, because it exhibits lower stability in free homeodomains and can 
sometimes be reported as an actual fourth helix. Helices 2 and 3 adopt a helix-turn-helix motif from 
residues 28 to 52. The three helices making up the Drosophila Antennapedia homeodomain are 
prototypic for all homeobox proteins, serving as the core structure even for divergent homeobox families. 
 
Figure 1.12 Homeodomain-DNA interactions between HOX proteins and the canonical TAAT core. 
A) The co-crystal structure of the Drosophila engrailed homeodomain with DNA [130] (PDB no.: 
1HDD) was taken as a reference and visualized using VMD software (a courtesy of Fabio Trovato, 
Scuola Normale Superiore). The homeodomain contacts DNA both at the major groove by helix 3 and at 
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the minor groove by its N-terminal flexible arm. B) The base-specific contacts made between the 
homeodomain amino acid residues 3, 5, 47 and 51 and the TAAT binding motif. Residues 3 and 5 of the 
homeodomain make contacts in the minor groove, whereas amino acids 47 and 51 make contacts to the 
DNA in the major groove. Residues 50 mainly, but also 54 and possibly others docking in the major 
groove, are further thought to make more stable contacts and thus ultimately impose a higher specificity. 
Nucleotides 5 and 6 are also thought to make specific contact with the homeodomain, as discussed in the 
main text. Modified from: [139]. 
 In addition to the homeodomain, the homeobox genes also encode other highly 
conserved structures (reported, as well, in Figure 1.11). The homeodomain itself ends 
with an acidic tail, with a yet undetermined structure. Furthermore, many homeodomain 
proteins, albeit not all, contain a highly conserved hexapeptide (consensus: 
hydrophobic-Y/F-P-W-M-K/R), named homeopeptide, just upstream of the 
homeodomain, to which it is linked by a linker that varies in length and sequence 
among different HOX proteins and species. The homeopeptide has been reported to be 
essential for the HOX proteins to achieve cooperative binding with HOX cofactors 
[140] (see paragraph 1.2.3.1). Finally, homeobox proteins contain a conserved amino-
terminal region followed by a variable region, usually rich in alanine, serine, glycine, 
proline or glutamine [138]. All proteins that contain a homeodomain and, possibly, 
other homeobox signatures, usually play a role in development, and many of these are 
sequence-specific transcription factors.  
1.2.3 The “HOX paradox”: transcriptional and functional specificity 
Hox genes encode transcription factors with a canonical homeodomain-structure 
responsible for DNA binding, with subsequent transcriptional activation or repression of 
the target gene. The recurrence of the homeodomain as a ubiquitous DNA binding 
domain found in all metazoans, coupled with the wide diversity in binding sites 
observed for these proteins, implies that this fold is highly versatile with respect to the 
possible target DNA sequences.  
 In general, when thinking about what a HOX binding site may look like, it is useful 
to distinguish between three types of HOX target genes: 1) those that must be highly 
specific for one HOX paralog (“paralog-specific”), 2) those that are shared by a subset 
of HOX proteins (“semi-paralog-specific”), and 3) those that are regulated by most or 
all Hox genes (“general”). In any case, the conserved TAAT motif recognized by the 
homeodomain in vitro (see Figure 1.12B) is by itself too short to account for the wide 
range of transcriptional specificity of the HOX transcription factors. Indeed, this four 
base-pair motif is potentially present in a very large number of promoter elements 
throughout the genome. For example, there are 87,307 copies of the sequence TAATTA 
and 86,201 copies of the sequence TAATGA in the Drosophila genome. Moreover, as 
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elegantly illustrated by the homeodomain-binding site survey studies (reviewed by 
Mann et al. [141]), TAAT[t/ g][a/g] is readily bound by most HOX homeodomains, as 
well as many non-HOX homeodomains. It is therefore clear that the large number of 
known HOX proteins definitely needs further regulatory principles if the functional 
specificity of individual HOX proteins is to be accounted for. These considerations, that 
DNA binding by an isolated HOX homeodomain does not provide the specificity 
necessary for context-specific gene regulation in vivo, constitute a conundrum termed 
the “HOX paradox”.  
 Several mechanisms have been reported, that could explain how selective DNA 
binding is achieved in vivo by HOX proteins, including: i) an intricate network of water-
mediated interactions [136]; ii) different flanking base pairs present both at the 5’ and 3’ 
of the canonical ATTA motif [142]; iii) HOX protein post-translational modifications, 
such as phosphorylation [143, 144]; iv) cooperativity with other trascription factors 
often bearing homeodomains, named HOX cofactors [140, 141]; v) sequence-dependent 
alterations of the DNA geometry and shape [145, 146]. The last two points of the list 
deserve a few more comments as they have recently shown to be the most crucial 
factors influencing HOX specificity. 
1.2.3.1 HOX cofactors and collaborators 
One critical finding explaining how HOX transcription factors could gain further 
specificity in their in vivo environment, was the identification of HOX cofactors. To 
date, the best-characterized cofactors are all TALE (Three Aminoacid Loop Extension) 
homeodomain proteins [147, 148]. In Drosophila, the known TALE HOX-cofactors are 
Extradenticle (Exd) and Homothorax (Hth). In the mouse, there are four Exd-related 
proteins (Pbx1, Pbx2, Pbx3, Pbx4) and five Hth-related proteins (Meis1, Meis2, Meis3, 
Prep1, and Prep2). These proteins all have the ability, at least on some DNA sequences, 
to bind with HOX proteins in a highly cooperative manner (reviewed by Mann et al. 
[141]). Variations to the TAAT motif have been characterized, with various HOX 
transcription factors binding to ATTA, TGAT, TTAT and TTAC sequences in 
conjunction with other cofactors [149, 150]. Several co-crystal structures of HOX 
proteins and cofactors bound to DNA have been reported [140, 141, 151]. These have 
revealed that the homeobox hexapeptide (Figure 1.11) is critical for the HOX-cofactor 
interaction, as one of its hydrophobic residues (usually a tryptophan) makes direct 
contacts with a hydrophobic pocket of the TALE motif in the cofactor homeodomains. 
For those HOX proteins that do not have an obvious homeopeptide motif, in particular 
the Abd-B paralogs, there is a conserved tryptophan residue that, at least for a subset of 
Abd-B paralogs, plays an important role in this protein-protein interaction [149, 150].  
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 However, increasing evidence suggests the more general idea that cofactors may 
have modes of interaction with other HOX proteins that are in addition to the classical 
homeopeptide-TALE interaction, and this could potentially expand their ability to 
recruit additional transcription factors at the target gene. Indeed, signal effector 
transcription factors are being identified as HOX collaborators in several cis-regulatory 
elements, such as SMADs, effectors of the TGF-beta and Decapentaplegic (Dpp) 
pathways in both vertebrate and Drosophila (reviewed by Mann et al. [141]). The 
HOX-SMAD interactions may be critical for building an enhanceosome-like structure 
on HOX-targeted cis-regulatory elements. Although the number of examples shown to 
have direct inputs by signaling effectors is currently low, genetic analyses suggest that 
this phenomenon is likely to be extended to other signaling pathways, including 
Hedgehog (Hh), Wnts, and Notch [141]. Overall these considerations allow drawing a 
two-step mechanism by which HOX proteins can gain specific transcriptional activity 
(depicted in Figure 1.13). The first step is DNA binding by HOX proteins: cofactors 
selectively target specific HOX proteins, with a subsequent selective DNA binding due 
to the cooperative HOX-cofactor action. The second step involves the recruitment of 
additional factors, generally named HOX collaborators, to the cis-regulatory element. 
The recruitment of these factors may depend on contacts between them and the DNA 
and/or protein-protein contacts between them and the HOX-cofactor complex. It is the 
recruitment of these collaborators that ultimately determines the sign of the 










 Yet, despite the flexibility of this model, it is critical to stress that the HOX protein 
plays the central role in the function (and/or the assembly) of these multiprotein 
Figure 1.13 Model of the two-step mechanism 
of HOX specificity. Details of the model are 
reported in the main text. Adapted from: Mann 
et al. [141]. 
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complexes, because without them, these complexes cannot function. Therefore, these 
multiprotein complexes containing the HOX proteins, their cofactors, and their 
collaborators have been named “Hoxasome”. 
1.2.3.2 Role of DNA shape in HOX specific DNA recognition 
In many protein-DNA complexes, the DNA assumes conformations that deviate from 
the structure of an ideal B-form double helix, in some cases bending, and in other 
undergoing large conformational changes in order to optimize the protein–DNA 
interface. These recognition mechanisms, relying on the propensity of a given sequence 
to assume a conformation that facilitates its binding to a particular protein, are often 
referred to with the term “indirect readout” [152]. A new mechanism of indirect readout 
has been recently proposed to explain the DNA binding specificity of HOX proteins by 
Joshi et al. [146]. The authors observed that only residues of the homeodomain N-
terminal arm and of the linker just upstream of it are critical for the specific in vitro and 
in vivo recognition properties of the Drosophila Src homeodomain variant. They further 
notice that these residues insert into an unusually narrow region of the minor groove, 
which in turn creates a local dip in electrostatic potential. Therefore they propose a two-
step model to explain how HOX protein realize a specific DNA binding, as depicted in 
Figure 1.14: first, HOX proteins recognize generic AT-rich sequences through the 
conserved interactions occurring both at the major and minor grooves (see Figure 1.12); 
but it is only the N-terminal arm and the upstream linker residues, likely helped by the 
presence of a cofactor, which select among these sites by reading the structure and 
electrostatic potential of the minor groove. Interestingly, two years later the same group 
reported that the creation of specific binding sites for positively charged aminoacids, 
typically arginines, within narrow minor grooves, is a general mechanism widely used 
in protein-DNA recognition [152].  
 
 
Figure 1.14 Model of the two levels of HOX-DNA binding specificity. DNA contacts made by residues 
of the N-terminal arm and of the third helix (blue) are used by all HOX proteins to bind general AT-rich 
DNA sequences, but are not good at distinguishing between Hox-paralogs specificities. With the help of 
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cofactors, paralog-specific DNA contacts are mediated by the homeopeptide, the linker and N-terminal 
arm residues. These “Paralog-specific” DNA contacts may read a DNA structure, such as the narrowing 
of the minor groove, rather than forming specific hydrogen bonds. Taken from: Mann et al. [141]. 
1.2.4 HOX proteins and cancer 
The proposed involvement of homeobox genes in cancer is fairly recent, when 
compared to the first studies of the homeotic proteins, and was first suggested after 
studies on mouse myeloid leukemia cell lines in early 1990s. This first hypothesis 
proposed that overexpression of a homeobox gene could lead to leukemia, as reviewed 
by Lawrence et al. [153]. Following these findings, the homeobox genes became a focal 
point for several research groups trying to elucidate the genetic control of 
carcinogenesis.  
 The molecular mechanisms involved in carcinogenesis deal with the acquisition, 
regulation and maintenance of cell identity; in this context, the homeodomain-
containing transcription factors represent potential candidates as oncogenic regulators, 
given their functional role in embryogenesis and normal development. Indeed, since the 
homeobox proteins are involved in the physiological processes of cell regulation during 
early development, it may be postulated that a deregulation of these genes in mature 
cells may lead to altered cell identities and possibly trigger the onset of cancerogenesis 
[154, 155].  
 To date, several Hox genes have been isolated from selected malignant tumours, 
among them: HOXA9, HOXB7 and HOXD11 have all been found to be misexpressed 
in primary colon cancer [117]; a frequent overexpression of HOXA7, HOXB7 and 
HOXA10 was reported in human lung cancer [156]; HOXD9 showed an ectopic 
expression in cervical cancer [157]; and several HOX members were found 
misexpressed of in human anaplastic thyroid cancer, including the silencing of HOXD9 
in all tested cancer cell lines compared to its expression in normal thyroid [125]. 
Notably, in T-cell malignancies as acute myeloid leukemia, the misexpression of the 
Hox genes often occurs by their rearrangement with the NUP98 locus to form a 
chimeric NUP98/Hox gene. This is the case for at least seven Hox genes: HOXA9, 
HOXA11, HOXA13, HOXD11, HOXD13, HOXC11, and HOXC13 [158, 159]. The 
mechanism of translocation to nucleoporin NUP98 has been reported for other proto-
oncogenes, such as topoisomerase I and topoisomerase II [160, 161]. 
 Thus, a significant change in the expression pattern of the Hox cluster, intended 
either as overexpression or as lack of expression, is observed in malignant phenotypes. 
Whether or not this misexpression is a cause or an effect of neoplastic transformations 
remains to be elucidated, although some data are strongly suggestive that both might be 
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the cases. In recent years, many studies have been carried out to elucidate what is the 
role of Hox genes in cancer development. This task has proven to be far more difficult 
than expected, due mainly to the fact that homeobox genes typically are expressed at 
low levels and that several different homeobox genes seem to cooperate in specific 
combinations in the different cellular pathways within the cell [138]. Some studies have 
produced promising results however, giving some hope for the characterization of the 
key regulators responsible for cancerogenesis. Among them these should be mentioned: 
i) HOXB7 directly trans-activates the basic fibroblast growth factor (bFGF) gene in 
melanomas, thus possibly deregulating essential growth factor pathways in the tumour 
cells [113]; ii) HOXD3 overexpression mediates the conversion of vascular endothelial 
cells from the resting to the angiogenic/invasive state [162]; iii) a lack of expression of 
HOXA5 is implicated as a cause for the loss of expression of p53 in human breast 
cancer, which could enable human breast tumour cells to evade p53 induced apoptosis 
[163, 164]; iv)  human SIX1 (a divergent homeodomain protein) overexpression is 
associated with abrogation of the G2 cell-cycle checkpoint in breast cancer [115]. 
 It should be noticed that two of the above mentioned tumorigenic mechanisms deal 
with a possible role of the homeotic proteins in the regulation of cell proliferation. 
Interestingly, some parallel studies conducted in the field of DNA replication revealed 
an affinity of several HOX proteins for human DNA replication origins [101]. In view 
of a possible connection between key elements of development and differentiation with 
the main events regulating cell proliferation, we will now review the state-of-the-art 
about the possible involvement of HOX proteins in cell-cycle regulation and DNA 
replication origin function.  
1.2.5 HOX proteins vs. DNA replication and cell-cycle regulation 
A large body of evidence points to HOX proteins as actors in the regulation of cell-
cycle progression, and in particular of DNA replication occurring at the S phase of the 
cell-cycle. As these two events are tightly interconnected, this paragraph actually 
summarizes, with chronological order, the most relevant findings concerning the both of 
them. 
 The search for cell-cycle regulatory and regulated genes in human carcinoma cells 
has allowed identifying several homeotic proteins. This was indeed the first indication 
that homeobox genes play a role in tumorigenesis and/or tumor progression, possibly 
through a cell-cycle regulative function. One of the first to be identified was HSIX1, a 
member of divergent homeobox genes (see paragraph 1.2.1). HSIX1 expression was 
found to be absent at the onset of and increased toward the end of S phase. 
Overexpression of HSIX1 in MCF7 cells resulted in abrogation of the G2 cell-cycle 
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checkpoint in response to X-ray irradiation. HSIX1 expression was absent or very low 
in normal mammary tissue, but was high in 44% of primary breast cancers and 90% of 
metastatic lesions. In addition, HSIX1 was expressed in a variety of cancer cell lines 
[115].  
 Parallel studies focused on the search for proteins participating in the regulation of 
human DNA replication, identified the HOX proteins to specifically bind the sequence 
of human replication origins. The first indication came from a yeast mono-hybrid screen 
for human proteins with affinity for the lamin B2 origin [101]. This study identified 
three HOX proteins, namely HOXA13, HOXC10 and HOXC13, for the specific 
recognition of a central portion of the origin. This 74bp sequence already showed to be 
bound by the replicative complex (RC) [84, 165]. The HOXC10 and HOXC13 proteins 
were shown to bind the same origin sequence both in vivo (CAT assay) and in vitro. 
Further studies revealed that the HOXC10 protein is present only in proliferating cells, 
where it oscillates in abundance during the cell-cycle until it is degraded early in mitosis 
by the ubiquitin pathway [102]. Mutations of two destruction boxes avoid its 
degradation and delay the metaphase to anaphase transition, indicating that the protein 
is indeed involved in mitotic progression.  
 Soon after, the cell-cycle regulator Geminin, an origin licensing inhibitor [24], was 
found to associate with members of the Hox-repressing polycomb complex, with the 
chromatin of Hox regulatory DNA elements and with a number of HOX proteins. The 
interaction between Geminin and HOX proteins prevents the latter from binding to 
DNA, inhibits HOX-dependent transcriptional activation and displaces Cdt1 from its 
complex with Geminin. Thus, by establishing competitive regulation, Geminin was 
proposed to function as a coordinator of developmental and proliferative control [66], as 
schematically depicted in Figure 1.15. 
 More recently, other abdominal-B orthologs, namely HOXD13, HOXA13 and 
HOXD11 were found to interact in vivo with several origins (lamin B2, TOP1, MCM4, 
c-MYC and FMR1). In particular, HOXD13 was found to stimulate RC assembly and 
DNA synthesis; Geminin, which interacts with HOXD13 as well, blocks HOXD13-
mediated assembly of pre-RC proteins and inhibits HOXD13-induced DNA replication. 
Thus, the HOX-Geminin competitive regulation works also in the context of replication 
origin licensing [103]. 
 Overall, these studies suggest that HOX poteins do exert a role in the control of cell 
proliferation. In particular, data point to a direct intervention of homeotic proteins in 
origin regulation, with no mediation by transcription, previously considered as the only 
way through which HOX proteins exert their function. Moreover, the affinity for origin 
sequences displayed by HOX proteins per se suggests that they could be directly 
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involved in origin function, besides via the competitive regulation of Cdt1-Geminin 
binding. An involvement in the regulation of origin activation of these proteins could 
finally help to explain the proto-oncogenic role often displayed by these proteins (see 
previous paragraph and [104]). Still, such considerations would need a thorough 
understanding of the origin activation/deactivation cycle to be achieved. 
 
 
Figure 1.15 Model of Geminin interplay between proliferation and differentiation. A) Cdt1-
dependent  role of Geminin in cell-cycle regulation. B) HOX-Cdt1 competition for the binding of 
Geminin. Details are reported in the main text. Taken from: Luo et al. [166]. 
 We chose to address the issue of HOX proteins involvement in origin function by 
exploring the spatio-temporal dynamics of a selected HOX protein in relation to DNA 
replication in living human cells. This approach took advantage of the use of several 
biophysical tools, which have so far proven helpful in the study of many biology fields, 
included DNA replication, as will be reviewed in the next paragraph. 
1.3 Biophysical approaches for the in vivo study of nuclear 
structure and function  
Recent advances in biophysical technologies combined to confocal or wide-field 
microscopy provide ideal strategies for approaching problems of various fields of 
biology. These advances were definitely favored by the discovery of the Green 
Fluorescent Protein (GFP), and by the subsequent development of numerous fluorescent 
protein (FP) derivatives spanning almost the whole UV-visible spectrum [167-172]. 
These actually constitute the unique category of genetically encoded fluorophores; since 
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their introduction, the ability to study protein functions in an intact cellular environment 
has been revolutionized, in that fluorescent labeling is achieved non-invasively by the 
expression of the protein of interest fused to the sequence coding for the desired FP. It is 
therefore not surprising that the pioneers of this tool were awarded with the 2008 Nobel 
Prize in Chemistry.  
 The development of FPs has led to the rapid evolution of live-cell imaging methods. 
The full spectrum of FP color variants is being exploited in multicolor fluorescence 
microscopy experiments to track the distribution of different proteins in the same living 
cells, allowing for the direct visualization of protein recruitment and/or interactions, co-
localization, and dynamics within subcellular compartments [173-175]. Through the 
combination of FPs and advanced digital imaging technologies, it is now possible to 
visualize diverse biological processes inside the living cell, providing an important 
complement to the biochemical methods, traditionally used as an exclusive tool in the 
field. Importantly, the availability of quantitative imaging approaches allows to extract 
the correct information from large digital imaging data sets; this is often the 
recommended way to gain reliable results in the typical context of cell-to-cell 
heterogeneity, which would make any qualitative analysis based on selected images 
difficult, if not impossible [176].  
 The mammalian cell nucleus represents a tempting subcellular environment where to 
test the potential advantages brought by biophysical approaches. It contains a variety of 
subnuclear domains where proteins with specialized functions are localized. These 
domains include spherical bodies (such as nucleoli, Cajal bodies, and the 
promyelocytic-leukemia-protein nuclear bodies or PML), irregular speckles (such as 
those of the subunits of the mRNA splicing machinery), as well as the diffuse structure 
of interphasic chromatin. The partitioning of the nucleus without intervening 
membranes indicates that subnuclear compartments likely formed by a process of self-
assembly. The mechanisms that regulate and maintain these highly ordered assembly of 
proteins in intact nuclei must be defined to understand their function. Therefore, the 
structure and function of nuclear architecture has been in the last years extensively 
studied (for representative reviews see: [177-181]). Such studies have confirmed that 
biochemical approaches are invaluable in the characterization of the multi-protein 
complexes involved in the maintenance of nuclear structures. However, what is missed 
by the in vitro analysis is the role that the organized microenvironment within the intact 
nucleus plays in the regulation of these complexes. In this context, the visualization of 
nuclear compartments by both indirect immunofluorescence microscopy and by labeling 
of the constituent proteins with FPs has been particularly advantageous (reviewed by 
Voss et al. [176]). The latter approach in particular has allowed applying quantitative 
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biophysical tools to explore nuclear dynamics with high spatial and temporal resolution. 
Among the most widely used biophysical techniques are FRAP and FRET microscopy, 
whose application in the nuclear context will be reviewed in the two next paragraphs. 
1.3.1 FRAP and FRET applied to the study of the nucleus  
Fluorescence Recovery After Photobleaching (FRAP) is a technique whereby the 
protein of interest is labeled by a fluorophore, e.g. it is fused to a FP and expressed in 
living cells; thereafter, it is photobleached in a region of interest (ROI) and the 
redistribution of the non-bleached protein population is monitored. From the plot of the 
recovery of fluorescence in the ROI vs. time important information about the mobility 
and diffusive properties of the protein can be derived. This procedure has been 
extensively used to analyze the dynamics of numerous nuclear proteins with particular 
regard to the kinetics of chromatin binding [182-188] (Figure 1.16). The quantitative 
analysis of nuclear FRAP experiments (reviewed in Appendix A of this thesis) has 
allowed to draw a dynamic vision of nuclear compartmentalization: nuclear proteins 
belonging to a particular subnuclear domain display a high tendency to actively 
exchange with other subnuclear domains. For transcription factors, this results in a 
partition of their distribution between nucleoplasm and chromatin, and in mean 
residence times onto chromatin of the order of seconds [182, 187-189]. This fast nuclear 
dynamics is supposed to be a means by which nuclear functions like gene expression 
and chromatin modification are regulated. Conversely, few nuclear proteins deviate 
from this rule and display stable chromatin binding and slow intranuclear exchange, 
namely histones [190], cohesin [191] and centromeric proteins [192]. Notably, these 
proteins share a structural role in the maintenance of nuclear architecture, which 
probably does not need the same plasticity as other nuclear functions for its regulation.  
 
 
Figure 1.16 Nuclear FRAP procedures. Nuclear FRAP procedures differ mainly in the geometry of the 
ROI which is bleached (grey area within the schematically depicted nucleus). A) Bleaching of a small 
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circle inside the nucleus; B) Bleaching of a strip across the nucleus; C) Bleaching of half nucleus. 
Representative plots of fluorescence recovery in the ROI vs. time are reported below each bleached 
nucleus. Adapted from: Mueller et al. [182]. 
  The formation of domains with separate functions in the nucleus requires the 
assembly of proteins which interact with each other. Thus, subnuclear organization 
likely reflects direct protein-protein interactions, but the optical resolution of the light 
microscope is not sufficient to detect this (Figure 1.17A). Fortunately, there are imaging 
techniques available that allow us to further define the spatial relationships between 
specific nuclear protein partners in living cells (reviewed by Voss et al. [176]). 
Fluorescence Resonance Energy Transfer (FRET) is used for the analysis in vivo of 
protein-protein interactions. A close proximity between two proteins of interest, i.e. a 
direct interaction between them, can be detected by their fusion to an appropriate couple 
of FP mutants with peculiar spectral properties (reviewed in Appendix B of this thesis), 
named donor and acceptor (Figure 1.17B). Because the distance within which energy 
transfer can occur between FPs is limited to less than about 8-10 nm, the detection of 
FRET provides measurements of the spatial relationship of the fluorophores on the scale 
of angstroms. There are several methods to detect FRET between two fluorolabelled 
interacting species. A very advantageous one is by detecting the reduction of donor 
lifetime in the presence of acceptor (graph of Figure 1.17B), as can be achieved by 




Figure 1.17 FRET to study mammalian cell nuclei. A) Fluorescence microscopy is limited by the 
diffraction of light to a resolution of approximately 200 nm, and objects that are closer will appear as a 
single object, so that considerable distances may actually separate proteins that appear co-localized by 
fluorescence microscopy. B) FRET microscopy detects the direct transfer of excitation energy (red arrow) 
from a donor D fluorophore to an acceptor A, when they are closer than 8-10 nm. When energy transfer 
occurs, the donor fluorescence signal is quenched. Right graph: FRET results in a shortening of the donor 
lifetime, i.e. the mean time that the fluorophore spends in the excited state prior to returning to the ground 
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state. FLIM (Fluorescence Lifetime Imaging Microscopy) allows the spatially-resolved quantification of 
FRET by donor lifetime measurements. Adapted from: Voss et al. [176]. 
1.3.2 Study of DNA replication regulation in living cells  
The mechanism of DNA replication, as summarized in paragraph 1.1, has also been 
studied in living cells by biophysical approaches, in order to elucidate both the 
dynamics of proteins involved in the DNA replication process, and the protein networks 
relevant for its regulation. 
 The in vivo study of DNA synthesis has unveiled interesting insights about how 
DNA replication is spatially organized in intact nuclei; furthermore, it has helped the 
understanding of how time-programmed origin activation (paragraph 1.1.2) is 
achieved throughout S phase progression. Replication sites were first detected by 
immunostaining of newly replicated DNA or replication enzymes [194] and later by 
monitoring GFP-tagged replication factors, like PCNA [195], Dnmt1 [196], RPA [28], 
DNA Ligase I [197]. To date, such fluorolabelled proteins constitute a very useful class 
of in vivo markers of S phase progression [197]. These approaches revealed that 
replication foci appear under the microscope as nuclear spots of varying size and 
position, yet their number per nucleus is far smaller than the expected number of 
genomic replication origins. The pattern of tagged replication loci changes significantly 
during S phase, consistently with the idea that replication origins self-assemble in 
replication foci [198]. Yet, the self-assembly relies on strong protein-protein 
interactions in the replication machinery, as FRAP experiments performed using FP 
fusions of PCNA have shown little if any turnover of the protein at replication sites [28, 
199]. Collectively, these data have led to a model in which replication origins are 
clustered together at the start of replication to form several replication factories 
dispersed within the nuclear architecture. Unreplicated DNA is pulled into the factory, 
whereas replicated sister strands might be extruded in the course of replication. 
Interestingly, a spatio-temporal order is maintained in the activation of the replication 
factories in the course of S phase. This represents the way by which DNA replication 
timing regulation is exerted [200]. Indeed, replicon clusters that fire at different times 
during S phase occupy different subnuclear compartments, with early replicating foci 
showing enrichment in the nuclear interior, whereas foci replicating later during S phase 
are enriched in perinucleolar regions and the nuclear periphery [194, 201, 202] (see also 
Figure 2.7 at next Chapter, paragraph 2.3). The order in which these segments 
replicate is established during early G1 phase [200], and seems to be an epigenetic mark 
depending on the differentiation state of a cell [33].  
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 The assembly of pre-RC occurring in G1 phase has also been investigated in living 
cells. In an interesting study by Mc Nairn and colleagues [203], GFP fusions of ORC1 
and ORC4 subunits have been expressed in mammalian cells and their nuclear 
dynamics investigated by FLIP (Fluorescence Loss in Photobleaching). In FLIP, a 
single spot in the nucleus is repeatedly bleached and the loss of fluorescence is 
quantified at locations away from the bleach spot, so this represents a complementary 
technique with respect to FRAP, but it actually provides similar information [204]. The 
authors observe very fast dynamics for both proteins, thus providing evidence that ORC 
can sample many sites throughout the nucleus within a very short period of time (order 
of seconds). They comment that this dynamic behavior could account for the many 
origin sequences that mammalian ORC is supposed to bind as well as for the many 
biological functions in which ORC has found to be involved, besides pre-RC assembly 
(paragraph 1.1.3). Interestingly, dynamic exchanges characterize ORC1 and ORC4 
binding to chromatin, while ORC complexes instead remain stably bound to chromatin 
during in vitro biochemical isolation procedures [205]. Therefore, they propose a model 
in which ORC forms stable chromatin-associated complexes consisting of rapidly 








 Taken together, these data indicate that biophysical approaches can be used in the 
study of DNA replication in living cells; indeed, the combination of these techniques 
and traditional biochemical approaches provide complementary information, that are 
useful for a better understanding of the dynamics of this process. 
 
Figure 1.18 Model of ORC dynamics. ORC may 
exist as a more stable chromatin-associated 
complex, consisting of dynamic subunits. Details 
are contained within the text. Taken from: Mac 
Nairn et al. [203] 
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1.4 Aim of the work 
The mechanisms by which DNA sequences are selected to be replication origins in 
metazoan (indeed, human) genomes are still not completely understood (see paragraph 
1.1.5). The finding that HOX proteins have an affinity for human replication origins 
[101], and take part to the regulation of cell-cycle as well as DNA replication 
(paragraph 1.2.5), makes them interesting candidates for a role in origin specification. 
An involvement in the regulation of origin activation of these proteins would not be 
surprising, in light of their morphogenetic and often proto-oncogenic role (see 
paragraph 1.2.4 and [104]). Nevertheless, this consideration raises a number of 
questions concerning the possible general role played by these proteins in the context of 
DNA replication regulation: does the affinity for origin sequences of HOX proteins 
correspond to an actual origin binding in vivo? What is the dynamics displayed by the 
HOX proteins at the origins? Does the origin binding by HOX proteins correlate 
temporally and spatially with the sites of DNA synthesis, in the context of cell-cycle 
progression? Can HOX be considered as RC members at the origin? 
 In order to answer to these questions, we have selected the human HOXC13 protein 
to be studied. This protein is and Abd-B paralog of the HOX family and was indeed 
shown to specifically recognize the Lamin B2 origin sequence [101]; furthermore, it 
was identified to be an oncoprotein [158]. 
 The combined advances in FP biology and imaging methods (as reported in 
paragraph 1.3) are here applied to the study in living human cells of HOXC13 protein 




2.1 Expression and localization of endogenous HOXC13 in 
human cells 
The investigation of HOXC13 function in vivo required a preliminary understanding of 
the cellular expression, as well as of the subcellular distribution, of the protein in human 
cells. To this purpose, we first explored the localization of endogenous HOXC13 in two 
human cell lines, namely U2OS and T98G cells, which showed to express the protein in 
significant detectable amounts (Figure 2.1A).  
 Immunofluorescence of endogenous HOXC13 was performed using a specific anti-
HOXC13 antibody (an antibody that does not recognize the homeodomain was chosen 
in order to increase the recognition specificity and to avoid epitope hindrance by the 
DNA in the DNA-binding moiety of the protein). Endogenous HOXC13 showed a 
mainly nuclear localization in asynchronously growing U2OS and T98G cells (Figure 
2.1B). The latter displayed also a cytoplasmic staining of the protein in a substantial 
part (!50%) of the investigated cell population.  
 
Figure 2.1 Expression and subcellular localization of endogenous HOXC13 in U2OS and T98G 
cells. A) Western blot detection of endogenous HOXC13 in whole cell extracts (WCE) of U2OS and 
T98G cells using a specific !-HOXC13 antibody: the most intense band runs at ! 37 kDa, consistently 
with the expected MW of 35.4 kDa of the protein. B) Immunofluorescence detection of endogenous 
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HOXC13 in U2OS and T98G cells using the same primary antibody as in panel A, subsequently detected 
with an Alexa647-conjugated secondary antibody. DAPI staining highlights cell nuclei. Scale bar: 20 µm. 
 We further characterized endogenous HOXC13 nuclear distribution. To this 
purpose, we performed, prior to cell fixation and subsequent HOXC13 
immunofluorescence, a detergent pre-extraction by subjecting cells to a short incubation 
with 0.5% Triton-X100 with PBS. This treatment resulted in the complete removal of 
cytoplasm (as verified by microscope analysis) and of the nucleoplasm soluble proteins 
from the chromatin fraction, as already reported [21, 56, 206]. Under these conditions, 
no HOXC13 should be detected in the nuclei if the protein were exclusively a soluble 
component. Instead, a significant amount of the protein was still retained in U2OS pre-
extracted nuclei (Figure 2.2A), providing a first indication that HOXC13 is a chromatin 
component; notably, this treatment unveiled a peculiar speckled-like, inhomogeneous 
distribution for chromatin-bound endogenous HOXC13 in both U2OS and T98G pre-
extracted nuclei (Figure 2.2B).  
 
Figure 2.2 Nuclear distribution of endogenous chromatin-bound HOXC13 in U2OS and T98G cells. 
A) Validation of the pre-extraction procedure for the detection of chromatin-bound proteins. U2OS cells 
were extracted with 0.5% Triton-X100 in PBS before fixation and subsequently subjected to 
immunofluorescence using primary antibodies against a non-nuclear protein (negative control, !-dsRed 
rabbit polyclonal) or against HOXC13 (!-HOXC13 rabbit polyclonal). Images were acquired using the 
same set up parameters. A significant amount (> twice the negative control) of HOXC13 was detected in 
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U2OS nuclei. Scale bar: 20 µm. B) Magnification of pre-extracted U2OS and T98G nuclei showing the 
inhomogeneous, speckled-like, distribution of endogenous chromatin-bound HOXC13. Primary 
antibodies were detected with an Alexa647-conjugated secondary antibody. DAPI staining highlights cell 
nuclei. Scale bar: 5 µm. 
 In order to elucidate whether the detergent-extraction resistance was due to an actual 
chromatin affinity by the protein, we performed a biochemical in vitro fractionation 
analysis in U2OS cells. We first separated the cytoplasmic fraction of asynchronous 
cells from intact nuclei by low-speed centrifugation [21, 207]; the nuclear envelope was 
then broken with 0.5% Nonidet-P40 and the nucleoplasm was separated again by 
centrifugation [205]. The residual chromatin was sequentially extracted with increasing 
NaCl concentrations (ranging from 150 mM to 2 M), performing the first extraction step 
both in the presence and in the absence of DNase I. We then determined the presence of 
endogenous HOXC13 protein in the various fractions comparing them with the protein 
detected in a whole cell extract; as shown in Figure 2.3 (first row), we found almost no 
detectable HOXC13 in the cytoplasm, while both nucleoplasm and chromatin fractions 
contained a significant amount of HOXC13. The bulk of HOXC13 could be extracted 
from the chromatin fractions only at salt concentrations "300 mM; in particular its 
presence in the 600 mM and 2 M fractions confirmed that this protein is tightly bound 
to the nuclear structure.  
 
Figure 2.3 Western Blot detection of endogenous HOXC13 in comparison with HP1"  in 
biochemically fractionated asynchronous U2OS cells. The soluble (left panel) and chromatin fractions 
(right panel) of asynchronous U2OS cells were investigated for the presence of endogenous HOXC13 and 
HP1" by Western Blot (tubulin is the control of actual cytoplasm/nucleus separation; actin is the loading 
control of chromatin fractions). The HOXC13 and HP1" protein levels detected in all fractions were 
compared to those of a whole-cell extract (WCE). CYT and NUP are cytoplasmic and nucleoplasmic 
fractions, respectively. The chromatin fractions are identified by the NaCl concentration used for the 
extraction. The first extraction step (150mM) was performed in the absence (-) or presence (+) of DNase 
I. 
DNase treatment changed significantly the salt extraction profile: in this case, most of 
the protein was eluted at 150-300 mM NaCl, while the 600 mM and 2 M fractions were 
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almost empty, providing evidence that HOXC13 is stably bound to the nuclear structure 
through its interaction with DNA. This behaviour was found to be specific for the 
HOXC13 protein; infact, the HP1" protein was investigated as a control, owing to its 
known chromatin-binding properties [207], and displayed a different fractionation 
profile when compared to that of HOXC13 in U2OS cells (Figure 2.3, second row). 
2.2 Expression of GFP fusions of HOXC13 protein in human 
cells 
In order to study HOXC13 in living cells, its sequence was fused to different variants of 
fluorescent proteins (FPs), spanning over almost the entire visible light spectrum. As 
schematically depicted in Figure 2.4A, the fluorophores were either fused at the N- or 
C-terminus of the protein. A longer linker was inserted between HOXC13 and FP in the 
C-terminal fusion construct with respect to the N-terminal one, to avoid steric hindrance 
of the protein homeodomain by the FP structure. The two constructs were transiently 
expressed in several human cell lines, namely U2OS (Figure 2.4B), HeLa (Figure 2.4C), 
T98G and MCF7 cells (data not shown); when expressed in all tested cell lines, both N- 
and C-terminal constructs showed a speckled-like nuclear localization very similar to 
that found for chromatin-bound endogenous HOXC13 (Figure 2.2B).  
 
Figure 2.4 Fluorolabelled HOXC13: design of fusion constructs and expression in human cells. A) 
Shematic picture of the prepared fluorolabelled HOXC13 constructs. The FP sequence was either fused at 
the N- (left panel) or at the C-terminus (right panel) of HOXC13 sequence. The linker peptide designed 
for the fusion is indicated by its aminoacidic sequence. The three blue bars at the end of HOXC13 
sequence represent the helix-turn-helix motif in the homeodomain (see Figure 1.11). B) Localization of 
mCherry-HOXC13 expressed in living U2OS cells. C) Localization of HOXC13-mOrange expressed in 
fixed HeLa cells. Scale bar: 5 µm. 
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 We thus concluded that fusion of HOXC13 to FP variants does not cause mis-
localization with respect to the endogenous protein. Although the N- or C- terminus 
positioning of the fluorophore did not seem to affect protein localization, in all 
subsequent experiments we chose to use the N-terminus fusion construct, in order to 
leave the DNA binding moiety free from the FP structure.  
 Further experiments were performed to test the correct expression and functionality 
of fluorolabelled HOXC13 constructs. First, biochemical extracts of U2OS cells 
transiently expressing mCherry-HOXC13 were investigated by Western Blot. The 
recombinant protein showed to be properly expressed in a whole cell extract, with no 
evident degradation of the construct (Figure 2.5A, first lane). Notably, the recombinant 
protein was absent in a U2OS cytoplasmic fraction (Figure 2.5A, second lane), similarly 
to what found for its endogenous counterpart (Figure 2.3). Conversely, a nuclear 
fraction was prepared by sequentially extracting U2OS nuclei with DNase I and 600 
mM NaCl. Indeed this condition was proven to extract all endogenous HOXC13 from 
chromatin (see Figure 2.3). This nuclear fraction was found to be greatly enriched in 
mCherry-HOXC13 content when compared to the whole cell extract (Figure 2.5A, third 
and first lanes respectively). Furthermore, immunofluorescence experiments confirmed 
that recombinant E0GFP-HOXC13 is recognized by the anti-HOXC13 antibody above 
described (Figure 2.5B) and, equally to the endogenous counterpart, retains detergent 
pre-extraction resistance possibly owing to its chromatin affinity (Figure 2.5C).  
 
 
Figure 2.5 Check of correct expression and functionality of recombinant fluorolabelled HOXC13. 
A) U2OS cells transiently transfected with mCherry-HOXC13 were biochemically extracted to obtain 
whole cell extract (WCE), cytoplasmic (CYT) and nuclear (NUC) fractions, and 20 µg of each fraction 
were loaded on a gel and blotted using !-dsRed antibody to detect only recombinant mCherry-HOXC13. 
The theoretical MW of the fusion construct is ~ 63kDa. B) Immunofluorescence of U2OS cells 
expressing E0GFP-HOXC13 using !-HOXC13 antibody, further detected with an Alexa 647 conjugated 
secondary antibody. The Merge image highlights the exact recognition of fluorolabelled HOXC13 by !-
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HOXC13. Scale bar: 5 µm. C) Same immunofluorescence as described in B), but performed in U2OS 
cells subjected to detergent pre-extraction with 0.5% Triton-X100. An image containing both 
untransfected and transfected U2OS is reported to visualize both endogenous and recombinant HOXC13 
detected with !-HOXC13 antibody (further detected with Alexa 647 conjugated secondary antibody). 
Scale bar: 10 µm. 
 Taken together, these data demonstrate that fluorolabelled HOXC13 retains, besides 
a similar nuclear distribution pattern, also the same properties of its endogenous 
counterpart, as far as chromatin affinity is concerned. Indeed, the recombinant protein is 
present only in the nucleus, where it is likely bound to chromatin, as proven by two 
parallel evidences: at first, a combination of high salt concentrations and chromatin 
DNA degradation greatly increases the amount of recombinant protein which can be 
recovered from U2OS nuclei, when compared to the protein detected in a whole cell 
extract (Figure 2.5A and Figure 2.3); in the second place, the protein is resistant to a 
detergent pre-extraction performed prior to cell fixation (Figure 2.5C). 
 Once the functionality of fluorolabelled HOXC13 was tested, we also investigated 
whether its over-expression, typical of all experiments performed by transient 
transfection of the construct, caused relevant cell-cycle alterations. HeLa cells 
transfected with E0GFP-HOXC13 (same as Figure 2.4) were fixed either when 
asynchronous or after 1 h release from a double overnight thymidine block, which 
results in a cell-synchronization at the G1/S border.  
 
Figure 2.6 Impact of HOXC13 over-expression on HeLa cell-cycle progression. A) Top: schematic 
picture of the fluorolabelled HOXC13 construct (same as Figure 2.4). Bottom: plot of DNA content 
detected by propidium iodide staining (FL2-A) vs. green fluorescence (FL1-H) for the asynchronous (AS-
HeLa, top panel) and the synchronized (Double thym-HeLa, bottom panel) samples. The green square 
corresponds to the selected cell population displaying green fluorescence at least 100-fold higher than 
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non-transfected cells. B) Cell-cycle profile of AS (left) or Double thym (right) HeLa cells after 
transfection without (top) or with (bottom) green-gate selection.  
 We measured by FACS the cell-cycle profile of transfected cells in the 
asynchronous and synchronized samples. In detail, we restricted this analysis only in the 
cell sub-population displaying a significant amount of transfected construct (i.e. we 
selected for green fluorescence, see Figure 2.6A). No significant difference in the cell-
cycle profiles were detected for the selected green-fluorescent subpopulation of either 
asynchronous or synchronized HeLa cells, with respect to non-gated transfected HeLa 
cultures (Figure 2.6B).  
 We therefore concluded that transient expression of recombinant fluorolabelled 
HOXC13 in human cells -further used in all subsequent experiments below reported- 
does not alter significantly cell-cycle progression. 
2.3 Co-localization of fluorolabelled HOXC13 with replication 
foci 
An involvement of HOXC13 protein with the regulation of origin function would 
require its cellular localization in the nuclear compartments where DNA is replicated. 
We addressed this issue by investigating whether the localization observed for 
fluorolabelled HOXC13 correlates with the sites of DNA synthesis. These were 
visualized by fluorolabeling of the replication foci (RF) in cells in S phase, the moment 
of the cell cycle when DNA replication occurs (see paragraph 1.1). Two different 
approaches can be used to tag RF in intact cell nuclei. One is the pulsed incubation of 
the living cells with modified nucleotide-analogs, which are secondarily detected with a 
fluorescent probe after an appropriate permeabilization of the cells [194, 208, 209]. 
Tipically, alogenated nucleotide analogues, like BrdUrd, are detected by 
immunofluorescence [202]. Another approach, more recently developed, is the 
expression in living cells of FP fusions of replication factors, such as PCNA, Dnmt1 
and DNA Ligase I, to visualize the dynamics of replication factories in vivo [195-197] 
(see paragraph 1.3.2 for more details).  
 In our studies, both these strategies were used, allowing us to obtain complementary 
information, which will be discussed separately in the next paragraphs 2.3.1 and 2.3.2, 
respectively.  Finally, in paragraph 2.3.3 we shall present results concerning the role of 
HOXC13 homeodomain in the definition of the co-localization with RF. 
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2.3.1 Pulsed BrdUrd immunofluorescence 
U2OS cells were transiently transfected with E0GFP-HOXC13. Thereafter, they were 
pulse-labelled with BrdUrd for 10-15 min, fixed and processed for BrdUrd 
immunofluorescence, similarly to what already described [197]. Briefly, sites of BrdUrd 
incorporation, i.e. RF, were stained with a specific anti-BrdUrd antibody in the presence 
of DNase I and subsequently detected using an Alexa647-conjugated secondary 
antibody. In this way, a positive staining with red fluorescence allowed us to identify 
cells in S phase and to classify them in three categories depending on the spatial 
organization of BrdUrd foci. These were assigned to three distinct moments of S phase 
progression [202], as shown in Figure 2.7: early S (numerous and ubiquitous foci in the 
nucleus), mid S (perinuclear and perinucleolar foci), late S (some perinuclear foci plus 
bigger central clusters of foci) phases. These three distinct patterns of RF, although 
more evidently marked in mouse cells, are conserved throughout the S phase of all 
mammalian cells (primary, immortalized, transformed [210]). 
 
Figure 2.7 Definition of replication foci (RF) nuclear patterns in U2OS cells. Efficiency of BrdUrd 
immunofluorescence, as described in the main text, was checked by simultaneous DAPI staining of the 
nucleus. Three different patterns of RF distribution could be distinguished, based on the BrdUrd staining, 
which are schematically depicted on the bottom panel and described in the main text. Scale bar: 5 µm. 
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 Moreover, the green fluorescence of transfected HOXC13 was related with the red 
one of RF, by performing a 3D co-localization analysis of the two channels [211, 212] 
at the three distinct moments of S phase above described. In detail, Z-stacks of BrdUrd 
and HOXC13 fluorescence images were sequentially acquired, comprising all nuclear 
thickness; images were restored by deconvolution and the Pearson’s coefficient of co-
localization (P) between the two channels was calculated (see paragraph 4.6.2 for 
calculation details). This approach allowed both to increase the resolution of the fine 
BrdUrd focal structure and to monitor the co-localization in the whole nuclear volume. 
Results are summarized in Table 2.1 and Figure 2.8. As shown by the graphs in Figure 
2.8, measurements performed in both U2OS (panel A) and HeLa cells (panel B) lead to 
analogous results and revealed a marked co-localization between HOXC13 and BrdUrd 
in early S phase cells, while the co-localization became progressively lower in mid S 
and it was almost lost in late S phase cells. Representative images of U2OS cells 
analyzed in these experiments, reported in panel C of the same figure, strengthen the 
finding that the co-localization of HOXC13 with RF is restricted to early S phase, while 
mid and late RF are gradually excluded from HOXC13 nuclear compartments.  
 These results could be reproducibly observed in two different human cell lines; 
nevertheless this approach suffers of the relatively invasive procedure used. Indeed, 
BrdUrd detection by the primary antibody requires destruction of the sorrounding 
nuclear DNA; this is usually achieved by acidic DNA denaturation in the presence of 
HCl before the antibody incubation [195] or, like we did in this study, by DNase 
treatment concomitant with antibody incubation [197]. We cannot exclude that such 
procedures, although performed in fixed cells, could result in some alteration of 
HOXC13 localization and nuclear solubility, as these were found to rely on its 
chromatin DNA affinity (Figures 2.2, 2.3 and 2.5).  
 In order to confirm our co-localization data in an intact chromatin context, we 
decided to use an alternative method to mark replication foci in living cells, as described 
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Figure 2.8. Co-localization analysis of fluorolabelled HOXC13 with RF throughout S phase 
progression (see previous page). Co-localization of HOXC13 with RF is quantified in each S phase 
moment by calculating the Pearson’s co-localization coefficient (P) between the two fluorescence 
channels. Distributions of obtained P values from early, mid, late S phase cells are plotted for U2OS (A) 
and HeLa cells (B): the mean P is reported as a sphere enclosed in a box, whose vertical length represents 
the SD; the 5–95 percentile distribution is reported as a vertical line at the middle of each box. Gray-scale 
box colors correspond to S phase progression, according to the top arrow. Individual P values are reported 
as black dots behind each box. Statistical significance, as reported in paragraph 4.6.2, was calculated by 
the Mann-Whitney test (!=0.01): * ~0.0001, ** ~0.0001, *** <0.0001. C) Nuclear z-projections of 
representative U2OS cells displaying early, mid, late S BrdUrd patterns and expressing E0GFP-HOXC13. 
The co-localization is highlighted by the Merge of the two channels. Scale bar: 5 µm. 
Table 2.1 Co-localization analysis of fluorolabelled HOXC13 with RF throughout S phase 
progression. Mean P values (± SD) obtained from BrdU immunofluorescence analysis of both U2OS 
cells (second column) and HeLa cells (third column) at three distinct moment of S phase (each for one 
row). n refers to the number of cells analyzed for each sample. 
Table 2.1 U2OS HeLa 
Early S phase P = 0.61±0.11 n=18 P = 0.81±0.08 n=8 
Mid S phase P = 0.42±0.08 n=15 P = 0.50±0.17 n=5 
Late S phase P = 0.13±0.12 n=12 P = 0.23±0.10 n=6 
 
2.3.2 Replication factories visualized in real-time in living cells 
In order to investigate whether the already described selective co-localization of 
HOXC13 with early S RF occurs also in living cells, human EGFP-HOXC13 was co-
transfected with RFP-PCNA, a known marker of RF for live cell imaging [195, 199]. In 
detail, the two proteins were expressed in NIH3T3 cells, as mouse cells display more 
pronounced changes in the nuclear pattern of RF throughout all S phase.  
 The localization of RFP-PCNA allowed straightforward identification of cells in S 
phase: indeed, this protein displays homogeneous nucleoplasmic staining in non-S cells, 
while in S cells it selectively targets the RF and undergoes the same dynamic changes of 
pattern throughout S phase, as those reported in Figure 2.7 [196]. When selectively 
looking at cells in S phase in asynchronous NIH3T3 cultures, again we found a marked 
co-localization of HOXC13 with early S RF; this was less evident in mid S, and was 
virtually completely absent in the late-S phase (Figure 2.9).  
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Figure 2.9 Cell-cycle modulated presence of HOXC13 at RF. EGFP-HOXC13 was co-transfected with 
RFP-PCNA [199] in NIH-3T3 cells. The co-localization of the two constructs during S phase can be 
evaluated by the Merge image. The intensity profile of green and red channels in a nuclear section 
(depicted as white bar across the nuclei of Merge images) is plotted below each Merge image: the 
different correlation between green and red signals in the three moments of S phase represents the 
differential co-localization of HOXC13 with RF throughout S phase. Scale bar: 5 µm. 
 Moreover, the availability of a marker for in vivo application allowed for time-lapse 
experiments throughout S phase in individual living cells expressing both constructs. 
Representative images of a time-lapse experiment of one analyzed cell are reported in 
Figure 2.10. These show an initial overlap of the green and red channels, i.e. HOXC13 
and PCNA respectively, when RF display an early S pattern; the two channels become 
progressively more separated, meaning loss of co-localization, as RF get re-organized 
and become less numerous in the nucleus; homogenization of PCNA nuclear staining 
finally marks the end of S phase, after 5 h and 30 min observation, which is consistent 
with the complete length of S phase in mouse fibroblast cancer cells [213].  
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Figure 2.10 Time-lapse imaging of S phase progression in NIH3T3 cells expressing EGFP-HOXC13 
and RFP-PCNA. An individual cell transfected with the two constructs was imaged at the indicated time 
points while constantly kept at 37°C and 5%CO2. The start point (t=0) corresponds to a typical early S 
pattern of RF. The co-localization course is highlighted by the Merge image. The intensity profile of 
green and red channels in a nuclear section (depicted as white bar across the nuclei of selected Merge 
images) is plotted below the Merge images, as already explained in Figure 2.9. PCNA homogeneous 
nuclear staining (see the profile of the red channel below the last Merge image) marks the end of S phase. 
Scale bar: 5 µm. 
2.3.3 Role of the homeodomain in the targeting of early replicating 
chromatin 
Data obtained in living cells (paragraph 2.3.2) are in agreement with, and complement, 
those obtained in fixed cells (paragraph 2.3.1). Indeed by BrdUrd immunofluorescence 
(Figure 2.8), we were able to quantify the degree of co-localization between HOXC13 
and RF, demonstrating that it is significantly modulated from early to late S. By live-
cell imaging (Figures 2.9 and 2.10), we confirmed that this actually occurs also in an 
intact chromatin context, and we were able to follow in real time their mutual nuclear 
re-distribution during S phase.  
 Also, results obtained by both these approaches point to the speckled-like, 
chromatin-bound, HOXC13 distribution as the actor for the selective targeting of the 
nuclear areas where early S DNA replication occurs. In order to assess whether 
chromatin binding is relevant to determine this selective co-localization, a 
fluorolabelled deletion mutant of HOXC13 was prepared, as reported in Figure 2.11, in 
which aminoacids 258–330 were deleted. Deleted residues encompass the 
homeodomain (compare the schematic picture of the full length protein with that of the 
deletion mutant in panel A). This conserved helix-turn-helix motif (described in detail 
in paragraph 1.2.2, Figures 1.11-12) is known to perform two functions: it allows 
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homeodomain proteins to bind chromatin DNA and it is a nuclear localization signal 
[106, 136]. Following removal of the homeodomain and in order to maintain nuclear 
localization properties to the mutant, a different localization sequence (NLSSV40) was 
added to the deletion mutant. When compared to the fluorolabelled wild type protein 
(see Figure 2.4), the deletion mutant displayed a homogeneous, diffused nuclear 
staining.  
 
Figure 2.11 Fluorolabelled deletion mutant of HOXC13.  A) Schematic picture representing both the 
mCherry fusion of full-length HOXC13 protein (top) and the fluorolabelled HOXC13 deletion mutant 
(bottom), devoid the homeodomain (residues 258-330) and supplemented with a NLSSV40 at N-terminal 
position. B) Western Blot control of the correct expression of HOXC13 deletion mutant (left lane) in 
comparison with the full-length (right lane) in U2OS whole cell extracts (20 µg loaded per well). The 
expected MW of the fluorolabelled deletion mutant is 55.3 kDa, while that of the fluorolabelled full-
length construct is ~ 63 kDa. C) Localization of HOXC13 deletion mutant expressed transiently in U2OS 
cells. Scale bar: 5 µm. 
 A co-localization analysis of the HOXC13 deletion mutant with RF would 
indiscriminately lead to the same result with all replication factories throughout S phase, 
due to its diffuse staining of the nucleus. Therefore, these findings demonstrate that the 
homeodomain is responsible for the speckled-like nuclear distribution of the full-length 
protein (see Figures 2.2 and 2.4). Importantly, the selective co-localization of HOXC13 
with early-S RF (see Figures 2.8-2.10) relies on the peculiar chromatin binding ability 
of its DNA-binding motif.  
 Overall, experiments reported so far in paragraphs 2.1-2.3 unveiled an important 
role for chromatin DNA affinity of HOXC13 homeodomain, not only for the definition 
of a precise nuclear localization of the protein, but also in the context of a possible role 
of the protein in DNA replication regulation. This motivated us to investigate HOXC13 
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nuclear dynamics properties: a description of the obtained results is reported in the 
following paragraph. 
2.4 HOXC13 nuclear dynamics 
After we demonstrated the homeodomain-dependent presence of fluorolabelled 
HOXC13 at replication factories located in early replicating chromatin, we next 
investigated its dynamics within these nuclear regions in living cells using Fluorescence 
Recovery After Photobleaching (FRAP).  
To the best of our knowledge, no FRAP experiments have been reported so far to 
analyze the nuclear dynamics of HOX proteins. Therefore, we decided to use a FRAP 
procedure, which was previously applied to study the dynamics of many different 
nuclear proteins, namely half-FRAP [188]. Briefly, this technique consists in the 
bleaching of half a nucleus of a cell expressing a GFP-tagged nuclear protein, and in the 
subsequent monitoring of signal recovery in the bleached area (see Figure 1.16C). 
Accordingly, experiments were performed, and obtained results will be presented here, 
following the logical scheme reported below:  
First. Define the correct experimental procedure in order to perform reliable 
and consistent half-FRAP experiments. This was achieved by using a nuclear 
protein, with known properties in terms of nuclear dynamics, as a standard to 
optimize our microscope set up for half-FRAP acquisitions (paragraph 2.4.1);  
Second. Choose a fluorophore, which could be ideally suited for half-FRAP 
procedures as well as long-term imaging in living cells, in order to tag HOXC13 
protein (paragraph 2.4.2); 
Third. Perform half-FRAP experiments on fluorolabelled HOXC13 protein. The 
aim here was to understand which are the key factors determining its dynamics 
properties (expression level of the construct? Chromatin binding by the 
construct? DNA binding ability of the construct? - paragraph 2.4.3); 
Fourth. Get quantitative, absolute parameters describing HOXC13 dynamics 
properties, so that a comparison with the same parameters reported for other 
nuclear proteins is possible (paragraph 2.4.4); 
Fifth. Compare HOXC13 dynamics to those of the numerous proteins 
investigated so far using the same procedure, such as transcription factors and 
coactivators, structural, and remodeling proteins [188, 191, 214], as well as 
replication proteins [196, 199, 215] (paragraph 2.4.5).  
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2.4.1 Half-FRAP experiments using the EGFP-HP1!  protein as a 
standard 
Our half-FRAP procedure was first tested for reliability by the analysis of a nuclear 
protein with known properties in terms of dynamics. To this purpose, we chose HP1! 
protein, as the dynamics of HP1 proteins has been extensively characterized by several 
biophysical tools, including half-FRAP [183, 184, 188, 189, 216, 217]. U2OS were 
transiently transfected with EGFP-HP1! construct; half nucleus of transfected cells was 
bleached, and fluorescence redistribution monitored in a subsequent time series (Figure 
2.12A); the resulting normalized recovery of fluorescence intensity in the bleached area 
was finally plotted vs. time (Figure 2.12B; see paragraph 4.7.2 for the details of 
normalization).  
 
Figure 2.12 Half-FRAP experiments performed with the EGFP-HP1!  protein in U2OS cells. A) 
Schematic picture of the construct used (top) and representative half-FRAP experiment (bottom) with 
EGFP-HP1!. The pre-bleach image (gray look up table) is an average of 10 frames acquired before 
bleaching; the post-bleach images (blue-green look up table) are single frames corresponding to the 
indicated times. The green square in the pre-bleach image represents the bleached area. Scale bar: 5 µm. 
B) Normalized fluorescence-intensity recovery vs. time for EGFP-HP1!. The curve is averaged from data 
of all analyzed cells (n=9). Standard errors values are reported on selected points. t1/2 and immobile 
fraction values are highlighted in red color. 
 From the recovery curve, we derived two parameters (highlighted in the same 
graph), which can give a general estimate of the dynamic properties of the protein: t1/2 is 
the recovery halftime and quantifies the rate at which molecules in the bleached area are 
replaced by molecules from the unbleached portion of the nucleus; the immobile 
fraction represents the amount of bleached protein which does not diffuse to the 
unbleached nucleus in the observed time-range, and is calculated as the difference 
between the total fluorescence recovery and the obtained plateau recovery. 
 For the EGFP-HP1! construct, we obtained t1/2 = 3.5-4 s and immobile fraction ! 
4%. Moreover, plateau fluorescence recovery was achieved within 60 s. These data are 
definitely in agreement with those already published for the protein, with typical values 
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of t1/2 # 10 s and immobile (or very slow) fractions ! 5% [183, 184, 188]. Thus, this 
preliminary experiment demonstrated the reliability of our microscope set up for half-
FRAP experiments so that we could proceed with the analysis of HOXC13 nuclear 
dynamics. 
2.4.2 Choice of a fluorophore suitable for the half-FRAP procedure 
Most of FRAP experiments reported so far for proteins tagged with FPs make use of the 
EGFP, due to the optimal combination of brightness, photostability, and possibility to 
achieve photobleaching by short, high laser pulses, offered by the green FP variant. 
Recently, red-emitting derivatives that equal the advanced properties of EGFP have 
been developed [168-172].  
 In order to exploit the advantages offered by red FPs (in particular, the reduced 
phototoxicity, due to their red-shifted laser excitation, during long-term imaging), we 
performed our half-FRAP experiments using the mCherry fluorophore, one of the most 
promising monomeric red FPs [170]. This choice was preliminary based on the 
observation that fusion of red rather than green FPs to HOXC13 did not result in 
localization changes nor did it affect expression of the fusion construct (Figure 2.4). 
Moreover, red FPs have been already used in dual-color FRAP experiments, in 
combination with EGFP [218-220]. Finally, we compared by half-FRAP the nuclear 
mobility of two equally designed EGFP- and mCherry- HOXC13 fusion constructs 
expressed in U2OS cells. We selected in both cases cells displaying various expression 




Figure 2.13 FRAP curves for EGFP- and mCherry- HOXC13 fusion constructs. Top: the two equally 
designed constructs (same as Figure 2.4). Bottom: mean recovery curves obtained from half-FRAP 
experiments performed in U2OS cells expressing EGFP-HOXC13 (n=14, green curve) or mCherry-
HOXC13 (n=12, red curve). Representative SD values are reported for selected points of the curves. 
 We found for the two constructs similar mean recovery curves (Figure 2.13) and, 
considering the spread of data around the mean value, we concluded that there is no 
relevant difference between the two FRAP curves. Together, the documentation in the 
literature and our experimental data demonstrate that mCherry is a suitable alternative 
fluorophore to EGFP in FRAP experiments, so that it could be used in the subsequent 
analysis of HOXC13 nuclear dynamics.  
2.4.3 Half-FRAP analysis of the nuclear dynamics of wt mCherry-
HOXC13 
The first issue that we addressed in the study of HOXC13 dynamics was the 
identification of the useful range of construct expression level ensuring reproducible 
results. The general rule of thumb, when performing FRAP experiments, is to consider 
only cells with medium-to-low expression profiles of the construct, to avoid over-
expression artifacts. However, in our case the variability observed for FRAP curves was 
unexpectedly high even in response to slight variations of the construct expression level, 
both for EGFP- and mCherry-HOXC13 (Figure 2.14A, B; see also the relatively high 
spread of data in Figure 2.13). This motivated us to investigate deeper the dependence 
of HOXC13 dynamics on its expression level.  
 To this purpose, half-FRAP measurements were performed in cells expressing 
various amounts of mCherry-HOXC13, keeping constant all set-up acquisition 
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parameters, but the fluorophore-excitation laser power (543 nm). In this way, laser 
power was directly linked to the expression level (high expression levels need low laser 
power to be visualized, vice versa for low expression levels). Mean t1/2 and immobile 
fraction were estimated from the recovery curves and were compared to the values 
obtained for a stable, very low expression of the same construct in U2OS cells. We 
found that high expression levels resulted in uncertain t1/2 overestimates (Figure 2.14C) 
and dramatically increased the immobile fraction (Figure 2.14D, E). On the contrary, as 
the protein concentration decreased, both parameters reached stable values; in detail, 
only cells acquired at 10-20 µW of laser power displayed t1/2 and immobile fraction 
stable values comparable to those obtained for a stable expression of the construct.  
 Therefore, based on these results, we decided to perform all subsequent half-FRAP 
experiments on transiently transfected cells, displaying expression levels within the 10-
20 µW laser power acquisition range. 
 
 
Figure 2.14 Dependence of wt HOXC13 nuclear dynamics on expression levels. FRAP curves of 4 
representative cells displaying different expression levels of EGFP-HOXC13 (panel A) and mCherry-
HOXC13 (panel B). The arrows represent protein concentration increase. Mean estimated t1/2 (panel C) 
and immobile fraction (panel D) of all analyzed mCherry-HOXC13-expressing cells (n=67) plotted vs. 
ranges of acquisition (from 0.1-1 to 15-20 µW) of 543 nm laser power (error bars are SD). Mean t1/2 and 
immobile fraction of a stable expression of the construct are reported as bold histogram bars. E) 
Dependence of the immobile fraction on protein concentration, expressed as [C] index: this was 
calculated as a ratio between mean pre-bleach nuclear fluorescence and acquisition laser power. Different 
gray-scale tones correspond to different laser power ranges of acquisition, as indicated; a similar gray-
scale is used in the graphs of panels A and B. 
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 We next investigated the nuclear dynamics of mCherry-HOXC13. To this purpose, 
three mCherry-tagged constructs (Figure 2.15A: NLSSV40-mCherry, mCherry-HOXC13, 
mCherry-Deletion mutant) were in turn expressed in U2OS cells, and analyzed by half-
FRAP as explained before (Figure 2.15B). Under these conditions, wt mCherry-
HOXC13 displayed the slowest average recovery curve of all constructs (Figure 2.15C). 
Its mean halftime of recovery was t1/2 = 35-40 s; within 300 s of post-bleach observation 
signal recovery reached a plateau corresponding to about 10% immobile fraction. The 
slow dynamics of wt HOXC13 was compared to the recovery rate under the same 
bleaching conditions of the NLSSV40-mCherry construct. The latter was chosen as a 
control to monitor unspecific binding events: we obtained t1/2! 0.75 s, full recovery in ~ 
6.5 s (similarly to what previously reported for NLSSV40-GFP [221]). In order to 
investigate whether this difference was caused by the anchoring of the homeodomain to 
the nuclear structure, we measured FRAP for the mCherry-HOXC13 deletion mutant 
devoid of the homeodomain, already described in Figure 2.11. We found that upon 
deletion of the homeodomain and insertion of NLSSV40 to rescue protein nuclear 
localization, the dynamics was very similar to that of the NLSSV40-mCherry control 
protein (t1/2! 1 s, full recovery in ~ 10.5 s).  
 Thus, we can conclude that wt HOXC13 displays a peculiar nuclear mobility, about 
50-fold slower than a non-interacting control, which relies on the chromatin affinity of 
its homeodomain. This observation is in agreement with the properties of chromatin 
interaction previously demonstrated for both endogenous and recombinant HOXC13 
(Figures 2.2, 2.3, 2.5). In particular, the presence of intact DNA was found to be 
relevant for the maintenance of endogenous HOXC13 at chromatin subnuclear-fractions 
(Figure 2.3). With regard to this finding, we further investigated HOXC13 nuclear 
mobility in response to changes in the homeodomain-DNA affinity. To this end, we 
mutated to alanine the homeodomain residues that create crucial contacts with DNA, as 
reported both by crystal structure [129, 130] and in vitro affinity studies [139]. 
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Figure 2.15 Half-FRAP analysis of wt mCherry-HOXC13. A) Schematic picture of the constructs 
used: (top, non-binding control) NLSSV40-mCherry, (middle) wt mCherry-HOXC13, and (bottom) 
mCherry-Deletion mutant of HOXC13 devoid of the homeodomain. B) Representative FRAP 
experiments with the three constructs. The pre-bleach image (gray look-up table) is an average of 5-10 
frames acquired before bleaching (red square in the same image); the post-bleach images (colored look-
up table) are single frames corresponding to the indicated times. Scale bar: 5 µm. C) Normalized 
fluorescence-intensity recovery vs. time for the three analyzed constructs (reported in different colors). 
The wt mCherry-HOXC13 construct was expressed either transiently (red dots) or stably (purple dots). 
Curves are averaged from data of all analyzed cells (NLSSV40-mCherry: n=11, mCherry-Deletion mutant: 
n=12, transient wt mCherry-HOXC13: n=40, stable wt mCherry-HOXC13: n=18). Standard error values 
are reported on selected points. D) Western Blot control of the correct expression of the three constructs. 
 Figure 2.16A schematically shows the mutated constructs prepared. The “HBX-
helix mutant” (top construct), was obtained by mutating three residues of the third helix 
of the homeobox (Ile47, Gln50, Asn51, numbers correspond to the classical homeobox 
numeration, as indicated in Figure 1.12 at paragraph 1.2.2). This is also known as 
“recognition helix”: it inserts into the DNA major groove, where the cited residues 
provide a contact with DNA bases (Figure 2.16C, top panel).  
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Figure 2.16 FRAP analysis of three homeodomain (HBX) mutants of mCherry-HOXC13. A) HBX 
mutant constructs: the HBX-helix mutant (top, three mutations in the third HBX recognition helix); the 
HBX-loop mutant (middle, single mutation at the HBX N-terminal loop); the HBX-combined mutant 
(bottom, combining both helix and loop mutations). B) Detection of the HBX-helix mutant (mut HOX) in 
comparison to the wt mCherry-HOXC13 (wt HOX) by Western Blot. C) The homeobox-DNA co-crystal 
structure is the same as Figure 1.12: the two panels correspond to a magnification of the interactions 
occurring at DNA major (top) and minor (bottom) groove. Only interactions mediated by the mutated 
residues described in A) are highlighted in the two panels. Top panel: HBX-major groove interaction is 
mainly mediated by two hydrogen bonds (depicted with black dashed lines) between residue Asn51 and 
adenine-13 base and Van der Waals contacts (light cyan surface contour) between Ile47, adenine-13 and 
thymine-14 and between Gln50 and thymine-23. Bottom panel: HBX-minor groove interaction is 
mediated, among others, by a hydrogen bond (black dashed line) between Arg5 and thymine-11. D) 
Normalized fluorescence-intensity recovery vs. time of the three mutants (colored dot-curves). The 
mCherry-Deletion mutant and the wt mCherry-HOXC13 curves (same as Figure 2.15) are also reported in 
gray color, as a reference for 0 and 100% DNA-binding activity, respectively. All data represent mean 
recovery curves (±SE, reported at selected time points) obtained from analyzed cells (HBX-helix mutant: 
n=38, HBX-loop mutant: n=20, HBX-combined mutant: n=37). 
 Mutation of these to alanine causes abolition of DNA binding capacity for residues 
50 and 51 [139]. The HBX-helix mutant was investigated by FRAP with the same 
protocol used for wt HOXC13; the observed nuclear mobility of this mutant was 
increased more than twice (t1/2! 17.5 s, 98% recovery in ~ 160s) with respect to the wt 
protein (Figure 2.16D). In the “HBX-loop mutant” (Figure 2.16A, middle construct) 
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Arg5 was mutated to alanine; Arg5 belongs to the N-terminal loop of the homeodomain 
and makes contact with the DNA minor groove (Figure 2.16C, top panel). Crystal 
structure shows that among all DNA-homeobox contacts, Arg5 forms the strongest 
hydrogen bond by interacting with a thymine base of the minor groove [129, 130]. Arg5 
mutated to alanine causes the total abolition of DNA-binding capacity in vitro [139]. 
Our FRAP data revealed that this mutant displays more than 4-fold increased mobility 
with respect to the wt protein (t1/2! 9s, full recovery in ~ 100s). We also combined the 
three mutations of HBX-helix with the HBX-loop one to get the “HBX-combined 
mutant” (Figure 2.16A, bottom construct), which yielded a 5-fold mobility increase 
(t1/2! 7s and full recovery in ~ 80s). Thus, these data provide evidence that DNA 
binding ability is responsible for the slow nuclear dynamics of the protein, and its 
progressive impairment causes an up to 5-fold increased mobility as well as the loss of 
immobile fraction in the observed time range. 
2.4.4 Quantitative analysis of wt mCherry-HOXC13 nuclear dynamics 
A comparison between HOXC13 and other nuclear proteins, as far as nuclear dynamics 
is concerned, requires the definition of quantitative parameters describing the kinetics of 
chromatin binding by the protein. This approach was indeed often used to describe the 
nuclear dynamics of chromatin-binding proteins investigated by FRAP [182, 185, 186, 
188, 214, 217]. To this purpose, we applied a simplified diffusion-reaction 
mathematical model to FRAP curves obtained from experiments in cells expressing 
mCherry-HOXC13. Although a detailed description of the model will be presented in 
Appendix A of this thesis, it is useful to define here the parameters that we can derive 
from the model, quantitatively defining HOXC13 chromatin-binding kinetics. 
 Briefly, the model describes the redistribution of unbleached protein within the 
bleached area, assuming that it is governed both by free diffusion and by 
immobilization due to chromatin binding, as shown for other proteins [186, 214, 217]. 
Fitting our FRAP curves to a function combining diffusion and interaction kinetics 
allowed to estimate three parameters, namely: 
• D, the diffusion coefficient of free protein. Actually, the estimate for D was too 
slow to be explained by free diffusion; therefore it is further referred to as 
effective D, or Deff. This is to underline that it probably reflects the process of 
effective diffusion, whereby fast and unspecific binding interactions combine 
with free diffusion to mimic a quite slowed diffusion [186, 214, 222]. 
• K=kon*/koff, the equilibrium constant of binding of chromatin-bound protein. For 
a direct comparison with published data [214], this parameter was further 
converted into Ffree (% free protein), using the following equation: 
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;   (Eq.2.1) 
where [F] and [C] represent the concentration of free and bound proteins, 
respectively.  
• koff, the dissociation rate of the protein interaction with chromatin. Again, in 
accordance with published data [188], this parameter was inverted to obtain the 
mean residence time of the protein in the chromatin-bound state, tmean=1/koff. 
We used two different approaches to apply this model, as reported in Figure 2.17. In the 
first case (see panel A), the fluorescence recovered in the whole bleached area was 
fitted, assuming that it was covering exactly half of the nucleus (dimensionally 
approximated by a parallelepiped defined by its nuclear length, l). Under these 
conditions, we obtained Deff = 5.03 ± 2.08 µm2/s, a value consistent with other D values 
calculated by FRAP for transcription factors with similar molecular weight [214, 217]. 
The obtained average Ffree reveals that HOXC13 is in equilibrium between the 
chromatin-bound (!60%) and the freely diffusing/transiently interacting forms (!40%), 
similarly to most of nuclear factors investigated by FRAP [188]. A relatively low value 
for Koff (0.009±0.003 s-1) was found that corresponds to a mean residence time on 
chromatin of 110±40 s. 
 For a protein with dynamics similar to the one found for HOXC13, characterized by 
both a high percentage of free protein and a slow dissociation from chromatin when 
compared to diffusion, Beaudoin et al. observed that the results of the half-nucleus fit, 
in a 2D approximation, are not optimal [214]. In particular, they propose to apply the 
model to fit only the average fluorescence of the 2nd and 5th slices of a series of 6 in 
which the nucleus is virtually dissected, in order to estimate the three binding 
parameters with better precision. Accordingly, we obtained the average recovery curve 
in the 5th slice (and loss in the 2nd slice) of the previously described analyzed nuclei, and 
applied our simplified model to calculate the results in this case as well. As shown in 
Figure 2.17B, we did not gain any improvement from this analysis: the three estimated 
binding parameters are in agreement with those obtained from the half-nucleus fit, but 
their spread is larger, in particular for the case of Deff and Ffree. 
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Figure 2.17 Quantitative analysis of wt mCherry-HOXC13 nuclear dynamics. FRAP curves obtained 
from cells expressing mCherry-HOXC13 were analyzed using a reaction-diffusion model, in which the 
nucleus is approximated to a parallelepiped with a defined nuclear length (left image). The average 
fluorescence in the whole bleached area (A) or in the 2nd and 5th of 6 slices dissecting the nucleus length 
(B) were fitted using the model. The two fits (red curve), superimposed to raw data (blue dots) of a 
representative cell, are reported in the two graphs. The fit results of all analyzed cells, for both cases, are 
reported on the Tables on the right. Scale bar: 5 µm. 
 Notably, both approaches revealed a clear dependence of the fit quality on the 
similarity between the real nuclear geometry of each analyzed cell and the 
approximated model geometry. Results reported here were obtained from a selection of 
the experiments which best fitted the model geometry (a total of 16 out of 40 analyzed 
cells). Selection criteria are reported in Appendix A of this thesis, together with the 
summary of the results on all cells which, in any case, does not change the conclusions 
obtained here, in particular concerning the HOXC13 residence time onto chromatin of 
the order of minutes.  
2.4.5 Concluding remarks about HOXC13 nuclear dynamics 
Although detailed considerations about this FRAP study will be presented in the 
Discussion section, some comments need to be done here to understand results reported 
in the following. Based on our FRAP data, a new scenario emerges for the role of 
HOXC13 that veers significantly from the commonly accepted dynamic vision of 
nuclear architecture and compartmentalization [187, 189], which has been presented in 
paragraph 1.3.1. In fact, we found that a large amount of HOXC13 is actually bound to 
chromatin very stably, with a mean residence time of the order of minutes. This means 
that, while the nucleoplasmic diffusion of the protein cannot be neglected, once the 
protein binds chromatin, it forms stable complexes and dissociates very slowly.  
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 These considerations make HOXC13 different from most nuclear proteins, 
especially transcription factors [182, 188]. In the context of a possible role for HOXC13 
in DNA replication regulation, it was interesting to find out that its nuclear dynamics is 
very different also from those reported for RC proteins. Indeed, ORC1, ORC4, and Cdt1 
proteins were found to be very dynamically exchanging with chromatin, when 
investigated by FRAP [203, 221]. It is possible that this derives from the low sequence-
specificity reported to characterize the DNA binding of these proteins [13, 17, 87]. 
Therefore, proteins like HOXC13, rather stably bound to chromatin, could be useful in 
the recruitment and stabilization of RC proteins at replication origin DNA. This would 
require a direct interaction between HOXC13 and proteins regulating replication origin 
activation. Accordingly, we explored the possible interactions of this homeotic protein 
with other proteins of the RC in living cells, which led to the results reported in the 
following paragraphs 2.5-2.6. 
2.5 Cell-cycle related changes of sub-cellular localization of 
RC proteins in living cells 
After we characterized the behaviour of fluorolabelled HOXC13 at early replicating 
chromatin in living cells, we applied a similar approach to study other selected RC 
proteins in comparison with HOXC13. Accordingly, RC proteins were tagged with FPs, 
similarly to what previously showed for HOXC13 (Figure 2.4). We created fusion 
constructs of four different RC proteins, namely ORC2, Cdc6, MCM3, and ORC1 with 
a green FP variant (Figure 2.18A) and checked by Western Blot their proper expression 
in living U2OS cells after immunoprecipitation with !-GFP antibody (Figure 2.18B). 
We found that ORC2 and MCM3 fusion constructs are expressed entirely; conversely, 
CDC6 and ORC1 fusion constructs display some degradation. The latter finding is 
consistent with the regulative degradation which the two respective endogenous 
proteins undergo throughout cell-cycle progression [22, 23, 49, 64, 223, 224]. However, 
in the case of ORC1-E0GFP construct, the abundant bands at lower MW than the full-
length construct could derive both from degradation of the construct and impurity of the 
immunoprecipitated sample. 
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Figure 2.18 Fluorolabelled RC proteins: design of fusion constructs and expression in human cells. 
A) Shematic picture of the prepared fluorolabelled RC proteins. The FP sequence was either fused at the 
N- (Cdc6, ORC2, MCM3) or at the C-terminus (ORC1) of the proteins. The linker peptide designed for 
the fusion is indicated by its aminoacidic sequence. B) Cell lysates from U2OS cells in turn transfected 
with the four constructs were immunoprecipitated using rabbit polyclonal !-GFP antibody. Protein was 
immunodetected using mouse monoclonal !-GFP antibody. The asterisks indicate the bands of full-length 
Cdc6 and ORC1 fusion constructs.  
 Thereafter we analyzed, by means of live imaging techniques, the dynamic changes 
of intracellular distribution of these proteins along the cell cycle, focusing in particular 
at the G1/S transition. This is indeed a fundamental step at which the cycle of origin 
activation/deactivation is regulated [23, 49, 53, 221, 225, 226], as reviewed in detail in 
paragraph 1.1.3.  
 Results obtained for each RC protein are reported separately in the four following 
paragraphs 2.5.1-2.5.4. The final paragraph 2.5.5 deals with a comparison between 
results presented here and those concerning HOXC13 localization presented in the 
previous paragraphs. 
2.5.1 ORC2 
E0GFP-ORC2 was expressed in HeLa and U2OS cells; in the latter cell line, it was 
expressed transiently as well as stably. In all these cases, the protein displayed a 
predominantly nuclear localization; interestingly, it exhibited various subnuclear 
configurations in asynchronous cells, spanning from highly concentrated at few 
aggregated structures to homogeneously diffused nuclear ORC2. Many intermediate 
distributions between these two were also represented (Figure 2.19). 
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Figure 2.19 Subnuclear distributions of E0GFP-ORC2 in human living cells. Representative images 
of the typical E0GFP-ORC2 nuclear localizations in asynchronous U2OS cells. Scale bar: 5 µm. 
 Immunofluorescence analysis revealed that the focal, aggregated ORC2 organization 
relies on the association with heterochromatin (Figure 2.20), as revealed by a marked 
co-localization with HP1! (panel A) and another heterochromatin marker like PML 
[227] (panel B). Notably, both these immunofluorescence analyses required the use of 
detergent in the experimental procedures (see paragraph 4.4). This resulted in the 
almost complete removal of diffused nuclear mCherry-ORC2 (red panels of Figure 
2.20). Thus, the diffused ORC2 likely corresponds to nucleoplasmic protein. 
 
Figure 2.20 Heterochromatic nature of E0GFP-ORC2 nuclear aggregation. The E0GFP-ORC2 focal 
structure displayed in G1 phase (Figure 2.21), relies on the association with heterochromatin. A) GFP-
HP1! and mCherry-ORC2 co-localize in the same foci (see the Merge image) in U2OS cells subjected to 
0.5% TritonX-100 pre-extraction prior to fixation. B) E0GFP-ORC2 foci partially co-localize with 
endogenous PML bodies (detected with a specific primary antibody in the presence of 0.1% Tween-20, 
further stained with an Alexa647-conjugated secondary antibody). Scale bar: 10 µm. 
 BrdUrd immunofluorescence experiments revealed that cells in S phase display only 
homogeneously diffused nuclear E0GFP-ORC2, whereas the ORC2 focal distribution is 
displayed only by non-S cells (Figure 2.21A). Time-lapse imaging analysis of U2OS 
cells, transiently or stably expressing E0GFP-ORC2, showed that the diffused 
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distribution is actually a temporal consecution of the aggregated one: within 13 hours, 
few big foci are disassembled into smaller ones, which then dissolve until a final 
homogeneous nucleoplasmic distribution is reached (Figure 2.21B).  
 
Figure 2.21 Dynamics of E0GFP-ORC2 localization at the G1/S transition. A) Pulsed BrdUrd 
immunofluorescence shows that cells having a diffused nuclear E0GFP-ORC2 localization are positively 
stained with BrdUrd, while cells displaying a nuclear focal structure for E0GFP-ORC2 do not incorporate 
BrdUrd (white arrow). B) Time-lapse imaging reveals that the big E0GFP-ORC2 nuclear foci are first 
disassembled into smaller ones, until a final nuclear diffused localization is reached within 13 hours 
(typical time observed with cells stably expressing the construct). Scale bar: 10 µm. 
 Taken together, these data depict the following spatio-temporal nuclear organization 
for ORC2 protein: in G1 phase, fluorolabelled ORC2 is tightly associated with 
heterochromatin, via a possibly direct interaction with HP1! protein occurring in 
defined nuclear foci. This interaction gradually fades, as the homogenization of ORC2 
nuclear distribution is necessary for the cells to undergo S phase. These observations are 
definitely in agreement with data reported for the localization of endogenous ORC2 
protein [53, 228, 229], thus providing evidence that the recombinant construct is 
functional and well-tolerated when expressed in human cells. The recent finding that 
human cells, when ORC2 is ectopically expressed, down-regulate the expression levels 
of endogenous ORC2 by a compensation mechanism [230], further support our results 




E0GFP-Cdc6 was expressed in U2OS cells. Similarly to ORC2, when investigated in 
asynchronous cells, also Cdc6 displayed various localizations, in this case spanning 
from nuclear to cytoplasmic, with various intermeditate distributions (Figure 2.22). 
Notably, all these subcellular localizations shared an intense staining of nucleoli, which 
likely results from a regulatory mechanism to avoid accumulation of the overexpressed 
protein at replicating chromatin [231]. 
 
Figure 2.22 Subcellular distributions of E0GFP-Cdc6 in human living cells. Representative images of 
the typical E0GFP-Cdc6 nuclear localizations in asynchronous U2OS cells. Scale bar: 5 µm. 
BrdUrd immunofluorescence experiments revealed that cells in S phase display only the 
cytoplasmic E0-Cdc6 localization (Figure 2.23A); instead, E0-Cdc6 is nuclear in non-S 
phase cells. Time-lapse imaging of U2OS cells expressing E0-Cdc6 showed that the 
nuclear and cytoplasmic localizations are temporally related: nuclear E0-Cdc6 is indeed 
gradually excluded to cytoplasm, typically within 15-20h observation, depending on the 
expression level of the construct (Figure 2.23B). 
 
Figure 2.23 Dynamics of E0GFP-Cdc6 localization at the G1/S transition. A) Pulsed BrdUrd 
immunofluorescence shows that cells having a diffused cytoplasmic E0GFP-Cdc6 localization are 
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positively stained with BrdUrd, while cells displaying nuclear E0GFP-Cdc6 do not incorporate BrdUrd 
(white arrow). B) Time-lapse imaging reveals that nuclear E0GFP-Cdc6 is gradually exported to 
cytoplasm, typically within 15 hours (mean time of several experiments performed with cells with low-
expression profile of the construct). Scale bar: 10 µm. 
The combination of BrdUrd immunofluorescence and time-lapse imaging data allow to 
define the following spatio-temporal dynamic distribution for Cdc6 protein: in G1 
phase, fluorolabelled Cdc6 is in the nucleus to exert its function in replication origin 
activation. Once origins are ready to fire, which corresponds to the switch to S phase, 
Cdc6 is excluded from nucleus to cytoplasm. This is certainly a regulatory mechanism 
of the G1 to S transition to avoid re-replication, i.e. the occurrence of multiple rounds of 
replication per cell-cycle (see Figure 1.4 at paragraph 1.1.3). These observations agree 
with data reported for the localization of endogenous Cdc6 protein [64, 224, 231, 232]. 
Infact, endogenous Cdc6 has been reported (albeit not univocally [233]) to undergo 
concerted events of phosphorylation [223] and acetylation [225], that determine its 
export to cytoplasm before the start of S phase.  
2.5.3 ORC1 
In order to study the localization of ORC1-E0GFP construct in human cells, no BrdUrd 
experiments were needed, as the ORC1 protein is degraded before S phase entry [23, 
48, 49], so that cells positively stained with BrdUrd or PCNA are negatively stained 
with ORC1 protein [234]. Therefore, we limited the analysis of this protein to the G1 
phase of the cell-cycle. Unfortunately, when transfected in U2OS cells, ORC1-E0GFP 
construct not only displayed low expression efficiency and probable degradation (see 
Figure 2.18), but also caused relevant cell-toxicity and death. This hampered a clear 
analysis of its localization patterns. Nevertheless, two distinct nuclear localizations were 
observed for ORC1-E0GFP construct (Figure 2.24): one displayed densely spotted 
ORC1 throughout the nucleus (left panel), the other one showed less concentrated 
ORC1 on nuclear periphery and in nucleoli (two panels on the right); intermediate 
phenotypes were also observed.  
 
Figure 2.24 Subnuclear distributions of E0GFP-ORC1 in human living cells. Representative images 
of the typical E0GFP-ORC1 nuclear localizations in asynchronous U2OS cells. Scale bar: 5 µm. 
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Although we argued that these two nuclear patterns could be temporally related in the 
context of cell-cycle progression, no clear interdependence between them was found by 
time-lapse imaging of cells expressing ORC1-E0GFP (i.e. in G1): within 20-24h 
observation, no evident subnuclear re-distribution of the protein could be detected, and 
often apoptosis occurred in the observed cells (data not shown). This could be explained 
by the fact that overexpressed ORC1 is not well tolerated by the cells and displays 
altered chromatin-binding properties when compared to its endogenous counterpart, as 
already observed for this protein [235].  
2.5.4 MCM3 
E0GFP-MCM3 was expressed in U2OS cells. Differently from what observed for ORC2 
(paragraph 2.5.2) and Cdc6 (paragraph 2.5.3), when investigated in asynchronous cells, 
fluorolabelled MCM3 displayed a unique, unchanging, homogeneous nuclear staining 
(Figure 2.25).  
 
Figure 2.25 Subnuclear distribution of E0GFP-MCM3 in human living cells. E0GFP-MCM3 
localization in asynchronous U2OS cells was diffused in the nucleus, as evident from the overlay of the 
fluorescence channel with the bright field image. Scale bar: 10 µm. 
 These data agree with previous observations in S. cerevisiae that MCM proteins are 
present in excess over the effective number of replication origins: only a small fraction 
of MCM tightly associates with chromatin, from late M phase to S phase, while the 
redundant rest of them are distributed to both nucleoplasm and cytoplasm in relatively 
constant levels throughout the cell cycle [236]. The same cell-cycle dependent 
chromatin loading of MCM proteins has been reported from studies in human cells [21]. 
Actually only pre-extraction procedures were found to successfully unveil the 
chromatin-bound localization patterns of MCM proteins hidden under the 
nucleoplasmic excess of protein in human cells [56].  
 
Cell-cycle related changes of sub-cellular localization of RC proteins in living cells 75 
2.5.5 Concluding remarks about RC proteins vs. HOXC13  
The data reported in the previous paragraphs 2.1-2-3 show that HOXC13, both in the 
endogenous and recombinant form, has an exclusively nuclear localization (Figures 2.1, 
2.3, 2.4) and does not undergo significant changes of intracellular distribution 
throughout cell cycle (data not shown); this is probably a result of the protein stable 
association with chromatin demonstrated by FRAP (Figures 2.15 and 2.16). Strikingly, 
as shown in the last four paragraphs, we found that this was not the case for other RC 
proteins, at least for ORC2, Cdc6 and ORC1. We indeed found distinct distributions of 
these proteins throughout the nucleus and also cytoplasm; for ORC2 and Cdc6, these 
changes of localization were clearly related to the G1/S transition.  
 The differential localizations of these RC proteins throughout the cell-cycle imply a 
differential co-localization of them with HOXC13, which is instead always nuclear. As 
concerns ORC2, we found that its aggregated structure typical of G1 phase (see Figure 
2.21) occurs in nuclear areas excluded from HOXC13 nuclear compartments; therefore 
these two proteins preferentially co-localize at the end of G1 and beginning of S phase, 
when ORC2 protein diffuses out of the heterochromatic foci to the nuclear areas where 
HOXC13 is (Figure 2.26). 
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Figure 2.26 ORC2/HOXC13 co-localization in human living cells. Representative images of the 
mutual distributions of E0-ORC2 (green channel) and mCherry-HOXC13 (red channel) proteins in 
asynchronous U2OS cells. Direction of cell-cycle progression, based on E0-ORC2 localization (Figure 
2.21), is represented by the top arrow. Scale bar: 5 µm. 
 As for Cdc6, the co-localization of this protein with HOXC13 is restricted to G1, the 
only phase when these proteins are in the nucleus, before Cdc6 is exported to cytoplasm 
in S phase (Figure 2.27). Notably the same Figure shows that nuclear E0-Cdc6, besides 
nucleolar addensation, displayed a peculiar focal distribution resembling that observed 
for replication foci in early S phase (see Figure 2.7). These Cdc6 foci are present in the 
nucleus during G1 phase, and therefore are not replication foci. Nevertheless, similarly 
to what already shown for replication foci (see paragraph 2.3), HOXC13 displayed a 
strong co-localization with Cdc6 nuclear foci, when these were ubiquitously distributed 
in the nucleus. 
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Figure 2.27 Cdc6/HOXC13 co-localization in human living cells. Representative images of the mutual 
distributions of E0-Cdc6 (green channel) and mCherry-HOXC13 (red channel) proteins in asynchronous 
U2OS cells. Direction of cell-cycle progression, based on E0-Cdc6 localization (Figure 2.23), is 
represented by the top arrow. Scale bar: 5 µm. 
 As concerns ORC1, neither nuclear localization reported for the fluorolabelled 
protein when investigated in asynchronous U2OS cell population (see Figure 2.24) 
displayed a significant co-localization with mCherry-HOXC13 (Figure 2.28).  
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Figure 2.28 ORC1/HOXC13 co-localization in human living cells. Representative images of the 
mutual distributions of ORC1-E0 (green channel) and mCherry-HOXC13 (red channel) proteins in 
asynchronous U2OS cells. Scale bar: 5 µm. 
 Finally, with regard to MCM3 protein, as this constantly displayed homogeneous 
nuclear staining, it was always found to co-localize with HOXC13 independently from 
cell-cycle progression (Figure 2.29). 
 
Figure 2.29 MCM3/HOXC13 co-localization in human living cells. Representative images of the 
mutual distributions of E0-MCM3 (green channel) and mCherry-HOXC13 (red channel) proteins in 
asynchronous U2OS cells. Scale bar: 5 µm. 
 We wondered at this point whether the above described evidence of co-localization 
between HOXC13 and some RC proteins corresponds to an actual vicinity of the 
proteins in living cells (see Figure 1.17A). In order to sharpen the in vivo protein-
protein interaction analysis in the very crowded context of the nucleus, we utilized a 
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Fluorescence Resonance Energy Transfer (FRET) approach to detect interactions within 
the nanometre scale (#10nm), as will be presented in detail in the following paragraph. 
2.6 In vivo detection of HOXC13 interaction with RC proteins 
The possible interactions of HOXC13 with RC proteins were investigated in living cells 
by using Fluorescence Resonance Energy Transfer (FRET). This approach allows to 
detect in living cells only short-range interactions between two proteins of interest once 
they are tagged with an appropriate couple of FP variants, one acting as donor and one 
as acceptor (see paragraph 1.3.1 and Appendix B of this thesis). FRET was detected by 
monitoring the reduction of the donor fluorescence lifetime in the presence of a close 
(#10nm) acceptor, as can be achieved on a pixel-by-pixel basis by Fluorescence 
Lifetime Imaging Microscopy (FLIM) [193].  
 We performed accordingly the FLIM measurements by using E0GFP [237, 238] and 
mCherry [170] as donor and acceptor, respectively. A summary of FRET/FLIM 
microscopy is reported in Appendix B, together with the description of the photophysic 
properties of the FRET-pair chosen in our study. Here it is just worth to recall that the 
optimized E0GFP/mCherry FRET-pair shows a negligible donor/acceptor cross-talk 
when compared to other GFP-based FRET pairs; moreover, it features a rather long, 
mono-exponential donor fluorescence decay when excited at 403nm (3.01 ns in vivo).  
Therefore, this choice allowed us to minimize the spectral bleed-through issue and to 
simplify the fitting procedures in FLIM analysis. 
 In our experiments, the E0GFP donor was fused to Cdc6, ORC2, ORC1 and MCM3 
proteins (see Figure 2.18): these were in turn co-expressed in U2OS cells with HOXC13 
fused to the mCherry acceptor. FLIM measurements were performed and the results so 
obtained will be presented in the next paragraphs according to the following order: 
First. From the comparison between the mean donor lifetime of E0GFP-RC 
protein alone or expressed with mCherry-HOXC13, we present which of the 
probed RC proteins does interact with HOXC13 in living cells (paragraph 
2.6.1); 
Second. By analyzing the donor lifetime maps obtained by FLIM analysis, we 
identify the nuclear compartments were the above mentioned protein-protein 
interactions occur (paragraph 2.6.2); 
Third. Considering the cell-cycle dependent localizations of the probed proteins 
previously described (paragraphs 2.3-2.5), we define the cell-cycle intervals 
when these interactions occur (paragraph 2.6.3); 
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Fourth. We finally provide a biochemical test of the affinity between the proteins 
involved in the above mentioned in vivo interactions (paragraph 2.6.4). 
2.6.1 FLIM detection of HOXC13-RC interactions in living cells 
Figure 2.30 reports, on the left side of each panel, four sets of representative images in 
which mCherry-HOXC13 was co-expressed with E0GFP fusions of nuclear Cdc6 (A), 
ORC2 (B), MCM3 (C) and ORC1 (D).  
 To obtain lifetime values, E0GFP was excited with a pulsed 403 nm laser, 
fluorescence decay was recorded and fitted in all nuclear pixels; the result was a 
distribution curve of the frequency of nuclear pixels vs. mean donor lifetime (&m). 
Cumulative &m distribution curves were obtained based on all analyzed cells expressing 
in turn E0GFP-Cdc6, E0GFP-ORC2, E0GFP-MCM3, ORC1-E0GFP with mCherry-
HOXC13 (red curves in the graphs of Figure 2.30 A, B, C and D respectively). In the 
same graphs, the blue curve is the &m distribution of cells expressing the respective 
E0GFP-RC protein alone; the black dashed area represents the negative control, i.e. an 
estimate of unspecific FRET signal between donor and acceptor when they are not 
supposed to interact. This was obtained either tranfecting E0GFP-NLSSV40 with 
mCherry-HOXC13 or E0GFP-pre-RC proteins with untagged mCherry. 
 The graphs show that, when expressed alone, all E0GFP-RC proteins display a 
similar average lifetime in the nucleus (from 2.97 to 3.03 ns, see also the first row of 
Table 2.2 at the end of the paragraph): these values are very close to those reported for 
untagged E0GFP [237]. Conversely, when co-expressed with mCherry-HOXC13, 
E0GFP-Cdc6 and E0GFP-ORC2, but not E0GFP-MCM3 and E0GFP-ORC1, display a 
significant &m reduction when compared either to the donor alone, or to the negative 
control curves (Figure 2.30 and Table 2.2, second and third rows). Thus, we can 
conclude that Cdc6 and ORC2 do interact with HOXC13 by analysis in living cells, 
while this does not seem to be the case for MCM3 and ORC1 proteins. In detail, by 
calculation of the FRET efficiency for the former samples (explained in Appendix B), 
we finally estimated that the actual distance in vivo between ORC2 and HOXC13 is 
6.40±0.04 nm, while that between Cdc6 and HOXC13 is 6.72±0.07 nm. 
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Figure 2.30 FLIM analysis of HOXC13 interaction with RC proteins. mCherry-HOXC13 was co-
expressed with E0GFP-fusions of Cdc6 (A), ORC2 (B), MCM3 (C) and ORC1 (D) in living cells. Left 
side of each panel: representative fluorescence-intensity images of the cells used in the FLIM study. In 
the graphs of each panel: plot of the frequency of nuclear pixels vs. the mean donor lifetime (&m) 
calculated for each pixel. Blue curve: &m distribution of cells expressing the respective RC protein alone. 
Dashed-black area: negative control, coming from the average of the two negative controls indicated in 
the main text in A, B, C panels. In panel D, only ORC1-E0GFP expressed with untagged mCherry was 
considered as negative control. Red curve: &m distribution for cells co-expressing the respective RC 
protein with HOXC13. All reported curves are cumulative sum-distribution data relative to all analyzed 
cells (see Table 2.2); the pixel frequency is normalized to the peak of each distribution curve. Scale bar: 
10 µm. 
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 A particular comment needs to be done for the case of ORC1/HOXC13 interaction 
(refer to panel D in Figure 2.30). In this case, both the two ORC1 localizations, 
aggregated and perinuclear (see Figure 2.24) were tested for the interaction with 
HOXC13. FLIM analysis of an equal amount of the two phenotypes resulted in a double 
peaked lifetime distribution for the donor alone (blue curve) as well as for the donor 
with acceptor (dashed area and red curve). In all three curves, the peaks at lower 
lifetime correspond to the more aggregated ORC1 phenotype only (left image of panel 
D). It is possible that, under the same acquisition set-up, the aggregated phenotype can 
lead per se to a lower lifetime with respect to the other perinuclear/nucleolar one, which 
is actually less concentrated. This artifact could also be responsible of the 2-fold 
increased unspecific FRET signal detected for the negative control of ORC1-E0GFP, 
when compared to the other probed proteins (second row of Table 2.2). It must be 
underlined that this wide range of unspecific interaction compromises any further 
consideration on the lifetime distribution curve obtained for ORC1 in the presence of 
HOXC13. 
 
Table 2.2 Mean lifetime values obtained with FLIM analysis. Each column corresponds to the RC 
protein indicated at the top. Reported values are &m (±SEM) obtained for the respective E0GFP-RC protein 
alone (first row), the negative control (second row) or the E0GFP-RC protein expressed with mCherry-
HOXC13 (third row). The row of the negative control comes from the average of the two negative 
controls indicated in the main text for Cdc6, ORC2 and MCM3 columns. For ORC1 protein, only ORC1-
E0GFP expressed with untagged mCherry was considered as negative control. The number of cells (n) 
used for the statistical analysis is reported below each corresponding &m value. 
































2.6.2 Spatial definition of HOXC13-RC interactions in the nucleus 
A lifetime value was calculated for all nuclear pixels of the analyzed cells. In this way 
we generated donor-lifetime maps at sub-cellular level (Figure 2.31). These &m maps are 
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superimposed onto the corresponding donor-intensity image (gray-scale image on the 
left side of each lifetime map). Pseudocolours represent lifetime values: as indicated in 
the colour calibration bar, red-shifted colours correspond to lower lifetime values and 
indicate FRET occurrence. Indeed, E0GFP fused to Cdc6 and ORC2 displays a red-
shifted lifetime map in presence of HOXC13 (panel B), when compared to the maps of 
the corresponding donor alone (panel A). Conversely, the lifetime map of MCM3 co-
expressed with HOXC13 (panel B) retains a blue-shifted colour similar to that of the 
donor alone (panel A).  
 
 
Figure 2.31 Analysis of the donor lifetime maps obtained by FLIM measurements. Representative 
donor lifetime maps (right) and corresponding intensity image (left), obtained for Cdc6 (up), ORC2 
(middle), and MCM3 (bottom) in the absence (panel A) or presence (panel B) of HOXC13. There are two 
calibration bars: that in gray-scale refers to fluorescence intensity images, that in pseudocolour refers to 
lifetime maps. Insets in the lifetime maps of panel B represent the fluorescence intensity image of 
mCherry-HOXC13 (same as Figure 2.30, panel A, B, C, respectively). Scale bar: 10 µm. 
  Notably, the red areas in Cdc6 and ORC2 lifetime maps are super-imposable to the 
areas of HOXC13 localization. Thus, we can conclude that the interaction of both Cdc6 
and ORC2 with HOXC13 occurs in the same nuclear regions where the homeodomain 
binds to chromatin (Figures 2.11, 2.15 and 2.16). Therefore, the interactions of 
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HOXC13 with the RC do not occur limitedly at the one or few origins to which the 
homeotic protein was demonstrated to bind in vitro [101], but rather appear to have a 
general relevance in the context of the nucleus. 
 It must be mentioned that, particularly for the case of Cdc6, some reduction of donor 
lifetime could be detected in nucleoli (see the green/yellow colour of these subcellular 
structures in the lifetime maps of E0-Cdc6 in Figure 2.31 A and B). This does not 
significantly affect the final lifetime distribution, however, since these areas are 
relatively small, when compared to the whole nuclear areas, and excluded from 
HOXC13 characteristic nuclear compartments and therefore from the FRET efficiency 
calculation (see Figures 2.27 in this paragraph and Figure B.3 in Appendix B). 
2.6.3 Temporal definition of HOXC13-RC interactions along cell-cycle 
progression 
The localization of fluorolabelled HOXC13 and RC proteins, as well as their dynamics 
within cell-cycle progression, have been previously shown in detail (paragraphs 2.3, 2.4 
and 2.5). These observations were particularly useful to establish the specific cell-cycle 
intervals in which Cdc6 and ORC2 interactions with HOXC13 occur in vivo. 
 The interaction of HOXC13 with Cdc6 is restricted to G1, the only phase when 
these proteins co-localize in the nucleus (see Figure 2.27). Indeed, as specified at the 
beginning of paragraph 2.6.2, only cells displaying nuclear E0GFP-Cdc6, i.e. in G1 
phase, were used for the FRET-FLIM study.  
 As for the interaction with ORC2, the lifetime distribution of E0GFP-ORC2 co-
expressed with mCherry-HOXC13 (Figure 2.30B, enlarged in Figure 2.32) displays two 
distinct peaks, one close to the negative control (~2.95 ns), the other one shifted towards 
lower-lifetime values (~2.82 ns). We argue that this stems from the different behaviour 
of cells in different moments of the cell-cycle that are simultaneously present when the 
interaction is investigated in asynchronous population. This could be expected from the 
fact that many different E0GFP-ORC2 configurations were tested, ranging from highly 
aggregated to completely homogeneous nuclear ORC2, and not all of them displayed 
the same co-localization pattern with mCherry-HOXC13 (see Figure 2.26).  
 In order to verify this hypothesis, cells were synchronized at the G1/S border. 
Resulting FLIM data are shown as a green, dashed curve in Figure 2.32. Upon 
aphidicolin block, an inversion of the amplitude of the two lifetime peaks was observed, 
as a consequence of an increase of the cell population in which ORC2 interacts with 
HOXC13. Thus, the maximum of direct interaction between ORC2 and HOXC13 
proteins occurs in late G1, before the start of S.  
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 Considering that the homeotic protein is present at replication foci of early S 
(paragraph 2.3), it is not surprising that its interaction with ORC2 and Cdc6 turns out to 
be maximized at this cell-cycle stage. 
 
 
Figure 2.32 FLIM analysis of ORC2/HOXC13 interaction resolved within cell-cycle progression. 
The graph is a magnification of the graph reported in Figure 2.30B, to which a supplemental green curve 
is added. The blue, dashed-black, red curves are the same as Figure 2.30. Green, dashed curve: 
cumulative &m distribution for cells (n=43) co-expressing E0GFP-ORC2 with HOXC13 after 24h 
aphidicolin treatment. 
2.6.5 Biochemical test of HOXC13-RC proteins affinity 
Results reported in the previous three paragraphs show that HOXC13 interacts in vivo 
with both Cdc6 and ORC2 in G1, before the start of S phase. In order to verify if such 
interactions rely on a specific affinity between the analyzed proteins, we performed co-
immunoprecipitation (co-IP) assays from lysates of cells expressing the probed 
recombinant proteins. Immunoprecipitations with an anti-GFP antibody confirmed the 
affinity of mCherry-HOXC13 for E0GFP-Cdc6 and E0GFP-ORC2, but not for E0GFP-
NLSSV40 (Figure 2.33A). Experiments with an antibody against GFP-HOXC13 
demonstrated also an affinity of the fluorolabelled homeotic protein for endogenous 
ORC2 protein (Figure 2.33B). These experiments were performed in asynchronous cell 
cultures. Synchronization of transfected cells in G1 phase was also performed before the 
co-immunoprecipiation assays, but no relevant difference between the presented results 
were obtained (data not shown). Indeed, both cases revealed a clear dependence of the 
co-IP yield on the quantity of immunoprecipitated material, so that the variability 
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observed experiment-by-experiment was greater than the difference between the 
experiments performed in asynchronous and synchronized cells. 
 Overall, we were able to assess that the interactions detected in vivo as described in 
paragraph 2.6.1 correspond to a specific affinity between HOXC13 and RC 
components detected by canonical in vitro biochemical assays. 
 
Figure 2.33 In vitro HOXC13 affinity for Cdc6 and ORC2 detected by co-immunoprecipitation. A) 
First three columns on the left: co-immunoprecipitation experiments performed with lysates from 
asynchronous U2OS cells (input) transfected with the constructs indicated on the top of the lanes. The IP 
was performed with an !-GFP antibody; both E0GFP and mCherry constructs were immunodetected (top 
and bottom lanes, respectively). The fourth column refers to a cross-reactivity control experiment: in 
lysates from cells expressing only mCherry-HOXC13, no protein could be detected by !-dsRed antibody 
after immunoprecipitation with !-GFP antibody. Thus, !-GFP antibody used in the IP does not recognize 
mCherry protein. C) Immunodetection of endogenous ORC2 after co-immunoprecipitation with 
exogenous GFP-tagged HOXC13 in transiently transfected asynchronous U2OS cells (input). Each co-IP 
was repeated at least twice. 
 
3. DISCUSSION 
In this work we have explored, by means of live-cell imaging techniques, the spatial and 
temporal dynamics of the interaction of HOXC13 with the replication factories as well 
as with the proteins of the RCs. The results indicate that HOXC13 is a rather stable 
component of chromatin, confined by the homeodomain in nuclear areas where early S 
DNA replication occurs; in addition it interacts with members of the RC in coincidence 
with origin activation and the interaction appears to be of general nature in the context 
of DNA replication regulation. We therefore propose that HOXC13 participates in 
origin specification, as will be discussed in detail in the following paragraphs. 
3.1 HOXC13 is a stable chromatin component 
This work provides an unprecedented in-depth study of the nuclear localization and of 
the chromatin binding properties of a homeotic protein, namely HOXC13, in human 
cells. We have obtained unambiguous evidence that HOXC13 is a stable chromatin 
component. This statement stems from several observations. As expected for a 
transcription factor, HOXC13 displays an almost exclusively nuclear localization in 
human cells, either as endogenous protein (Figure 2.1) or as fluorolabelled recombinant 
construct (Figure 2.4). Its peculiar speckled-like nuclear distribution relies on the 
presence of the homeodomain: indeed, a deletion mutant devoid of the homeodomain 
displays homogeneous nuclear staining only after it is forced to achieve nuclear 
localization, as this property is lost upon homeodomain removal [136] (Figure 2.11). 
Interestingly, HOXC13 detection in the nucleus is resistant to detergent pre-extraction 
procedures (Figures 2.2 and 2.5), which are typically used to uncover the components of 
chromatin and/or nuclear matrix from the excess of nucleoplasmic proteins [21, 56, 206, 
239, 240]. Based on our U2OS cells biochemical fractionation experiment (Figure 2.3), 
we can assert that HOXC13 is actually a chromatin, and not a nuclear matrix, 
component. Indeed, nuclear matrix is biochemically defined as the nuclear non-
chromatin structure that is resistant to nuclease digestion followed by high-salt 
treatment [241, 242]. HOXC13, although resistant to high salt extraction (it is detected 
in chromatin extractions performed with up to 2 M salt concentration), is not resistant to 
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DNase treatment (this indeed changes the protein solubility, so that it can be extracted at 
salt concentrations #300 mM).  
 However, most of our understanding of the chromatin-binding properties of 
HOXC13 comes from the FRAP data obtained in living cells. These confirm that 
HOXC13 is actually a stable component of intact chromatin because, at least in 
interphase, over half of it is chromatin-bound, with a mean residence time of the order 
of minutes (Figures 2.15 and 2.17). The remaining protein is instead not chromatin-
bound, consistently with the detection of endogenous HOXC13 both in nucleoplasm 
and chromatin fractions of biochemically fractionated U2OS cells (Figure 2.3). Notably, 
such slow nuclear dynamics relies completely on the presence of the homeodomain 
(Figure 2.15), and in particular on its DNA binding activity (Figure 2.16).  
 By comparing HOXC13 nuclear dynamics to that of the other numerous nuclear 
proteins so far investigated by similar biophysical approaches, we can finally classify 
HOXC13 as a stably chromatin-bound protein, with properties intermediate between the 
rapidly exchanging transcription factors [188] and the almost immobile structural 
proteins like histones [190], cohesin [191], CENP at centromeres [192] or PCNA at 
replication foci [28, 199]. Crucially, HOXC13 deviates from the dynamic nuclear 
organization typical of all gene transcription regulators [180, 187, 189] (reviewed in 
paragraph 1.3.1). This suggests that its nuclear mobility properties could be exploited 
in other functions, besides transcription regulation. 
3.2 HOXC13 is present at early S replication foci due to its 
homeodomain 
Our data demonstrate that HOX13 is a stable component selectively targeted to the 
chromatin that is replicated first during S phase progression. This claim is supported by 
our study of the spatio-temporal correlation of HOXC13 with replication factories 
(paragraph 2.3), achieved by using two different, complementary approaches. By 
BrdUrd immunofluorescence of cells expressing E0GFP-HOXC13 (Figure 2.8), we 
quantify the degree of co-localization between HOXC13 and RF, demonstrating that it 
is significantly modulated from high in early S to almost null in late S. In this case, 
working in fixed cells was crucial, because it allowed to freeze cells at three distinct 
points of S phase (Figure 2.7); the fine BrdUrd focal structure could be resolved for 
each of the three moments by deconvolution microscopy and the co-localization 
analysis was thus more accurate [211, 212]. Alternatively, the live-cell imaging of 
EGFP-HOXC13 co-expressed with RFP-PCNA (Figure 2.9) confirms that the selective 
co-localization of HOXC13 with early S replication foci occurs also in an intact 
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chromatin context, and this can be monitored in real time by time-lapse imaging of a 
nucleus expressing the two constructs (Figure 2.10). Furthermore, our data show that 
the selective co-localization of HOXC13 with early-S RF relies on the peculiar 
speckled-like distribution set by its DNA-binding motif (Figure 2.11). Thus, the 
homeodomain is not only responsible of the stable binding of chromatin by the protein 
(Figures 2.15-2.17), but also of the targeting of the protein to the chromatin which is 
earliest replicated during S phase progression.  
 It is certainly not surprising to find a transcription factor at early replicating 
chromatin: indeed, early DNA replication has been reported to occur at open, 
transcriptionally-active chromatin by several groups [14, 34, 243-246]. HOXC13 must 
be located in these regions if it plays a role in transcriptional activity. Furthermore, 
early replicating foci could be those in closest proximity with replication origins, where 
the homeotic protein could be involved in origin function. This observation is consistent 
with the reported affinity of HOXC13 protein, detected both in vitro and in vivo, for the 
DNA sequence of the Lamin B2 origin, that is an early replicating origin [101]. 
Moreover, our results concerning HOXC13 are in agreement with those reported for the 
c-Myc transcription factor: this was also found to co-localize with early-S RF, to bind 
early-S replication origins and to be involved in origin activity in human cells [100].  
 In this context, it was very interesting to find out that nuclear E0GFP-Cdc6 displays 
a peculiar focal distribution resembling the one observed for RF in the three different 
moments of S phase: early (numerous and ubiquitous foci in the nucleus), mid 
(perinuclear and perinucleolar foci), late (few bigger central clusters of foci) phases 
(first three images on the left of Figure 2.22; see also the progressive disappearance of 
these foci in the course of cell-cycle progression in Figure 2.23B). These Cdc6 foci are 
present in the nucleus during G1 phase (Figure 2.23), and therefore are not RF, but still 
they display a spatio-temporal organization comparable to that of RF. These 
observations support a model (Figure 3.1) in which pre-RC proteins, among them Cdc6, 
associate with chromatin during the G1 phase probably defining the sites of RC 
assembly in a precise spatio-temporal fashion that anticipates the replication fork 
movement during S phase. Thus, pre-RC assembly sites anticipate and determine the 
patterns of RF during replication timing. A similar model was already proposed to 
explain the G1 localization patterns of early- and late- replicating chromosomal 




Figure 3.1 Model for the spatio-temporal determination of RF by pre-RC sites assembled during 
the G1 phase of the cell-cycle. Details of this model are discussed in the text. 
 In this view, it is worth to underline that, similarly to what already reported for RF 
(Figures 2.8-2.10), HOXC13 displayed a significant co-localization with Cdc6 nuclear 
foci when these were numerous and ubiquitous in the nucleus (Figure 2.27). Thus, 
under the assumptions of this model, it is likely that HOXC13 is present at early 
replicating chromatin already in G1.  
 These data, together with those previously discussed, depict a possible role for 
HOXC13 in origin function, that will be presented in the next paragraph. 
3.3 HOXC13 contributes to origin specification in human 
DNA replication 
The mechanism that governs the selection of replication origins in human (and, more 
generally, metazoan) genomes, in the course of G1 phase of the cell-cycle, is still poorly 
understood (reviewed in paragraph 1.1.5). The lack of DNA-sequence consensus 
among well-characterized replication origins [84-86], together with the little binding-
specificity displayed by ORC [13, 17, 87], suggest that the binding of ORC at 
sequences selected as origins might rather be determined by local chromatin structures 
and/or accessory targeting factors. HOXC13 represents an ideal candidate for a role in 
origin specification, because it combines an affinity for ORC and RC proteins, with 
structural chromatin-binding properties relevant in the context of DNA replication 
initiation. 
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 HOXC13 displays affinity for the RC, as demonstrated by the FLIM study of the 
interaction of this protein with Cdc6 and ORC2 detected in living cells (paragraph 2.6). 
These interactions correlate with origin function: indeed, HOXC13 interacts with Cdc6 
during G1 phase (Figures 2.27 and 2.30), and with ORC2 at the end of G1 phase, before 
the start of S (Figures 2.26, 2.30 and 2.32). Moreover, these interactions occur in the 
chromatin compartments defined by the homeodomain (Figure 2.31), i.e. in the nuclear 
areas where early replication origins are collected in G1 phase (Figure 3.1). With these 
considerations, it is tempting to suppose that HOXC13 contributes to the specification 
of early origins by recruitment and stabilization of the RC onto replication origin 
sequences. This hypothesis stems not only from the above-cited direct interactions of 
HOXC13 with the RC. Indeed, it has to be remembered that HOXC3 is a stable 
component of early replicating chromatin (see the two previous paragraphs). Both its 
nuclear localization and dynamics are almost constant throughout cell-cycle 
progression. Thus, HOXC13 does not undergo the specific chromatin loading at the 
beginning of S phase, which was reported to be crucial for MCM [21] or PCNA [28] 
proteins to exert their role during elongation. This, again, points to a role of the 
homeotic protein at the stage of replication initiation, rather than elongation. The stable 
chromatin binding of HOXC13 could be usefully exploited by the RC (via direct 
interaction with ORC2 and Cdc6), which instead undergoes a regulatory dynamic 
exchange with chromatin and often subcellular re-localization of its components during 
cell-cycle [22, 23, 49, 64, 224, 225, 231, 232]. Indeed, an accepted model for the RC 
proposes that it is a stable complex consisting of dynamic subunits [203] (reported in 
Figure 1.18). The dynamic model of the RC subunits is also supported by our 
observation that four selected RC proteins, namely Cdc6, ORC2, ORC1, MCM3, 
although supposed to be part of the same complex, displayed four different localizations 
when their fluorescent fusion constructs were expressed in U2OS cells (paragraph 
2.5).  
 Nevertheless, the hypothesis of HOXC13 as a key protein for origin specification 
suffers of the relatively low sequence-specificity displayed by the HOX family, when 
considered for its role in transcription [247] (reviewed in paragraph 1.2.3). HOXC13, 
like all homeotic proteins, has a preference for the binding of AT-rich DNA sequences 
[136]: the presence of asymmetric A/T stretches is up to date the only relatively 
conserved feature among origin sequences studied by genome-wide approaches [15]. 
Our FRAP data indicate that most of the HOXC13 stabilization onto chromatin relies on 
the anchoring of the homeodomain to DNA (Figures 2.15-2.16). Notably, not all 
mutations that did show to completely abolish the DNA-binding of the homeodomain in 
vitro [139] had the same effect in our in vivo analysis. In particular, we have indication 
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that most of the stabilization onto chromatin depends on the interaction of the Arg-5 
residue of the homeodomain with the DNA minor groove. Interestingly, N-terminal 
arginine residues of the homeobox were recently indicated as the only residues 
necessary to confer specificity in the DNA binding by HOX and other homeotic 
proteins (paragraph 1.2.3.2) [146]. Such recognition property may provide the 
relatively loose sequence specificity contribution of HOXC13 that could lead to precise 
origin specification, in combination with other partial but converging specificities. 
Indeed, minor groove anchoring by arginine residues seems to constitute the basis for a 
new, general DNA-recognition mechanism used by many families of DNA-binding 
proteins [152]. This suggests that other proteins, with DNA-binding properties similar 
to HOXC13, could play a role as structural “chromatin-marker” of early replication 
origins. In this context, it is worth mentioning that also other homeotic proteins 
(HOXA13, HOXC10, HOXD11 and HOXD13) were reported to have affinity for the 
lamin B2 origin [101, 103], suggesting that the interaction of HOXC13 with the 
replication origins might occur in the context of a multi-protein homeotic effector. This 
is indeed the rule when HOX proteins exert their function in transcription, by forming a 
multi-protein complex named “Hoxasome”, including HOX proteins, homeobox 
cofactors and possibly other transcription factors [248, 249] (Figure 1.13). In this 
perspective, we should expect that, besides HOXC13, other homeotic proteins could 
display a stable interaction with chromatin based on the conserved Arg-5 at DNA minor 
groove. Moreover, it should be stressed that among proteins taking part to the pre-RC, 
HOX proteins share some similarity with S. pombe ORC4 and with HMG1 protein; both 
proteins were shown to bind to the minor groove of AT-rich stretches of the origin 
sequence and thus contribute to origin specification [99, 250].  
 With all these considerations, we might propose a “network/combinatorial” 
approach as a possible guide for solving the puzzle of metazoan origin selection: 
according to this model, constitutively open-chromatin sequences may be bound 
preferentially by topoisomerases [92], assuring a local negatively-supercoiled status, or 
by other proteins recognizing yet to be defined features of the sequence (asymmetric AT 
stretches, bent DNA, narrow minor grooves?), and by the homeoprotein complex that, 
thanks to the interaction with the RC, facilitates the assembly of this complex onto the 
origin. In this view, the property of replication origin might emerge from a limited 
number of combinations of the structural features mentioned above, in an appropriate 
cellular context, in which certain protein categories are available. 
 Finally, it appears certainly stimulating to discover a connection between an element 
of the DNA replication regulation and an actor of development and differentiation 
[104]: actually, the HOXC13 protein may be only the first identified of possibly several 
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go-betweens of the two processes. It would be interesting to elucidate whether the 
involvement in origin specification is a specific feature of Abd-B Hox paralogs (Figure 
1.10), since, so far, all HOX proteins found to recognize origin sequences belong to this 
class [104]. If this were the case, the specific structural elements of Abd-B HOX 
proteins conferring this property, and their interaction modes with the elements of the 
replicative complexes should be determined. This would allow the description of the 
features of this HOX family in terms of protein-DNA and protein-protein interaction 
that are required for origin function, also in relation with their function in differentiation 
processes. Moreover, more detailed functional studies should be performed to 
investigate the effect of HOXC13 (and other related interacting homeoproteins) 
depletion on origin function. This would finally lead to uncover the precise moment, in 





4. MATERIALS AND METHODS 
4.1 Expression constructs 
All constructs used in this study were prepared using standard cloning procedures. 
Primers for PCR amplification were from Sigma; restriction enzymes and ligases were 
from New England Biolabs; DNA polymerases from Invitrogen and Stratagene; dNTPs 
were from Eppendorf. The complete sequence of all obtained constructs was always 
verified by nucleotide sequencing prior to use. 
4.1.1 HOXC13 protein constructs 
To generate the N-terminal fluorolabelled HOXC13, the sequence of full length 
HOXC13 (1–330) was BamHI/XbaI amplified and cloned downstream a 
HindIII/BamHI amplified mCherry, mOrange (both are kind gifts of R.Y. Tsien), EGFP 
or E0GFP [238] sequence in a pcDNA3.1(+) vector (Invitrogen), thus obtainining the 
mCherry-HOXC13, mOrange-HOXC13, EGFP-HOXC13, and E0GFP-HOXC13 fusion 
constructs, respectively. For the preparation of C-terminal fluorolabelled HOXC13, a 
HindIII/BamHI amplified HOXC13 was cloned upstream BamHI/XbaI amplifications 
of the same fluorophores above mentioned in a pcDNA3.1(+) vector. In this case, a 20-
aminoacids linker (RGSASGGGGGLVPRGSASGA) was interposed between protein 
and fluorophore, to avoid hampering of the homeodomain by the FP structure.  
 HOXC13 N-terminal portion (1–257), devoid of the homeodomain, was subcloned 
into the BamHI/EcoRI sites of a pcDNA3.1(+) vector in which a KpnI/BamHI NLSSV40-
mCherry fusion was previously inserted, to get the mCherry-Deletion mutant.  
 The mCherry-HOXC13 construct was mutated (Stratagene Site-directed 
Mutagenesis Kit) in three residues of the third homeobox helix (I47A, Q50A, N51A, 
where numbers correspond to the homeodomain numeration) to generate the “HBX-
helix mutant”. Site-directed mutagenesis was also performed to convert Arg5 of the 
homeodomain N-terminal loop into alanine to generate the “HBX-loop mutant”. Both 
mutations of the third helix and of the N-terminal loop were inserted in the “HBX-
combined mutant”.  
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4.1.2 Control constructs 
NLSSV40-mCherry sequence was cloned in the Kpn/BamHI sites of a pcDNA3.1(+) 
vector and used as control in FRAP experiments. EGFP-NLSSV40 similarly cloned in 
pcDNA3.1(+) vector (a kind gift of Dr. Michela Serresi) was subjected to EGFP-point 
mutation to generate E0GFP fluorophore and used as control in FRET experiments. 
mCherry was also cloned alone in the HindIII/BamHI sites of a pcDNA3.1/Hygro 
vector (Invitrogen) and used as control in FRET experiments.  
4.1.3 RC proteins constructs  
RFP-PCNA [199] was a kind gift of M.C. Cardoso and H. Leonhardt. All Cdc6, ORC2, 
ORC1 and MCM3 sequences were cloned into pEGFP-C1 or pEGFP-N1 vectors 
(Clontech). The cDNA of ORC2 and Cdc6 proteins (KpnI/SmaI and KpnI/BamHI 
amplified, respectively) were cloned into pEGFP-C1 vector. EGFP-MCM3 and ORC1-
EGFP constructs were a kind gift of Dr. Roberta Paolinelli and Dr. Ramiro Mendoza-
Maldonado. All these four EGFP constructs were subjected to EGFP-point mutation to 
generate E0GFP fluorophore. 
4.1.4 Other nuclear proteins constructs 
GFP-HP1! was a kind gift of Dr. Roberta Paolinelli and Dr. Ramiro Mendoza-
Maldonado. 
4.2 Cell culture, transient and stable transfection, 
synchronization  
U2OS, MCF7, HeLa cells (ATCC: HTB96, HTB22, CCL2, respectively) were grown in 
DMEM, supplemented with 2 mM glutamine, 1 mM sodium pyruvate, 10 U/L 
penicillin, 10 $g/L streptomycin and 10% fetal bovine serum (Gibco). NIH3T3 cells 
(ATCC: CRL1658) were grown in the same conditions, but using 10% calf serum 
(ATCC). Sub-confluent U2OS, MCF7, HeLa cells were transfected using Effectene 
reagent (Qiagen), while confluent NIH3T3 cells with Lipofectamine 2000 (Invitrogen), 
following the manufacturer’s protocol.  24-48h after transfection cells plated onto 35-
mm glass-bottom dishes (WillCo-dish GWSt-3522) were usually imaged at 37°C, 5% 
CO2, otherwise they were processed for fixed-cell microscopy or for biochemical 
analysis. U2OS cell lines stably expressing the desired recombinant fluorescent 
construct were generated by selecting transfected cells with 700 µg/ml Neomycin 
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(Gibco); typically, after one week selection, they were pooled, expanded and usually 
kept in culture for 2-3 weeks in the constant presence of antibiotic.  
 For synchronization, U2OS cells were synchronized at the G1/S border by 24 hours 
incubation with 5 µg/ml aphidicolin (Sigma). HeLa cells were synchronized at the G1/S 
border by subjecting cells to a double 16 h block with 2.5 mM thymidine (Sigma), 
spaced out by 9 h release in fresh DMEM. To evaluate the synchronization, an aliquot 
(" 5·104) of treated cells was washed twice in ice-cold PBS, fixed in frozen absolute 
ethanol, and further stained with Propidium Iodide (Sigma), in PBS buffer 
supplemented with RNase (Sigma) and 0.1% Nonidet-P40, before FACS analysis of the 
DNA content. 
4.3 Antibodies  
The following primary antibodies were used for either immunofluorescence (IF) or 
Western Blot (WB) experiments: rabbit polyclonal !%HOXC13 (IF: 1:50 for detection 
of endogenous protein, 1:100 for detection of recombinant protein; WB: 1:500); mouse 
monoclonal !%tubulin, clone B-512 Sigma (WB: 1:5000); mouse monoclonal !%actin, 
clone AC-40 Sigma (WB: 1:2000); goat polyclonal !%ORC2, clone B-18 Santa Cruz 
Biotechnology (WB: 1:200); mouse monoclonal and rabbit polyclonal !%GFP, ab1218 
and ab290 Abcam (WB: 1:1000); mouse monoclonal !%dsRed, 6323392 Clontech 
(WB: 1:300/500); rabbit polyclonal !%dsRed, 632496 Clontech (IF: 1:100); mouse 
monoclonal !%HP1", MAB3448 Chemicon (WB: 1:1000); mouse monoclonal !%PG-
M3 antibody, sc-966 Santa Cruz Biotechnolgy (IF: 1:100); mouse monoclonal !%
BrdUrd antibody, sc-32323 Santa Cruz Biotechnology (IF: 1:100). Secondary 
antibodies, for WB (1:2500) and IF (1:100) applications, were from Biorad and Jackson 
Immunoresearch, respectively.  
4.4 Immunofluorescence 
Cells were plated at sub-confluence on coverslips and, if needed, transfected with the 
desired construct; 48-72 h later, they were rinsed with ice-cold PBS, fixed with 4% 
paraformaldehyde for 10 minutes, permeabilized in 0.25% Triton X-100 in 0.5-1% 
BSA/PBS for 10 minutes. When detergent pre-extraction was required to detect only 
chromatin-bound proteins, cells were incubated with 0.5% Triton X-100 in PBS (plus 
protease inhibitors) on ice prior to fixation. In this case no further permeabilization was 
needed. Cells were blocked in 1-2% BSA/PBS before incubation with the primary 
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antibody diluted in 0.5-1% BSA/PBS. 1-3 h incubations at room temperature were 
typically used. Coverslips were washed 3 times with PBS before incubation with the 
secondary antibody, diluted in 0.5% BSA/PBS, for 1h at room temperature. 
 Secondary antibodies were usually conjugated to Alexa647. Slides were washed 3 
times with PBS and once with H2O and finally mounted with Vectashield/DAPI 
mounting medium (Vector Labs). For BrdUrd immunofluorescence, cells were pulse-
labelled with 100mM BrdUrd (Sigma) in DMEM for 15 minutes, washed with PBS, 
fixed and permeabilized as above described. The anti-BrdUrd antibody was 1:100 
diluted in 33 mM Tris-HCl pH 8, 3 mM MgCl2, 0.5 mM "-mercaptoethanol, 0.5% BSA, 
40 U/ml DNase (Roche, 10 U/$l), similarly to what already reported [197]. For PML 
protein immunofluorescence, permeabilized cells were incubated with !%PGM3 
antibody 1:100 diluted in 0.5% BSA/PBS supplemented with 0.1%Tween-20, as 
already reported [251]. 
4.5 Biochemical cell extraction, fractionation and co-
immunoprecipitation 
Cell extracts were required to check endogenous HOXC13 and its fluorolabelled 
constructs for correct expression and possible degradation. In this case, total cell 
extracts were usually obtained scraping 3-5%106 cells in RIPA buffer (Sigma), 
supplemented with protease inhibitors tablets (Roche).  
 Cell fractionation was required to analyze the subcellular localization and chromatin 
affinity of endogenous HOXC13. To this purpose, typically 3-5%107 cells were used for 
each fractionation: these were harvested by trypsinization, counted and washed twice 
with ice-cold PBS. 5%106 cells were lysed in RIPA buffer and further referred to as 
whole cell extract. The remaining cells were sequentially fractionated. First cytoplasm 
was extracted, similarly to what already reported [21, 207], resuspending cells (at 
4%107cells/ml) in ice-cold 15 mM Tris-HCl pH 7.5, 10 mM KCl, 10 mM NaCl, 5 mM 
MgCl2, 1 mM CaCl2, 300 mM sucrose, 10% glycerol and 0.1% Triton-X100 for 7’. 
Low-speed centrifugation (1300g, 5’) allowed separating cytoplasm (supernatant) from 
intact nuclei. These were washed three times before performing the nucleoplasm 
extraction (at 1.2%108cells/ml) in ice cold 25 mM Tris-HCl pH 8, 20 mM NaCl, 5 mM 
MgCl2, 1 mM EDTA, 10% glycerol and 0.5% NP-40 for 20’. Low-speed centrifugation 
(1500g, 5’) allowed separating nucleoplasm (supernatant) from chromatin. Chromatin 
was washed once and then salt-extracted in ice-cold 25 mM Tris-HCl pH 8, 0.5 mM 
MgCl2, 300 mM sucrose, 10% glycerol and sequentially increasing NaCl concentrations 
(150, 300, 600 mM, and 2M NaCl). The 150 mM extraction step was either performed 
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without or with 200U DNase I (Roche) and 6 mM MgCl2 (in this case, extraction was 
performed at 22°C). Each extraction step lasted 30’ under rotation and was followed by 
centrifugation at 14000g for 5-15’ before subsequent pellet extraction with increasing 
NaCl. All obtained fractions were clarified (at 16000g for 30’). The described buffers 
were supplemented with protease inhibitors (leupeptin, aprotinin, PMSF), phosphatase 
inhibitors (NaF, Sodium orthovanadate), 1 mM DTT and 1 mM ATP prior to use. All 
centrifugation steps were performed, if not differently indicated, at 4°C. 
 The co-immunoprecipitation assays were performed using transfected U2OS cell 
nuclei, extracted using a sequential combination of DNase I + 600 mM NaCl 
extractions. 250 µg of nuclear extract (1:10 diluted in PBS) were incubated for 2 h at 
4°C with Dynabeads-protein A (Invitrogen), previously functionalized either with rabbit 
!%GFP, or with control rabbit IgG. Beads were washed twice with a phosphate buffer 
supplemented with 300 mM NaCl before investigation of the immunoprecipitated 
proteins by Western Blot. 
 Lysate protein concentration was always estimated by Bradford assay (Pierce) and 
usually ~10-30 µg were analyzed by SDS-PAGE and transferred onto nitrocellulose 
filters, before subsequent protein detection by Western Blot. 
4.6 Co-localization analysis 
4.6.1 Image acquisition  
All co-localization analyses were performed between sequentially acquired, separated 
fluorescence channels. Laser line excitation and acquisition ranges were optimized to 
the following values: 
• DAPI/Alexa647 co-localization:  
   blue channel (DAPI): 403nm laser line excitation with [405-480nm]  
   acquisition range;  
   far-red channel (Alexa 647): 633nm laser line excitation with [650-750nm] 
   acquisition range;  
• EGFP(or E0GFP)/mCherry co-localization:  
   green channel (EGFP/E0GFP): 488nm laser line excitation with [495-530nm] 
   acquisition range; 
   red channel (mCherry): 543 or 561nm laser line excitation with [585-650nm] 
   acquisition range; 
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• EGFP(or E0GFP)/Alexa647 co-localization:  
   green channel (EGFP/E0GFP): 476nm laser line excitation with [485-550nm] 
   acquisition range; 
   far-red channel (Alexa 647): 633nm laser line excitation with [650-750nm] 
   acquisition range. 
For the co-localization of E0GFP-HOXC13 with pulsed BrdUrd foci labeled with 
Alexa647, of DAPI with endogenous HOXC13 labeled with Alexa647, images were 
acquired with a Leica TCS SP2 inverted confocal microscope (Leica Microsystems) 
using a 40X (NA 1.25) oil immersion objective and pinhole set to 1 AU. DAPI was 
detected at the Leica microscope by a 403 nm pulsed diode laser (M8903-01; 
Hamamatsu), tuned at 50 MHz repetition rate. To evaluate the co-localization in the 
whole nuclear volume, an optimized number of z-sections of cell nuclei were acquired 
in the separated fluorescence channels. For the co-localization of EGFP-HOXC13 with 
RFP-PCNA, images were acquired with an Olympus FluoView 1000-ASW-2.0 
confocal microscope (Olympus), using a 60X (NA 1.35) oil immersion objective and 
pinhole set to 1 AU. In both cases, typically, frame size was 512'512 pixels and frame 
physical length ranged from 25 to 50 µm, depending on the nucleus size.  
4.6.2 Image data analysis 
Usually, co-localization was estimated by the Merge image of the two fluorescence 
channels. In the case of the co-localization of HOXC13 with BrdUrd (paragraph 
2.3.1), a quantitative co-localization analysis was performed. The z-sections of cell 
nuclei were first deconvolved using the Huygens Essential Deconvolution Software, as 
previously described [212]. Deconvolved 3D Z-stacks were finally analyzed with the 
“colocalization analyzer tool” of this software to get the Pearson’s coefficient (P). Mean 
P values (±SD) were obtained out of all analyzed cells and used to compare the co-
localization obtained from cells at different moments of S phase (see Figure 2.7). 
Statistical significance was determined by Mann-Whitney test, with ! < 0.01 considered 
as significant. Under these conditions, P values obtained for early-, mid- and late-S 
U2OS cells were found to be statistically different one from each other (see Figure 2.8). 
For the same experiment performed with HeLa cells, the cell sampling is not sufficient 
to determine statistical significance. The analysis of HeLa cells is only intended to 
prove that the modulation of co-localization between fluorolabelled HOXC13 and RF 
does not specifically occur in U2OS cells only. 
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4.7 FRAP 
4.7.1 Image acquisition 
FRAP experiments were performed with an Olympus FluoView 1000-ASW-2.0 
confocal laser scanning microscope, equipped with an incubator chamber set to 37°C 
and 5% CO2. All images were acquired using a 60X/1.42NA oil immersion objective 
and a frame size of 256%256 pixels (0.138 µm constant pixel size). mCherry-tagged 
constructs were imaged with the 543nm laser line (acquisition range: 555-655 nm), at 
variable laser power (optimal: 10 -20 µW), constant 760 V PMT voltage and pinhole set 
to 200 µm (! 2AU). mCherry photobleaching was achieved using a single pulse with all 
543, 514, 488, 458nm laser lines set to full power for the necessary time to bleach a 
ROI covering half of the nucleus (typically: 250-600 msec, depending on the nucleus 
size). To verify the suitability of mCherry fluorophore for FRAP experiments, a GFP-
tagged version of HOXC13 was used in control FRAP measurements, together with the 
reference GFP-HP1! construct. These were imaged with the 488nm laser line 
(acquisition range: 495-595nm), at variable laser power, constant 680V PMT voltage 
and pinhole set to 200 µm. GFP photobleaching was achieved with the same procedure 
above described for mCherry, but using the 405, 458, 488nm laser lines set to full 
power for the GFP bleaching. Time series were recorded for 5 minutes at 0.129 
ms/frame sampling rate with 20 pre-bleach frames for slow proteins; for 30 seconds at 
0.065ms/frame sampling rate with 5 pre-bleach frames for fast constructs (NLSSV40-
mCherry and HOXC13 deletion mutant). Longer time series were also acquired for the 
wt mCherry-HOXC13 construct. In this case, images were acquired for 30 minutes at 
2s/frame sampling rate with 5 pre-bleach frames. These experiments were only intended 
to prove that the immobile fraction of ~10% reported for the construct within 300 s 
observation (Figure 2.15) is actually a very slow component of the recovery; therefore 
they are not reported in this thesis in the presentation of the results of the FRAP 
analysis. 
4.7.2 Image data analysis 
For each analyzed nucleus, the average fluorescence intensities of the bleached area for 
each time point were background substracted, normalized to the pre-bleach average 
value and also for total nuclear fluorescence (in order to correct for photobleaching 
during acquisition). Data were finally normalized for the bleach depth [221]. For each 
analyzed construct, the FRAP curves of 10-40 cells were averaged and the mean curve 
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(±SE) was used to compare the mobility of all analyzed constructs. To get quantitative 
information about the chromatin binding properties and the dynamics of the wt 
mCherry-HOXC13, a simplified diffusion-reaction mathematical model was applied to 
the analysis of FRAP data (see Appendix A of this thesis for detailed information). The 
fits where performed using Wolfram Mathematica 6.0.1.0, and as explained in 
Appendix A the quality of the fit was checked in selected cases, by looking if there was 
a clear minimum for the #2 (see Figure A.2 in Appendix A). 
4.8 FLIM  
4.8.1 Image acquisition  
Measurements were performed with a Leica TCS SP2 inverted confocal microscope 
(Leica Microsystems), equipped with an incubator chamber set to 37°C and 5% CO2. 
The microscope was interfaced with fast photon counting external detectors 
(Hamamatsu, H7422P-40) and time-correlated single-photon counting (TCSPC) 
electronics (Becker & Hickl). All images were acquired using a 40X (NA 1.25) oil 
immersion objective. First, reference intensity images were obtained for E0GFP 
constructs and, when co-expressed, mCherry constructs, at 512%512 frame size using 
488 and 561nm laser lines, respectively. Then the donor image was acquired at the 
frame size of 128%128 pixels using the photon counting mode: in this case, 403nm-
excitation of E0GFP was achieved using a pulsed diode laser (M8903-01; Hamamatsu) 
set at 10MHz repetition rate and 3-5 µW laser power. These conditions ensured neither 
photobleaching nor photoactivation of the donor fluorophore, as well as photon 
counting rates between 104–105 cps. Time of acquisition ranged from 80 to 200s 
(typically 120s), depending on donor expression level. 
4.8.2 Image data analysis  
The images of the donor, following pulsed 403nm excitation, were used to obtain 
lifetime values from fluorescence decays using a pixel-by-pixel fitting procedure. 
Usually fluorescence decays were optimally fitted after binning of 1-3. Only pixels 
within cell nuclei were considered: lifetimes were repeatedly fitted until all nuclear 
pixels displayed a &2#1.3. First, decays of cells expressing donor alone were fitted with 
a monoexponential decay equation, to obtain the mean lifetime value of the donor alone, 
&D. When the donor was expressed with the acceptor, it was assumed to exist either in 
the unbound or in the acceptor-bound state (see also paragraph B.2 in Appendix B); 
therefore data were fitted with the following biexponential equation: 
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     ,    (Eq. 4.1) 
where &D was known from the previous monoexponential fit and therefore was fixed. 
&DA, the shorter lifetime of the donor involved in FRET with the acceptor, was the fitting 
parameter together with a1 and a2. The resulting & was an average of &D and &DA 
components weighted for the respective subpopulations. In the main text, both & derived 
from mono- and bi-exponential fittings are referred to as &m (mean lifetime). Lifetime 
distribution histograms were obtained from all analyzed nuclei and were normalized to 
the nucleus area (i.e. pixels number). The sum of all distribution histograms of each 
analyzed cell was used to calculate the weighted mean lifetime, &m, reported in Table 2.2 
(paragraph 2.6.1). This sum histogram was also fitted with a standard Gaussian curve 
for presentation purposes (see graphs of Figure 2.30). The peak value of the Gaussian 
curves is representative of the &m reported in Table 2.2; moreover these graphs give an 
idea of the distribution of lifetime values around &m.  
 The fitting analysis was performed with SPC-Image software (Becker & Hickl). 
Data and images were further analyzed by Origin Pro 7.0 and ImageJ softwares. 
4.9 Time lapse imaging  
4.9.1 Image acquisition 
The time-lapse imaging of E0GFP-ORC2 or E0GFP-Cdc6 expressed in U2OS cells was 
performed with a Leica TCS SP2 confocal microscope, using the 488nm laser line 
excitation, a 40X/1.25NA oil immersion objective, pinhole set to 3AU and 1024%1024 
pixels frame size. Four to five z-sections encompassing all nucleus thickness were 
imaged every 30 minutes for maximum 16-20 hours. The time-lapse videos of EGFP-
HOXC13 and RFP-PCNA co-expressed in NIH3T3 cells were acquired with an 
Olympus FluoView 1000-ASW-2.0 confocal microscope, with 488 and 543nm laser 
lines sequential excitation, 60X/1.35NA oil immersion objective, pinhole set to 1AU 
and 512%512 pixels frame size. The middle section of the nucleus was manually 
searched and imaged every 30 minutes for maximum 6-8 hours (S phase). All images 
were acquired at constant 37°C and 5% CO2, at the lowest possible laser power to avoid 
both photobleaching and phototoxicity artifacts. 
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4.9.2 Time-lapse imaging presentation  
For the time-lapse imaging of E0GFP-ORC2 and E0GFP-Cdc6, the maximum Z- 
projection of each time point was used to build up the final movie. For the time-lapse 
imaging of EGFP- HOXC13 and RFP-PCNA, either the single fluorescence channels, 
or the Merge of the two channels, were used to build up the final movie. 
4.10 Image presentation 
Images were analyzed and prepared for presentation using ImageJ, Adobe Photoshop 
CS3, Adobe Illustrator CS3 and CS4 softwares. All acquired images were always 
background subtracted before analysis. All presented images were subjected to linear 
contrast enhancement after image acquisition. Magnification is reported with a white 
scale bar in the images.  
 
APPENDIX A 
Models for the FRAP analysis of chromatin-binding by 
nuclear proteins  
This appendix reviews the mathematical models that can be used for the FRAP analysis 
of nuclear proteins dynamics, in order to obtain quantitative parameters about 
chromatin-binding kinetics. The outline here reported is by no means complete and is 
only intended to provide a quick reference. More extensive and detailed information 
about these models can be found elsewhere [182, 185, 186, 188, 214, 217, 222, 252].  
A.1 Available models to analyze the nuclear dynamics of 
chromatin-binding proteins 
Three models are most commonly reported for the analysis of nuclear dynamics: 
1. the diffusion-dominant model, assuming that proteins are freely diffusing in the 
nucleus; 
2. the reaction-dominant model, assuming that diffusion is very fast compared to 
binding on the timescale of the FRAP measurement; 
3. the diffusion-reaction model, which considers contributions from both binding 
and diffusion on similar timescales. 
The first model is usually adopted for the study of nuclear proteins exchanging very 
rapidly within chromatin, as is the case of HP1 proteins at euchromatic nuclear regions 
[217]. The second one has been extensively reported in many biological studies (for 
example, of nuclear proteins), where it was assumed that diffusion could be neglected to 
simplify the analysis because the redistribution of fluorescence between bleached and 
unbleached areas is slow compared to the case of freely diffusing molecules [188, 253-
255]. Unfortunately, this assumption is not always correct, because very transient 
interactions in cases when diffusion is clearly limiting, can also lead to slow 
fluorescence redistributions [186, 214]. For this reason, most of FRAP studies more 
recently reported [182, 217, 252] make use of the third method, the diffusion-reaction 
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model, to analyze nuclear dynamics of chromatin-binding proteins. Accordingly, this 
was the method of our choice in the study of HOXC13 nuclear dynamics. 
A.2 Equations of the diffusion-reaction model  
The diffusion-reaction model assumes that proteins are immobile when bound to 
chromatin, because chromatin does not show large-scale movements over 1 h in 
mammalian cells [256-258], while free molecules can normally diffuse within the whole 
nucleus with a single diffusion coefficient D following Fick’s second law: 
   (Eq. A1)
 
where  is the local concentration of unbound fluorescent molecules.  
The interaction between protein and chromatin can be written as: 
    
! 
F + S
koff" # "  
kon
$ " "  
C, (Eq. A2) 
where F represents free molecules, S vacant binding sites, C bound [FS] complexes, and 
kon and koff are the on- and off-rates, respectively [186, 214]. 
 In order to apply the model to the analysis of half-nuclear FRAP experiments, we 
assume that the biological system has reached equilibrium before photobleaching, and 
that the number of free binding sites [S] does not fluctuate appreciably during the FRAP 
experiment; under these assumptions, applicable in many biological situations, one can 
consider a pseudo-first-order rate constant given by
! 
kon
* = kon S[ ]eq , where [S]eq is the 
concentration of the binding sites at equilibrium; we consider  [S]eq homogeneous in the 
nucleus as a further simplification. 
 Combining diffusion and interaction kinetics, changes in the local concentrations of 
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where f and c represent free and bound molecule concentrations, respectively; D is the 
diffusion coefficient for f; koff is the off-rate; kon* is the association rate at equilibrium. 
Boundary conditions require no flux of f cross the boundary; at equilibrium, c=K f, 
where .  
 We substituted in Eq. A3 k*on=Kkoff and calculated the solution of the Fourier-
transform in of the resulting system of differential equations with the initial condition 
 (
! 
˜ c  and 
! 
˜ f  are the spatial Fuorier transform of c and f, 
respectively;   
! 
! q  is the transform variable of  and the solutions depend only on   
! 
q = ! q ). 
The final result in real space ( ) clearly depends on the model geometry chosen to 
approximate the actual geometry and on the initial conditions of the experiment, as is 
explained in the following two paragraphs. 
A.2.1 Half-nuclear geometry 
At first, the resulting system of differential equations (Eq. A3) was solved for a spatial 
geometry resembling the whole half-bleached nucleus. We calculated the Fourier series 
for the 1D solution of Eq. A3, i.e. the solution for a nucleus approximated as a 
rectangular parallelepiped, with initial conditions that the border between the bleached 
and unbleached parts is a symmetry plane of the system. The fluorescence as a function 
of time and space is given by ; an example of the solution for this 
function is reported in Figure A.1. Accordingly, the FRAP recovery curves were fitted 




where D, K and koff are fitting parameters (their presence in every term of the sum on the 
right is not explicit), N is the number of non-zero terms considered in the Fourier series, 
and l is the total length of the rectangular parallelepiped best approximating the nucleus. 
h(t) is the integral of  in the bleached part, and represents the change of 
the average fluorescence in the bleached part normalized between 0 (at the starting 
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Figure A.1 Fluorescence re-distribution in a half-bleached nucleus. The different curves correspond 
to the fluorescence distribution in the nucleus, at the indicated different times (from 0 to 300s), according 
to the solution of Eq. A4 approximated with N=10 non-zero and non-trivial terms in the Fourier series for 
l=30µm, D=5.03µm2/s, K=1.56, koff=0.009s-1.  
 Since the bleach depth normalization in the experimental FRAP data forces them to 
start at zero, in order to correct for truncation or rounding errors we actually fitted the 
data with the function: 
      
! 
h(t;D,K,koff ) " h(0)
1" h(0)
,    (Eq. A5) 
where h(t=0) is usually <<1 in absolute value, does not depend on the values of D, K 
and koff, but depends on N. We verified that the results of the fit didn’t change 
significantly for N between 6 and 15; for the results presented in this work, N was 
usually 10 (actually corresponding to a Fourier series with 22 terms, including the first 
one for q=0). The fits where performed using Wolfram Mathematica 6.0.1.0, and we 
checked in selected cases that there was a clear minimum for the #2 (proportional to the 
sum of the square of the residuals from fit); this was clearly the case considering the 
plane of parameters (D, koff) and (K, koff), whereas this analysis revealed a strong 
correlation in the plane (D, K), with the consequence that a bigger uncertainty is 
expected for D and K parameters (Figure A.2). 
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Figure A.2 Maps of Log10 (# 2) obtained in the fitting procedure. The three graphs correspond to the 
variation of Log10 (#2) with respect to the planes of parameters (D, koff), (K, koff) and (K, D), respectively, 
with the third fitting parameter corresponding to the one of the best fit. The fit refers to a representative 
analyzed cell. Blue-shifted colors correspond to lower Log10 (#2) values, while yellow-shifted colors to 
high Log10 (#2) values; level lines every 0.2 change of Log10 (#2). 
 Fitting raw FRAP curves to this function allowed to obtain, for each analyzed cell, 
three parameters, namely D, K, and koff, once l was fixed cell-by-cell. Actually, in order 
to give results directly comparable to those reported in literature [188, 214], the three 
parameters are presented here and in Chapter 2 (paragraph 2.4.4) as: 
• D = Deff. This is to underline that this parameter probably represents the process 
of effective diffusion, whereby fast and unspecific binding interactions combine 
with free diffusion to mimic a slowed diffusion [186, 214, 222]. 
• K=kon*/koff, the equilibrium constant of binding of chromatin-bound protein. This 
parameter was further converted into Ffree (i.e. the percentage of free protein), 
using the following equation:     (Eq.A6) 
• koff, the dissociation rate of the protein interaction with chromatin. This 
parameter was inverted to obtain the mean residence time of the protein in the 
chromatin-bound state, tmean=1/koff, according to what reported by Phair et al. 
[188]. 
The mean value obtained for each parameter (±SD) is reported in the Results section 
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A.2.2 2nd/5th nuclear slices geometry 
For a protein with dynamics similar to the one found for HOXC13, Beaudoin et al. 
observed that the results of the fit in a 2D approximation was better when fitting only 
the average fluorescence of the 2nd and 5th slices of a series of 6 in which the nucleus 
was virtually dissected [214]; we therefore applied our simplified model to calculate the 
results also in these case; the average recovery in the 5th slice (and loss in the 2nd slice) 
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 (Eq. A7) 
where the same arguments about Eq. A4, including the application of a “normalization” 
similar to Eq. A5, apply.  
 In order to decrease the noise in the fitted data and to partially correct for possible 
asymmetries in the physical systems but not in the model, we averaged the loss in the 
2nd slice with the recovery in the 5th slice, and fitted the results with Eq. A7. 
 Again, by fitting raw FRAP curves to this function we derived the same Deff, Ffree, 
and koff parameters described in the previous paragraph. Their mean values (±SD) are 
reported for each parameter in the Results section (see Figure 2.17B), finding results not 
significantly different from the ones obtained using the model in Eq. A4. Further 
comments are reported in Chapter 2, paragraph 2.4.4. 
A.2.3 Selection criteria of FRAP experiments for the fitting with the 
diffusion-reaction model  
When we applied the fit to the FRAP curves of all analyzed cells (n= 40), expressing 
transiently wt mCherry-HOXC13 at low levels, we obtained the following results: Deff= 
5.10±3.88 µm2/s, Ffree=42.0±24.7%,  Koff=0.008± 0.003s-1. Values reported in the 
presentation of results (Figure 2.17A and B) actually refer to a selection of the 16 
experiments displaying the most similar geometry with respect to the model. The most 
stringent criterion in the choice of suitable cells was the length of the bleached area 
when compared to the whole nucleus. As the initial conditions of the model were that 
the border between the bleached and unbleached parts is a symmetry plane of the 
system, we discarded all experiments in which the bleached region was in length less 
than 44% (or more than 56%) of the whole nucleus. For analogous reasons, nuclei that 
moved significantly vs. the bleached or unbleached region during the time series were 
discarded as well. Finally, also nuclei presenting a visible non-homogeneity between 
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bleached and unbleached regions were discarded. This criterion was requested because 
we considered  [S]eq (the concentration of chromatin binding sites) homogeneous in the 
nucleus as a further simplification for the resolution of the model. 
 To conclude, we shall underline that the presented selection of suitable experiments 
was only intended to obtain more accurate estimates of the three binding parameters. 
Indeed, the fit performed on all acquired cells did not lead to significantly different 




FRET/FLIM Microscopy for the detection of protein-protein 
interactions in living cells  
This appendix reviews some basis of FRET (Fluorescence Resonance Energy Transfer) 
and FLIM (Fluorescence Lifetime Imaging Microscopy). This outline is intended to 
provide a general explanation in order to better understand the results presented in 
paragraph 2.6. More extensive and detailed information about FRET and FLIM 
microscopy can be found elsewhere [193, 259-264].  
B.1 Definition of FRET 
FRET is a distance-dependent physical process whereby energy is transferred 
nonradiatively from an excited molecular fluorophore (donor) to another fluorophore 
(acceptor) by means of dipole-dipole coupling. FRET can provide an accurate 
measurement of the intra- or inter- molecular proximity between two properly labeled 
entities, on a molecular scale (10-100 Å).  
 We consider two different chromophores, with absorption and fluorescence emission 
spectra as shown in Figure B.1. The donor (D) is the chromophore with absorption at 
higher energy, and the other one is the acceptor (A). We consider only the ground 
singlet states (Da, Aa) and first excited singlet states (Db, Ab) of each chromophore. Upon 
excitation, the donor will rapidly lose energy by internal conversion until it reaches the 
ground vibrational level of the first excited singlet, Db. If donor emission energies are 
coincident with acceptor absorption energies, the very weak coupling can permit the 
following resonance to take place: 
         (Eq. B1) 
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Figure B.1 Spectral properties of the E0GFP/mCherry FRET pair. Normalized absorption spectra 
(dashed curves) and fluorescence emission spectra (continuous curves) of the donor E0GFP (green) and 
acceptor mCherry (red) fluorescent proteins. The overlap of the green dashed area (donor emission) with 
the red dashed area (acceptor absorption) leads to FRET between the two fluorophores. 
 The energy transfer resonance shifts the relative population of excited donors and 
acceptors. The donor becomes quenched, the acceptor becomes excited, and if it is 
fluorescent it can emit, if not, the energy is dissipated as heat. A physical theory 
predicting the distance-dependence of FRET was proposed by Förster [265, 266]. 
Förster’s theory predicted that energy could be transferred by resonance dipole-dipole 
mechanism over distances between 10 and 100 Å depending on the spectroscopic 
parameters of D and A. The rate of transfer is: 
 
          (Eq. B2) 
 
where !D is the fluorescence lifetime of D measured in the absence of A; r is the 
distance between D and A; R0 is a distance parameter calculated from the spectroscopic 
parameters and mutual-dipole-orientations of D and A; when r=R0, kT=1/ !D, i.e. half the 
donor molecules decay by energy transfer and half decay by the usual radiative and 
non-radiative rates. R0 is also commonly defined as the distance at which FRET 
efficiency (E) is 50%. 
 From a kinetic point of view, E is the ratio of kT to the total sum of rates of all 
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   (Eq.B3) 
where the subscript ‘i’ refers to the different pathways of deactivation from the Db state. 
E can be measured in several ways. Generally, at steady state, the efficiency of transfer 
can be calculated according to the equation: 
 
           (Eq. B4) 
 
Thus, E depends strongly on the D-A distance, and it decays at long distances as r-6.  
 Because of its dependence on the distance FRET has become an important tool to 
verify whether labeled proteins are physically linked and to determine distances on the 
nanometer scale. Technological advances in confocal microscopy imaging, combined 
with the availability of genetically encoded fluorescent proteins, provide the tools 
necessary to obtain detection of protein interactions in living cells with spatial and 
temporal resolution. The spectroscopic properties that are carefully considered in 
selecting GFPs as workable FRET pairs include sufficient separation in absorption 
spectra to avoid cross-excitation of the two fluorophores; an overlap between the 
emission spectrum of the donor and the absoption spectrum of the acceptor to obtain 
efficient energy transfer; and reasonable separation in emission spectra between donor 
and acceptor GFPs to allow independent measurement of the fluorescence of each 
fluorophore.  
B.2 FRET detection by FLIM: the ideally suited E0GFP-
mCherry FRET pair 
Several techniques can be applied to the evaluation of FRET efficiency. Some of them 
are based either on the measurement of the donor to acceptor emission ratio or on the 
quantification of the recovery of donor fluorescence after acceptor photobleaching. One 
of the main problems of these steady-state FRET techniques is that the concentrations of 
donor and acceptor may change throughout the sample. In living cells expressing 
genetically encoded fluorophores, the concentration of fluorescent probes can not be 
easily controlled. The technique we chose to quantify FRET is based instead on the 
measurement of donor lifetime, which changes as a function of E; since within 
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fluorophore, Fluorescence Lifetime Imaging Microscopy (FLIM) has become a valuable 
tool to map protein associations on the molecular scale in living cells. 
 Consider the E0GFP-mCherry FRET pair (with spectral properties reported in Figure 
B.1). In our FLIM measurements, the use of this FRET pair offered several advantages 
[237]. E0GFP is the H231L-F64L mutant of wt GFP and belongs to the UV-excitable FP 
family. It was chosen as donor for mainly two reasons: i) it displays a large Stokes shift 
(i.e. separation from absorption and emission spectra, this is important to avoid cross-
excitation artifacts); ii) it displays a fluorescence decay curve (Figure B.2, green curve) 
which is optimally fitted by a monoexponential function, of the type:  





#D ,    (Eq. B5) 
where I is the donor fluorescence intensity, t is time, and !D is the fluorescence lifetime 
of D.  
The acceptor (mCherry) is one of the most commonly used monomeric proteins derived 
from stony-coral DsRed [167, 170, 171], and displays: i) fast maturation, ii) large 
absorption cross-section, iii) high photostability. It was already reported as a good 
FRET acceptor [267]. In the presence of a close mCherry molecule, E0GFP fluorescence 
lifetime becomes shorter when compared to its lifetime in absence of acceptor (Figure 
B.2, red and blue curves).  
 
Figure B.2 Fluorescence intensity decays for E0GFP in the presence of mCherry. Fluorescence decay 
upon pulsed excitation at 403 nm for E0GFP (green line), and two FRET constructs where E0GFP is 
directly fused to mCherry with linkers of different lengths (red and blue curves). The green donor shows a 
monoexponential decay while the two FRET constructs display faster components owing to FRET. For 
more details about this Figure, see Albertazzi et al. [237]. 
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 The total donor decay curve, resulting on a combination of interacting and non-
interacting FRET couples, can be approximated by the following double exponential 
function: 
      
! 
I(t) = a1" e
#
t
$DA + a2 " e
#
t
$D ,   (Eq. B6) 
where !DA is a fast donor lifetime component from the interacting (quenched) donor 
molecules and !D is the lifetime of the non-interacting donor, and is assumed to be equal 
to that of the donor alone. If the labeling is complete, as it is expected in cells 
expressing fusion proteins of the GFPs, the decay components a1 and a2 directly 
represent the fractions of interacting and non-interacting proteins. Thus, FLIM double 
exponential decay analysis using the E0GFP/mCherry FRET pair directly delivers the 
lifetimes of the interacting and non-interacting donor species, !DA and !D, and the 
intensity factors of the two decay components. This is not always the case when using 
other well-established FRET pairs, like the CFP/YFP one, as CFPs present per se a 
multiexponential decay that makes lifetime analyses much more complicated [268]. 
B.3 Distance calculation by FLIM 
In FLIM experiments the FRET efficiency (E) can be calculated from the lifetimes of 
the interacting and non-interacting donor species, !DA and !D, according to: 




.     (Eq. B7) 
The calculated E value can be used to estimate the mean D-A distance when the donor 
is interacting with the acceptor using Eq. B4. Accordingly, we used this approach to 
calculate the mean distance between interacting species labeled with E0GFP and 
mCherry.  
 In our experiments, we found a significant lifetime reduction of E0GFP fused to 
Cdc6 and ORC2 when these were in turn co-expressed with mCherry-HOXC13 (Figure 
2.30). For these two cases, the FRET efficiency was calculated using Eq. B7 (see Figure 
B.3 for the image analysis leading to E calculation) and further converted in a mean 
distance of interaction using Eq. B4, with R0= 5.1nm for the E0GFP/mCherry FRET pair 
[237]. We finally estimated that the actual vicinity for ORC2 and HOXC13 is 6.40±0.04 
nm, while that between Cdc6 and HOXC13 is 6.72±0.07 nm. A summary of obtained 
results is reported in Table B.1. 
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Figure B.3 Image analysis for the calculation of E for the ORC2-HOXC13 and Cdc6-HOXC13 
interaction. A) Summary of the image analysis method. The two top images represent a typical analyzed 
cell in which the donor (fused to ORC2 or Cdc6) was expressed with the acceptor (fused with HOXC13). 
The donor image was fitted with Eq. B6 in all nuclear pixels and we derived a lifetime map of the donor 
interacting with the acceptor (&DA map, left middle image). The acceptor image was converted into a mask 
of acceptor localization (right middle image) and superimposed onto the &DA map. In this way, it was 
possible to select only the &DA-map pixels in which both donor and acceptor were present. The final &DA 
distributions derived from all analyzed cells were summed and a cumulative &DA distribution was obtained 
for the study of ORC2-HOXC13 (B) and Cdc6-HOXC13 (C) interactions. The weighted mean values 
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Table B.1 E and distance calculation by FLIM. &D and &DA components (mean±SEM) derived from 
FLIM image analysis were used to calculate E using Eq. B7, and further converted into distance of 
interaction using Eq. B4, with R0= 5.1nm [237]. &D values are the same as those reported in the first row 
of Table 2.2. For the case of ORC2 protein, only a selection of cells (those displaying the closest ORC2-
HOXC13 interaction, as explained in Figure 2.32) were considered in the &DA calculations (n refers to the 
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